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1. Summary 
One of the fundamental challenges in basic neuroscience is to understand the molecular 
genetic networks associated with building the brain. As malfunction in these genetic 
pathways can lead to disorders like cancer, brain development is also a crucial research 
area for clinical neuroscience. In the course of this thesis, different molecular aspects of 
Drosophila brain development and related neoplastic disease were analyzed using high-
density oligonucleotide arrays.  
The homeotic selector gene labial (lab) plays an important role in specification of 
neuronal identity in the embryonic brain of Drosophila. In labial mutants presumptive 
neurons in the posterior tritocerebrum fail to differentiate. This leads to severe defects 
in tritocerebral axon pathways.  
Using high density oligonucleotide arrays we identified downstream target genes of 
Labial and showed that only a limited and distinct set of genes expressed in the embryo 
is regulated by this homeoprotein. Furthermore, we performed genetic rescue 
experiments to analyze the functional equivalence of Drosophila Hox gene products in 
specification of the tritocerebral neuromere. Surprisingly, all tested homeotic proteins, 
with the exception of Abd-B, were able to rescue the labial mutant phenotype in the 
tritocerebrum. These results indicate that the specificity of homeotic gene action in 
embryonic brain development has to be modulated by cis-acting regulatory elements. 
Another study circled around the homeobox transcription factor otd and its human 
homolog Otx2. Cross-phylum rescue experiments have shown that these genes are 
functionally equivalent. We used quantitative transcript imaging to analyze otd and Otx 
gene action in the Drosophila embryo at a genomic level. Our experiments suggest that 
about one third of the Otd-regulated transcripts in Drosophila can also be controlled by 
the human Otx2. These common otd/Otx2 downstream genes are likely to represent the 
molecular basis for the functional equivalence of otd and Otx2 gene action in Drosophila. 
glial cells missing (gcm) is a key control gene of gliogenesis.  gcm loss-of-function leads to 
a transformation of glial cells into neurons and, conversely, when gcm is ectopically 
misexpressed, presumptive neurons become glia.  Since gcm encodes a transcription 
factor it is supposed that a set of downstream genes are regulated by GCM that in turn 
execute the glial differentiation program. Again, a set of full-genome transcript profiling 
experiments was conducted to identify gcm downstream genes in a comprehensive 
manner. A set of several hundred candidate gcm target genes were identified in this 
screen, giving new insights into neuroglial fate specification in Drosophila. 
Brain tumors have been extensively studied by looking at genetic alterations and 
mutations that lead to malignant growth. Still, the causes of brain tumorigenesis are 
largely unknown. Model systems like Drosophila can be of great help to shed light on 
altered transcriptional activity in brain tumor phenotypes. 
To investigate the in vivo transcriptional activity associated with a brain tumor, we 
conducted genome-wide microarray expression analyses of an adult brain tumor in 
Drosophila caused by homozygous mutation in the tumor suppressor gene brain tumor 
(brat). Two independent gene expression studies using two different oligonucleotide 
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microarray platforms were used to compare the transcriptome of adult wildtype flies 
with mutants displaying the adult bratk06028 mutant brain tumor. Cross-validation and 
stringent statistical criteria identified a core transcriptional signature of bratk06028 
neoplastic tissue. We found highly significant expression level changes for 321 annotated 
genes associated with the adult neoplastic bratk06028 tissue indicating elevated and 
aberrant metabolic and cell cycle activity, upregulation of the basal transcriptional 
machinery, as well as elevated and aberrant activity of ribosome synthesis and 
translation control. One fifth of these genes show homology to known mammalian genes 
involved in cancer formation. These results identify for the first time the genome-wide 
transcriptional alterations associated with an adult brain tumor in Drosophila and 
reveal insights into the possible mechanisms of tumor formation caused by homozygous 
mutation of the translational repressor brat. 
 - 6 -
 
2. Introduction 
 
2.1. Drosophila as a model system 
Drosophila melanogaster has been an important genetic model system for nearly one hundred 
years. The wealth of genetic, molecular and transgenic tools available today, combined with a 
short lifecycle of the species and low maintenance cost makes it a superior system to answer a 
wide variety of biological questions.  
Studies conducted on the vinegar fly have elucidated many of the fundamental principles of 
eukaryotic genetics. The application of a wide range of genetic tools used in Drosophila 
research led to a large amount of well characterized genetic mutants that are available to the 
research community as stable lines from a number of stock centers. Technologies for the 
efficient production of genetic mosaics and transposon based methods of altering genes 
facilitate the identification and functional analysis of genes and their epigenetic interactions.  
Comparison of data assembled with molecular cloning and analysis of genes in Drosophila 
with functional genetic data from mammalian systems has shown that a surprisingly large 
number of Drosophila genes have homologs with similar function in mammalian systems. 
These include transcription factors and their regulatory targets, structural proteins, 
chromosomal proteins, ion channels, and signaling proteins. The evolutionary conservation 
extends to higher-level processes, like development (Riddle and Tabin, 1999), behavior, sleep 
(Hendricks et al., 2000), and responses to drugs at the physiological level (Moore et al., 
1998). 
 
2.2. The development of the Drosophila brain 
The work reported here revolves around the Drosophila brain. As it is still largely a mystery 
how such a complex organ is generated through genetic mechanisms (Fig. 1), research on 
brain development is a challenging task.  
 Fig.1. The life cycle of Drosophila. The middle panel shows the different stages throughout 
development from the embryo via the larva and pupa to the adult. The timings are shown in the circle. 
The panel at the upper right shows a schematic picture of an early embryo after patterning of the 
neuroectoderm; PNE protocerebral neuroectoderm, VNE ventral neuroectoderm . On the lower right 
there is a schematic representation of a larval CNS; pr protocerebrum, de deuterocerebrum, tr 
tritocerebrum, sb subesophageal ganglion with the labial, maxillary and mandibular neuromeres, bn 
Bolwig´s nerve, an antennal nerve, lr/hy labral/hypopharyngeal nerve, ncc nerve to corpora cardiaca  . 
The schematic on the upper left shows the adult CNS; oce ocellar nerve (modified after Hirth). 
The embryonic brain is composed of a supraesophageal ganglion lying anteriorly and a 
posterior subesophageal ganglion. The supraesophageal ganglion can be divided into the 
protocerebrum (b1), deutocerebrum (b2) and tritocerebrum (b3), and the gnathal 
subesophageal ganglion can be separated into the mandibular (s1), maxillary (s2) and labial 
(s3) neuromeres (Reichert and Boyan, 1997; Therianos et al., 1995; Younossi-Hartenstein et 
al., 1996). This layout can also be found in the adult brain with the mouth parts being 
innervated by sensory and motor nerves from the subesophageal ganglion and the 
tritocerebrum, which also innervates the stomatogastric ganglion. The deutocerebrum, being 
the major olfactory center, receives the antennal nerves and projects onto the motorneurons of 
the ventral nervous system (VNC). The protocerebrum constitutes the biggest part of the brain 
and contains the mushroom bodies (corpora pedunculata) and their major afferent tract 
(antennocerebral tract), the central complex, pars intercerebralis, optic tubercles, and optic 
lobes (Nassif et al., 1998). 
The mushroom bodies in the dorsal protocerebrum are considered to be a center for learning 
and memory and are composed of Kenyon cells whose axons form characteristic structures 
called calyx, peduncle and the α, β, and γ lobes. More medially lies the pars intercerebralis 
containing neurosecretory cells and interconnecting the basal brain regions and the VNC with 
axons that form the median bundle. The central complex, thought to be involved in flight 
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control, is an unpaired structure situated between the mushroom body calyxes. The central 
complex receives input from the ventral body at the base of the protocerebrum. These 
structures form the so-called forebrain which is bordered on both sides by the optic lobes. An 
optic lobe can be divided into lamina and medulla lying distally and the inner optic neuropil 
called lobula complex. The compound eyes project their axons into the lamina. Lamina and 
medulla project into the lobula complex, which innervated its contralateral counterpart as well 
as the lateral midbrain (Nassif et al., 1998). 
How the complex adult brain is formed starting from the embryonic brainanlage through the 
larval and pupal stages of Drosophila is becoming a subject of detailed study.  
 
Early in the embryo zygotically expressed genes interact in patterning the germ layers. The 
dorsoventral neural patterning in Drosophila relies on three signaling pathways. The dorsal 
(dl) signaling cascade is acting in formation of the ventral mesoderm and neuroectoderm, 
while dpp signaling defines the dorsal border of the neurogenic region. Epidermal growth 
factor receptor (Egfr) signaling is crucial for the ventral and intermediate neuroectoderm 
specification (Fig. 2) (Cornell and Ohlen, 2000). 
 
The transcription factor dorsal is a member of the Rel/NF kappa B family and acts in the 
onset of dorsoventral patterning (Steward, 1987). Its gene product is located in the cytoplasm 
of oocytes and is transported into the nucleus after fertilization. In the early embryo a nuclear 
concentration gradient of DL can be found along the dorsoventral axis. The DL gradient 
initiates differentiation of the mesoderm, the neuroectoderm and the dorsal ectoderm by 
concentration-dependent regulation of several zygotically active target genes. 
The mesodermal genes twist and snail are activated by high concentrations of DL on the 
ventral side, leading to a repression of neuroectoderm formation.  
Lower levels of DL gives rise to neuroectoderm and are required to activate neural gene 
expression. One of the direct target genes in the neurogenic domain seems to be short 
gastrulation (sog). The DL gradient also functions as a context-dependent repressor that 
restricts the expression of genes like decapentaplegic (dpp) to dorsal regions (Stathopoulos et 
al., 2002). 
The dpp gene product is a member of the transforming growth factor beta (TGF-beta) 
superfamily and has a role as an inhibitor of neural tissue formation. In the early embryo it is 
localised in the dorsal-most 40% of nuclei, defining the dorsal border of the presumptive 
neuroectoderm. Other essential roles are establishment of dorsal embryonic tissues including 
dorsal ectoderm. dpp loss-of-function leads to expansion of the neurogenic neuroectoderm at 
the expense of other dorsal tissues (Wharton et al., 1993). In the gain-of-function situation 
dpp can induce dorsal structures and inhibit neurogenic tissue formation (Ferguson and 
Anderson, 1992; Wharton et al., 1993).  
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 Fig. 2. Neuroectoderm formation in the early embryo. Left: Cross-section through a Drosophila embryo 
at gastrulation stages. The mesoderm invaginates into the inside of the embryo and the neuroectoderm 
forms at the ventrolateral side. The dorsal side gives rise to non-neural ectoderm and extra-embryonic 
tissue (amnioserosa). Right: In blastdoderm stages Dorsal (DL) proteins forms a nuclear gradient with 
highest concentration at the ventral body side. short gastrulation (sog) is expressed in ventrolateral cells 
comprising the neuroectoderm, and decapentaplecig (dpp) is expressed in dorsal cells comprising the 
non-neuronal ectoderm. SOG antagonizes DPP signaling in the neuroectoderm. The genes ventral 
nervous system defective (vnd), intermediate neuroblast defective (ind), and muscle segment homeobox 
(msh) pattern the neuroectoderm in three columnar domains (modified according to Cornell and Von 
Ohlen, 2000). g is expressed in two broad lateral stripes and is activated by a distinct concentration level 
thin the nuclear DL gradient coinciding with the borders of the presumptive neuroectoderm 
 the ventral side of the embryo. The sog gene product is a secreted protein and forms a 
orphogenetic gradient, thereby acting as an antagonist for DPP. Thus SOG prevents the 
uroectoderm from becoming dorsal epidermis (Ferguson, 1996). Loss of sog function leads 
 a reduction of the neuroectoderm and expansion of the dorsal epidermis. 
 
e processes that pattern the neuroectodermal tissue along the dorsoventral axis are less well 
aracterized than those that specify it. The early ventral neuroectoderm consists of three 
rsoventral columns (Fig. 2). The neural precursors within these regions can be 
aracterized by expression of different homeobox transcription factors. These are the 
oducts of the ventral nervous system defective (vnd), intermediate neuroblast defective 
d), and muscle segment homeobox (msh) genes. vnd expression can be found ventrally, ind 
expressed intermediately, whereas msh expression is defining the dorsal-most column. In 
fr mutants dorsal genes are expressed in the intermediate neuroectoderm and intermediate 
ural precursors fail to form, suggesting a role of Egfr in controlling the limits of the 
termediate column (Udolph et al., 1998; von Ohlen and Doe, 2000).  
rthermore, there exists a hierarchy of transcriptional repression where the more ventral 
lumnar genes repress the more dorsal genes. 
ss-of-function of columnar genes leads to a strong reduction of delaminating neuroblasts in 
e mutant region, suggesting an important role of the columnar genes in formation and 
ecification of neural progenitor cells (Cornell and Ohlen, 2000; von Ohlen and Doe, 2000). 
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2.2.1. The Drosophila neuroblasts 
Neurogenesis is initiated via a set of progenitor cells called neuroblasts. These cells are 
specified via the proneural genes that encode for basic helix-loop-helix (bHLH) transcription 
factors. Known proneural genes are the genes of the achaete-scute complex (asc) which 
includes acheate (ac), scute (sc), lethal of scute (l’sc) and asense (ase) (Campuzano and 
Modolell, 1992). More recent data added the gene atonal (ato) to the proneural family 
(Bertrand et al., 2002). After a cell-cell interaction process called lateral inhibition, single 
cells are selected to adopt a neuroblast fate. Lateral inhibition works with the proneural genes 
inhibiting themselves in neighboring cells to thereby effectively hinder those cells in taking 
on the neuroblast cell fate. The signaling pathway acting in this cell communication process is 
the Delta/Notch system (Skeath and Thor, 2003). 
 
In Drosophila there are about 100 individual neuroblasts in the procephalic neurogenic region 
that divide in a stereotype spatio-temporal fashion. The process in which the neuroblast leaves 
the epithelium and begins to divide along its apical-basal axis is called delamination (Fig. 3a). 
Each neuroblast is characterized by a unique cascade of genes expressed during delamination 
and production of daughter cells (Urbach and Technau, 2003). 
The neuroblasts divide asymmetrically to produce a ganglion mother cell (GMC) and a 
neuroblast which can go on to divide. The GMCs in turn divide symmetrically to produce two 
neuronal precursor cells that ultimately differentiate into neurons (Fig. 3) (Jan and Jan, 1998). 
The gene expression profiles of neuroblasts and GMCs are different. Examples for neural 
precursor genes expressed in neuroblasts and repressed in GMCs are ase and deadpan (dpn) 
(Bier et al., 1992; Brand et al., 1993). even-skipped (eve) and fushi tarazu (ftz), on the other 
hand, are expressed in GMCs, where they may help confer GMC identity (Doe et al., 1988a; 
Doe et al., 1988b).  
On the basal side of a mitotic neuroblast Miranda (mira) tethers Prospero (pros) to the cortex 
(Matsuzaki et al., 1998; Shen et al., 1998). On the apical side another group of proteins is 
responsible for orienting the mitotic spindle in a way that ensures segregation of Prospero and 
Miranda exclusively into the daughter cell – the GMC. These proteins include Bazooka (baz), 
DmPar-6, DaPKC, inscuteable (insc) and Rapsynoid (raps). Inscuteable is the only 
component of these complexes that cannot be found in the neuroepitheleal cells before 
neuroblast specification (Chia and Yang, 2002; Doe et al., 1998; Jan and Jan, 2000). 
Prospero, which is translocated into the nucleus of the new-born GMC, represses transcription 
of cell-cycle genes, effectively limiting the mitotic potential of the cell to one division. 
Numb protein is also preferentially segregated into the basal GMC and has been shown to be 
crucial for cell fate determination of sibling neurons in certain GMC divisions in the CNS 
(Buescher et al., 1998; Skeath and Doe, 1998). 
 
Although the neuroblasts of the larval brain are of embryonic origin, their properties in terms 
of division modes and transcriptional characteristics have been shown to be different. In early 
larvae, neuroblasts divide symmetrically to add to the pool of stem cells. In the later larval 
stages the mode is asymmetric again producing the usual GMC that again divides quickly to 
produce neuronal offspring. The switch in mode seems to be associated with the localization 
of Inscuteable, which is only apically localized in the case of asymmetric divisions. Another 
difference to the embryonic stages is the missing colocalisation of Prospero with Miranda in 
the cortical crescent of mitotic neuroblasts (Ceron et al., 2001).  
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Fig. 3. Specification and divison of a neuroblast. a: neuroblast delaminates from the neuroectoderm.  
b: It has produced two ganglion mother cells, which divide once giving rise to neurons or/and glia cells 
(modified according to Skeath 2003). 
 
mporal control over cell fate of GMCs is based on the sequential expression of five genes 
 neuroblasts, GMCs and neurons. These genes are hunchback (hb), Kruppel (Kr), nubbin 
ub, formerly pdm), castor (cas) and grainy head (grh). The gene expression of one gene 
ays represses the expression of that after the next in the cascade. This mechanism adds 
other layer of complexity to the abovementioned spatial coordinate system and opens up the 
ssibility for more precision in genetically defining cell fate (Fig. 4, (Isshiki et al., 2001; 
eath and Thor, 2003) reviewed in (Skeath and Thor, 2003)). 
e postmitotic neurons created by the GMC are characterised by differentiation marker gene 
pression, such as embryonic lethal, abnormal vision (elav). - 11 -
Fig. 4. The temporal gene cascade. 
Different genes are expressed at different 
times during specification of GMCs 
(modified according to Skeath 2003).
.2. Gliogenesis in Drosophila  
other important cell type of neural origin in the brain is the glia cell. Glia have been found 
 carry out various crucial functions throughout development and in the adult. These actions 
clude secretion of neurotrophic factors (Xiong and Montell, 1995) and control of 
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proliferative rates of neighboring neurons (Ebens et al., 1993). Other functions comprise 
guidance of axonal growth via interaction with the neurons (Klaes et al., 1994) and, in 
vertebrates, the electrical insulation of axons. 
In the Drosophila central nervous system (CNS) glia are derived from the mesoderm and the 
procephalic and ventral neuroectoderm. The mesodermal glia are enveloping the commissural 
axon bundles, the neuroectodermal glia are generated from neuroglial precursor cells and 
comprise a variety of functions. 
 
Control of neuronal versus glial fate in the Drosophila neuroectoderm is dependent of a 
transcription factor encoded by the glial cells missing (gcm) gene. The expression of gcm in 
the CNS appears first transiently at embryonic stage 10. It can then be found in two small 
groups of neuroectodermal cells per hemisegment. The fist glial markers can be found in a 
single gcm-expressing precursor delaminating from each of these two groups. This process 
goes on through embryogenesis leading to increasing numbers of gcm-positive progenitors. 
Transient expression of gcm seems to be a trait of all gliogenic cells emanating from the 
neuroectoderm throughout the CNS and the peripheral nervous system (PNS). At the end of 
embryogenesis, no GCM protein is detectable anymore (Hosoya et al., 1995; Jones et al., 
1995; Vincent et al., 1996). The mesodermally derived midline glia follow a different 
transcriptional program that is independent of gcm action (Granderath and Klambt, 1999).  
Fig. 5.  Two division patterns in neuroglial development.  Neuroglioblasts (NGB) have singled out 
through Notch/Delta mediated lateral inhibition.  NGBs delaminate from proneural neuroectoderm 
clusters (grey) and generate neuronal and glial cells in a mixed lineage.  Two different types of NGBs 
exist.  Left: A first type of NGBs bifurcates into a glioblast (GB) and a neuroblast (NB) during their 
first division and hence creates precursors with restricted developmental potential that give rise either to 
neurons or to glial cells (e.g. NB6-4T).  Right: In contrast, a second type of NGBs creates intermediate 
precursors that have the potential to generate neurons as well as glia via asymmetric cell division (e.g. 
NB1-1A).  Notch is used for specifying the glial part of the lineage (modified according to Udolph et 
al., 2001 and Egger 2003).   
In summary, this makes gcm a key regulator of glial specification acting as a binary switch 
between neuronal and glial fate in the neuroectoderm.   
 
In Drosophila and in mammals there exist neural stem cell lineages generating both neurons 
and glial cells. In the embryonic neuroectoderm of Drosophila about 30 neural progenitor 
cells per hemisegment delaminate in five discrete waves (Doe, 1992), among which are seven 
neuroglioblasts (NGB). These give rise to neurons and glial cells, whereas neuroblasts (NB) 
and glioblasts (GB) exclusively generate neurons or glial cells, respectively (Bossing et al., 
1996; Schmid et al., 1999; Schmidt et al., 1997). Glial cells can be produced by NGBs in two 
distinct ways. Either the NGB divides asymmetrically, producing a neuroblast and a glioblast, 
or a GMC divides into a neuron and a glia. Both ways are gcm-dependent. 
The decision to produce neurogenic or gliogenic cells can happen at various time points (Fig. 
5). It is possible that an NGB first produces a row of cells with neuronal fate and then 
switches to a glial mode (Bernardoni et al., 1999). 
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2.2.3. Patterning the brain via the otd and the homeotic genes 
On a larger scale the embryonic brain of Drosophila is patterned via an evolutionary 
conserved set of genes including the cephalic gap genes orthodenticle (otd) and empty 
spiracles (ems) and the homeotic genes labial (lab), Deformed (Dfd) and proboscipedia (pb) 
(Fig. 6). 
Loss-of-function experiments have shown that otd plays a critical role in patterning the most 
anterior part of the brain (Hirth et al., 1995). In homozygous otd mutants the protocerebral 
anlage is deleted because the specification of cells in the neuroectoderm is disrupted, leading 
to a loss of neuroblasts in this region. The role of otd brain patterning is evolutionary 
conserved. In the mouse there are two homologous genes called Otx1 and Otx2. Both genes 
are expressed in the embryonic head and brain. Early in embryonic mouse development Otx2 
is expressed in the forebrain and midbrain regions right down to the midbrain-hindbrain 
boundary (reviewed in (Reichert, 2002)). Loss-of-function experiments with Otx2 have shown 
that the resulting mice are early embryonic lethal. Among the reasons for this lethality is the 
fact that the anterior neurectoderm is not specified. This structure is in wildtype mice 
responsible for building the forebrain, midbrain and the rostral hindbrain (reviewed in 
(Reichert, 2002). Cross-phylum rescue experiments in Drosophila and Mus have shown the 
strong evolutionary conservation of the Otx proteins. The human Otx1 and Otx2 genes where 
overexpressed in the Drosophila otd mutant (Leuzinger et al., 1998) and the murine Otx1 
gene was replaced with the Drosophila otd gene (Acampora et al., 1998). In both cases a 
reasonably good rescue of mutant defects was observed. 
 
The products of the homeotic genes are setting up the posterior regions of the embryonic 
brain. In Drosophila, the homeotic genes are arranged in one cluster, but map to the separated 
Antennapedia (ANT-C) and Bithorax (BX-C) complexes, which are collectively referred to as 
the Homeotic complex (HOM-C). The ANT-C confines the genes labial (lab), proboscipedia 
(pb), Deformed (Dfd), Sex combs reduced (Scr), and Antennapedia (Antp). The BX-C contains 
the genes Ultrabithorax (Ubx), abdominal-A (abd-A) and Abdominal-B (Abd-B) (Akam, 
1989). An interesting feature of the homeotic genes is their spatial co-linearity in terms of 
chromosomal arrangement and expression pattern. More 3' located genes are expressed more 
anteriorly along the body axis of the embryo, whereas more 5' located genes are expressed 
more posterior. This colinearity is also present on the functional level, as more posteriorly 
expressed Hox genes are functionally dominant over more anteriorly expressed Hox genes - a 
phenomenon termed "posterior prevalence" (Duboule and Morata, 1994). The homeotic gene 
with the most defined anterior expression domain in the embryonic brain is lab, which is 
expressed in the posterior tritocerebrum. lab expression is followed by non-overlapping 
domains of Dfd, Scr and Antp expression in the mandibular, maxillary and labial neuromeres, 
respectively (Fig. 6). The BX-C genes are expressed in the more posterior thoracic and 
abdominal neuromeres (Hirth et al., 1998). 
Loss-of-function experiments clearly show the importance of the homeotic genes in 
controlling development of the central nervous system. Knock-out of labial or Deformed lead 
to axonal patterning defects in the tritocerebrum or in the mandibular neuromere, respectively. 
These defects are not due to loss of cells in the brain, but happen because of loss of neuronal 
identity in the defective brain neuromeres. This, in turn, leads to a failure of longitudinal and 
commissural axonal pathway formation because the postmitotic cells adjacent to the mutant 
neuromeres do not extend their axons into the area containing the unspecified cells (Hirth et 
al., 1998). 
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t has been shown that a lot of the genetic mechanisms involved in building a brain are 
volutionary conserved between Drosophila and vertebrates. The striking similarity in 
tructure and function of genes related to neurogenesis could be demonstrated for many basic 
athways controlling brain development, such as for the proneural genes (Lee, 1997), the 
eurogenic genes (Chan and Jan, 1999), the Hox genes (Lumsden and Krumlauf, 1996), and 
he otd/Otx genes (Acampora and Simeone, 1999). 
the homeotic genes and of otd 
in the brain and in adjacent 
neuromeres.  
B1: protocerebrum, B2 
deutocerebrum, B3: 
tritocerebrum, S1 mandibular, 
S2: maxillary, S3: labial 
neuromere. 
.2.4. The three phases of neurogenesis 
ummarizing brain development in Drosophila, there are three phases of neurogenesis. The 
irst phase takes place in the embryo including neuroectodermal proliferation of neuroblasts, 
atterning of the neuraxis and differentiation into neurons and glia that constitute the brain of 
he 1st instar larvae. The optic lobe and central brain neuroblasts become quiescent towards 
he end of embryogenesis. Exceptional in this regard are the neuroblasts building the 
ushroom bodies, as they continue to proliferate through all developmental stages. During 
he larval stages a second wave of neurogenesis begins to build the structures for the adult 
rain. This second phase is based on re-activation of quiescent embryonic neuroblasts. The 
hird phase of neurogenesis happens during metamorphosis in the pupal stages where the 
roliferation of neuroblasts stops and the neurons terminally differentiate into mature adult 
ells (Figure 1, (Truman and Bate, 1988).  
.3. The Drosophila genome and high density oligonucleotide arrays 
he high degree of functional conservation between flies and mammals has made Drosophila 
n invaluable tool to facilitate entry into functional genetic studies of mammalian models. 
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However, in the study of genetic pathways and epigenetic interrelations the lack of 
information on the full genomic scale has always been a major obstacle in trying to 
understand how complex organs like the brain are generated during development. 
In the year 2000 the genome sequence of Drosophila melanogaster has been published 
(Adams et al., 2000). The current annotated release (as per September 2004 – Release 3) of 
the genome contains about 14000 genes. The fact that the genome is relatively compact and 
contains few duplicate genes adds to the attractiveness of the model. 
With the sequence available, full-genome experiments have become possible, such as 
massively parallel analysis of gene expression. In the past decade microarrays (Schena et al., 
1995) and oligonucleotide arrays (Lipshutz et al., 1999) have become major tools for 
comprehensive analysis of gene expression. This new quality in functional study on the 
nucleic acid level opens new possibilities for looking into the genetic pathways that underlie 
development in complex organisms. 
Microarrays are manufactured by spotting thousands of cDNA clones taken from the 3´ region 
of the transcript onto a coated glass surface using a high-speed robot. During the main course 
of a microarray experiment, total RNA from both the test and reference sample is 
fluorescently labeled with two different fluorescent markers. The fluorescent targets are 
pooled and hybridized under stringent conditions to the clones on the microarray. The 
intensity of the two fluorescent signals is measured using a confocal scanning laser 
microscope and the resulting images are pseudo-colored, merged and the measured spots are 
annotated with information including gene name, intensity values, intensity ratio, 
normalization constant and confidence interval. Increase or decrease of transcript levels 
between experimental conditions can be can be viewed as a normalized ratio of the two 
fluorescent intensities (Duggan et al., 1999). 
 
The other main technology used to conduct gene expression studies on the genomic scale are 
high density oligonucleotide arrays (HDOAs) also called GeneChips. This is also the method 
used in the studies described throughout this thesis. These arrays are manufactured by using 
light directed synthesis of nucleotides on a glass surface (Fig. 7). By this means it is possible 
to fit hundreds of thousands of different oligonucleotides, named probes, onto a small surface.  
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Fig. 7. Light directed oligonucleotide synthesis. A solid support is derivatized with a covalent linker 
molecule terminated with a photolabile protecting group. Light is directed through a mask to deprotect 
and activate selected sites, and protected nucleotides couple to the activated sites. The process is 
repeated, activating different sets of sites and coupling different bases allowing arbitrary DNA probes to 
be constructed at each site. (modified from Lipshutz, 1999 #27). 
 
 gene is not represented by a single spot of a cDNA species but by up to 20 spots of 25-mers 
hat are taken from different regions of the gene of interest. These spots of oligonucleotides 
re synthesized on the surface in pairs, with one of the two spots containing the perfect match 
equence and the other spot having a single-base mismatch in the middle of the sequence 
Lipshutz et al., 1999). The full complement of probes representing a single gene is called a 
robeset (Fig. 8). The HDOAs used in some of the studies reported here contain probesets 
epresenting all genes in the genome of Drosophila melanogaster. In case of the larger 
ertebrate genomes the genes are split into several arrays. 
n an experiment using HDOAs, biotinylated cRNA prepared from total RNA and extracted 
rom the tissue of interest is hybridized to the array which is subsequently scanned with a 
onfocal laser scanner. The resulting image is annotated and analyzed using a variety of 
lgorithms. The relatively complex setup of molecules on the array containing surface adds 
he possibility of controlling for unspecific cross-hybridizations. The actual relative 
xpression level of the genes represented on the array is derived statistically from the 
easured intensities of the probes. The result takes into account the signals for the mismatch 
robes leading to a high confidence measure of the abundance of hybridized labeled target 
RNA species (Lipshutz et al., 1999). 
icroarrays and GeneChips have become major tools in functional genomics as they make it 
easible to take genome-wide snapshots of gene expression in one single experiment. The 
ange of array-based studies conducted is quickly getting wider. 
n Drosophila research microarray technology has been used to study a wide array of topics. 
ne approach in designing an array experiment is to sample the transcriptional profiles of 
ildtype animals or tissues, looking for spatially or temporally differential expression of 
enes during development. This has been done in studies that established a transcriptional 
ime course of Drosophila embryonic development (Tomancak et al., 2002) or even profiled 
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through all stages including adulthood (Arbeitman et al., 2002). Other studies within this 
paradigm fished for spatially restricted gene expression during dorso-ventral patterning 
(Stathopoulos et al., 2002), in wing development (Butler et al., 2003), mesoderm development 
(Furlong et al., 2001), and metamorphosis (White et al., 1999). Further surveys looked at the 
establishment of olfactory learning (Dubnau et al., 2003) and at transcriptional differences 
between the sexes (Parisi et al., 2004). 
Another conceptual way to conduct full-genome expression profiling is to set up a comparison 
of different conditions in terms of external influences. This has been done with studies 
examining the immune response of flies (Irving et al., 2001) or the resistance to drugs or 
toxins (Le Goff et al., 2003; Pedra et al., 2004).  
Fig 8. Expression probe and array design. Oligonucleotide probes are chosen based on uniqueness criteria 
and composition design rules. For eukaryotic organisms, probes are chosen typically from the 3´ end of the 
gene or transcript (nearer to the poly(A) tail) to reduce problems that may arise from the use of partially 
degraded mRNA. The use of the PM minus MM differences averaged across a set of probes greatly reduces 
the contribution of background and cross-hybridization and increases the quantitative accuracy and 
reproducibility of the measurements (modified after {Lipshutz, 1999 #27}). 
Functional genomic studies can also be carried out by using loss- and gain-of function 
genotypes, often in search for target genes of the protein of interest. This approach has been 
exploited by labs looking into trithorax genes (Beltran et al., 2003), Ras overexpression in the 
hematopoietic system (Asha et al., 2003) and into genes regulating neuronal morphogenesis 
(Brenman et al., 2001). 
 
2.4. Drosophila as a model in cancer research 
Cancer research has produced a large body of data during the past 25 years. The discovery of 
oncogenes, producing dominant gain-of-function phenotypes and tumor suppressors 
displaying recessive loss-of-function phenotypes was only the beginning leading the field into 
the extremely complex biology of this disease. 
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However, yet no small set of principles governing tumorigenesis have emerged. The 
transformation of a normal cell into a cancer cell seems to involve a complex series of 
genomic alterations. Combined with the more than 100 known types of cancer this body of 
evidence makes the identification of the critical genetic pathways a difficult task.  
From a functional point of view, most vertebrate cancer cells can be characterized by a set of 
features including self-sufficiency in growth signals, insensitivity to growth inhibition, 
ignorance of apoptotic signals, sustained angiogenesis, unrestrained replicative potential, and 
the ability to invade other tissues and produce metastases. The events that lead to these 
cellular capabilities can be very disparate, with single events sometimes enabling multiple 
traits (reviewed in (Hanahan and Weinberg, 2000)). 
 
A lot of the abovementioned prerequisites can be directly linked to basic mechanisms of brain 
development. The growing group of genes involved in basic developmental and cell 
biological pathways that have links to cancer is growing quickly. Prime candidates for this 
group are genes controlling cell growth, differentiation and death (Wechsler-Reya and Scott, 
2001). Also, there is growing evidence that the functional conservation between Drosophila 
and mammals also extends to tumor suppressors. The strong evolutionary conservation of 
gene pathways and the striking similarity in cellular processes between Drosophila and 
mammals show that research on fly tumorigenesis can add substantially to the understanding 
of human brain tumors (reviewed in (Potter et al., 2000)). Also, there is growing evidence that 
functional conservation between Drosophila and mammals also extends to tumor suppressors. 
Examples for this are genes like brain tumor (brat), malignant brain tumor (mbt), lethal giant 
larvae (lgl) and disc large (dlg). Mutations in those genes lead to tumor phenotypes in the 
larval brains consisting of malignant and invasive neoplasms (reviewed in (Arama et al., 
2000)).  
It can be very productive to use Drosophila as a sidestep in research on mammalian cancer to 
take advantage of the easier genetic accessibility, the smaller genome and the wealth of tools 
that exist for this model system. Knowledge gained in looking at fly genetic pathways can 
often be directly used in vertebrate systems. This has been done with the patched/hedegehog 
pathway. The human patched acts as a tumor suppressor and is mutated in the nevoid basal 
cell carcinoma syndrome. Investigation of the Drosophila patched/hedgehog pathway led to 
the discovery of several other genes acting in vertebrate tumor formation (Hahn et al., 1996; 
Xie et al., 1998).  
 
2.4.1. The brain tumor gene acts as a tumor suppressor in Drosophila 
The brat gene is a prime example for a Drosophila tumor suppressor gene. The brat locus 
spans about 38 000 base pairs on chromosome 2L at position 37C6. There are at least five 
exons and four introns with a coding region that is confined to exon 5 only. cDNA analysis 
suggested two transcripts. The derived amino acid sequence of Brat indicates a protein of 
1037 amino acids. Analysis of the protein sequence revealed two B-box zinc-finger motifs, a 
coiled-coil domain, and a C-terminal beta-propeller domain with the amino acid sequence of 
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the Brat C-terminal repeats being highly similar to the NHL consensus sequence. All these 
motifs are reported to be involved in protein - protein interactions (Arama et al., 2000).  
 
Brat belongs to the B-box family of proteins which contains a large number of members 
involved in functions like axial patterning, growth control, differentiation, transcriptional 
regulation and cancer formation. The B-box family genes have been implied to have roles in 
very fundamental biological processes including human tumor formation (Jensen et al., 2001; 
Torok and Etkin, 2001). Homologous proteins can be found in Caenorhabditis elegans, Mus 
Musculus, Rattus norvegicus and Homo sapiens (Arama et al., 2000). The highest similarity 
can be found in the C.  elegans protein NCL-1, which has been shown to be a functional 
homolog of brat. This is supported by the fact that Drosophila brat can functionally replace 
ncl-1 in a cross-phylum rescue experiments. NCL-1 is an inhibitor of cell growth and 
negatively regulates RNA polymerase I and III transcription in nematodes (Frank and Roth, 
1998). A mammalian homolog of brat with some known properties is the Rattus protein 
BERP, which is interacting with alpha-actinin-4 (El-Husseini et al., 2000). The other 
mammalian homologs of Brat are of mostly unknown function and include KIAA0517 in 
Homo and the Mus protein HAC1 (Arama et al., 2000).  
 
In the embryo, brat expression can be found in the developing brain, in the ventral nerve cord 
and in the peripheral nervous system from embryonic stage 11 onwards. Apart from 
expression in ganglion mother cells (GMCs) and neuroblasts in the central nervous system, 
transcript can also be detected in the differentiating sensilla and in the chordotonal organs 
(Arama et al., 2000). Larval expression can be found uniformly in the entire brain 
hemispheres including the optic lobes of third instar larvae. Weaker but also quite uniformly 
distributed levels of transcript are detected in the imaginal discs of third instar larvae. In eye 
discs brat is expressed in small cell clusters along the morphogenetic furrow (Frank et al., 
2002). Among findings about Brat function is the translational repression of hunchback (hb) 
mRNA in the abdomen of the early Drosophila embryo. This repression requires the 
recruitment of Brat by Nanos and Pumilio to form a quaternary complex with the 3’ 
untranslated region of hb mRNA (Sonoda and Wharton, 2001). It has been suggested that the 
regulation of hb translation can take place by removal of the poly(A) tail of hb mRNA and by 
a poly(A)-independent process that directly affects translation (Chagnovich and Lehmann, 
2001). Furthermore, misexpression experiments have shown that Brat can block cell 
proliferation in a variety of tissues and organs, and that it can inhibit cell division in culture 
cells (Sarnatzki et al., 2003). Also, there is evidence that brat mutant cells have larger nucleoli 
and excess rRNA whereas an overexpression of brat negatively regulates the level of cellular 
rRNA. brat overexpression in eye- and wingdiscs leads to a decrease in organ size, inhibiting 
cell growth and slowing down cell division (Frank et al., 2002). Taken together, the functional 
data support a role for brat in cell proliferation, translational repression and RNA metabolism. 
There are several brat alleles available in Drosophila and some of them have been shown to 
lead to a severe overproliferation of the larval brain. Most of the alleles that display these 
larval neoplasms have mutations in the beta-propeller domain (Arama et al., 2000). Neither 
the critical time for tumorigenesis in development nor the cellular nature of the tumor is 
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known to date. Some evidence suggests that the tumor arises from a population of cells in the 
third instar larval brain that is only as big as a few hundred, representing only a small 
percentage of the complete cellular pool. When transplanted into wildtype hosts, primary 
tumors from mutant larval brains form secondary tumors and invade tissues that are remote 
from the place of implantation (Woodhouse et al., 1998). 
 
 
2.6. Scope of this thesis 
 
This thesis draws a bow from functional genetics of Drosophila brain development to cancer 
research in a full-genome transcriptional analysis of a Drosophila brain tumor. 
 
As a pilot study in functional genomics of Drosophila custom-made high density 
oligonucleotide arrays were used to capture the transcriptional profile of 1500 genes under 
standard conditions and in response to heatshock. The analysis of differential gene expression 
following heat shock application revealed substantial expression level changes for known heat 
shock genes and identified novel heat shock-inducible genes. These results demonstrate that 
high-density oligonucleotide arrays are sensitive, efficient and quantitative instruments for the 
analysis of large scale gene expression in Drosophila (Leemans et al., 2000). 
 
Analyzing the genetics of brain patterning in the embryo of Drosophila we studied the 
functional equivalence of Hox gene products in specification of the tritocerebrum. During 
embryonic development of the Drosophila brain, the Hox gene labial is required for the 
regionalized specification of the tritocerebral neuromere. In the absence of labial, the cells in 
this brain region do not acquire a neuronal identity leading to major axonal pathfinding 
deficits. Using genetic methods, the labial gene was replaced in the tritocerebrum with all 
other known Drosophila Hox genes. We could show, that with the exception of Abdominal-B 
all Hox genes are able to functionally replace labial in its role of specifying tritocerebral 
identity. The rescue efficiency correlated with the arrangement of the Hox genes on the 
chromosome (Hirth et al., 2001). 
 
Homeotic protein action is based on the regulation of specific downstream genes in a variety 
of developmental processes. However, only a small number of target genes of homeodomain 
transcription factors have been found. By using transgenic flies carrying the lab gene under 
the control of a heat-inducible promoter, lab was ubiquitously overexpressed following heat-
shock treatment in Drosophila embryos. Expression profiles suing HDOAs identified 
differences in transcript levels in response to lab overexpression. The results demonstrate that 
overexpression of lab leads to activation and repression of genes encoding proteins that cover 
a wide variety of molecular functions. The analysis identified a novel set of candidate LAB 
target genes and thus, provides a set of data for further functional analysis of hometic gene 
action (Leemans et al., 2001). 
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Furthermore, full-genome transcriptional profiling experiment was conducted to analyse the 
functional equivalence of Drosophila otd and vertebrate Otx2 gene action. This was 
accomplished by comparing Drosophila embryos overexpressing the fly otd gene with 
embryos overexpressing the human Otx2 gene. The experiments showed that approximately 
one third of the otd-regulated transcripts also respond to overexpression of the human Otx2 
gene in Drosophila. These common otd/Otx2 downstream genes are likely to represent the 
molecular basis of the functional equivalence of otd and Otx2 gene action in Drosophila 
(Montalta-He et al., 2002).  
 
Also, oligonucleotide arrays were used to compare the complete transcriptome of wildtypoe 
Drosophila embryos with embryos overexpressing the glial cells missing (gcm) gene 
throughout the complete neuroectoderm. The experiment was conducted for two different 
timepoints in embryonic development. Results included hundreds of genes that were 
differentially expressed following gcm misexpression. These genes are potentially involved in 
aspects of glial development. In vivo validation of the array data was performed for a subset 
of the data. 
Being one of the first full-genome analyses of gene expression events downstream of a key 
developmental transcription factor this study puts forth reveals new insights into the genetic 
pathways involved in initiation and maintenance of cell fate determination in the CNS (Egger 
et al., 2002). 
 
The main focus of this thesis was the transcriptional analysis of an adult Drosophila brain 
tumor using full-genome high density oligonucleotide arrays. The tumor was caused by a 
mutation in the brain tumor (brat) gene. Two independent genome-wide gene expression 
studies using two different oligonucleotide microarray platforms were used to compare the 
transcriptome of adult wildtype flies with mutants displaying the adult bratk06028 mutant 
brain tumor. Cross-validation and stringent statistical criteria identified a core transcriptional 
signature of bratk06028 neoplastic tissue. We find significant expression level changes for 
321 annotated genes associated with the adult neoplastic bratk06028 tissue indicating elevated 
and aberrant metabolic and cell cycle activity, upregulation of the basal transcriptional 
machinery, as well as elevated and aberrant activity of ribosome synthesis and translation 
control. One fifth of these genes show homology to known mammalian genes involved in 
cancer formation. Our results identify for the first time the genome-wide transcriptional 
alterations associated with an adult brain tumor in Drosophila and reveal insights into the 
possible mechanisms of tumor formation caused by homozygous mutation of the translational 
repressor brat (Loop et al., 2004). 
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3. Quantitative transcript imaging in normal and heat shocked Drosophila 
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Abstract 
Embryonic development in Drosophila is characterized by an early phase during which a 
cellular blastoderm is formed and gastrulation takes place, and by a later postgastrulation 
phase in which key morphogenetic processes such as segmentation and organogenesis occur.  
We have focused on this later phase in embryogenesis with the goal of obtaining a 
comprehensive analysis of the zygotic gene expression that occurs during development under 
normal and altered environmental conditions.  For this, a novel functional genomic approach 
to embryogenesis has been developed which uses high density oligonucleotide arrays 
(GeneChips®) for large scale detection and quantification of gene expression.  These 
oligonucleotide arrays were used for quantitative transcript imaging of embryonically 
expressed genes under standard conditions and in response to heat shock.  In embryos raised 
under standard conditions, transcripts were detected for 37% of the 1519 identified genes 
represented on the arrays, and highly reproducible quantification of gene expression was 
achieved in all cases.  Analysis of differential gene expression following heat shock revealed 
substantial expression level changes for known heat shock genes and identified novel heat 
shock-inducible genes.  These results demonstrate that high-density oligonucleotide arrays are 
sensitive, efficient and quantitative instruments for the analysis of large scale gene expression 
in Drosophila embryos. 
 
Recently the genome of the first multicellular eukaryote C. elegans has been completely 
elucidated (1).  Sequencing of the Drosophila melanogaster genome has also been carried out 
and currently the corresponding putative open reading frames are being defined (2).  On the 
basis of this complete genomic information, it will now be important to determine the 
complex expression of all encoded genes and analyse physiological as well as pathological 
phenomena from a global genetic perspective.  Large scale transcript analysis is made 
possible by DNA micro arrays or oligonucleotide arrays (3, 4), both of which allow the 
simultaneous monitoring of hundreds of mRNA expression profiles (5, 6).  In this study, we 
used Drosophila high density oligonucleotide arrays to monitor the simultaneous expression 
of zygotically active genes during the later postgastrulation stages of embryonic development 
(7-9).  We analyzed the relative abundance levels of hundreds of embryonically expressed 
genes under normal physiological conditions and in response to heat shock (10).  In embryos 
raised under normal conditions, we obtained highly reproducible quantification for 563 
expressed genes corresponding to different functional classes. Following a 36˚C heat shock, 
we detected increases in expression levels for known heat shock genes and identified novel 
heat shock-inducible genes.   
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Materials and Methods 
 
Embryos.   
Drosophila melanogaster Oregon R stocks were kept on standard cornmeal/yeast/agar 
medium at 25˚C.  Embryos were collected overnight on grapejuice plates for 12 hours and 
were kept for further 5 hours at 25˚C before RNA isolation.  Therefore, at the time of RNA 
isolation these embryos were at embryonic stages 10-17 (9).  In heat shock experiments, 
embryos were collected overnight in the same way, kept for further 4 hours at 25˚C and then 
subjected to a 36˚C heat shock for 25 minutes followed by a recovery period of 25 min at 
25˚C before RNA isolation.  Embryos younger than embryonic stage 10 were not used, since 
heat shock in these earlier stages results in lethality (11).  Embryos used for in situ 
hybridization studies were collected and heat shock treated in the same way.   
 
Preparation of biotinylated cRNA. 
Initial experiments designed to determine the sensitivity and reproducibility of hybridization 
showed that the use of total RNA versus poly(A)+  RNA as template for cDNA synthesis and 
subsequent amplification (synthesis of cRNA) gave comparable results, despite the fact that 
we consistently detected 5S RNA and histone genes present on the array with cRNA derived 
from total RNA.  Based on these findings, all experiments were carried out using a total RNA 
protocol (12, 13).   
Total RNA was isolated from 200 mg of embryonic tissue, using guanidinium isothiocyanate 
in combination with acidic phenol (pH 4.0) (fast RNA tube green kit from BIO101) in a fast 
prep homogenizer FP120 (Bio 101).  After precipitation the RNA was dissolved in DEPC-
treated water (Ambion) and spectrophotometrically quantified using a GeneQuant RNA/DNA 
calculator (Pharmacia Biotech).  The quality of the RNA was checked on a 0.5x TBE agarose 
gel and the samples were stored at -80˚C. cDNA was synthesized upon total RNA as a 
template, using the SuperScript Choice System for cDNA synthesis (Gibco/BRL) with a T7-
(T)24 DNA primer. This primer (5'-
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(T)24VN-3') was PAGE-
gel purified.  For first strand cDNA synthesis, a typical 40 µl reaction contained 25 µg RNA, 
200 pmoles T7-(T)24 primer, 500 µM of each dNTPs and 800 units reverse transcriptase 
(AMV Superscript II).  The reaction was incubated for one hour at 42˚C.  Second strand 
cDNA synthesis was carried out at 18˚C for two hours  in a total volume of 340 µl, using 20 
units E. coli DNA ligase, 80 units E. coli DNA polymerase I and 4 units RNase H in the 
presence of 250 µM of each dNTP.  After 2nd strand cDNA synthesis, 0.5 µl RNase A 
(100mg/ml) (Qiagen) was added and the samples were incubated at 37˚C for half an hour.  
Thereafter 7.5 µl proteinase K (10mg/ml) (Sigma) was added and the samples were further 
incubated at 37˚C for another half hour.  After cDNA synthesis was completed, samples were 
phenol-chloroform extracted (3 times) using Phase Lock Gel (5 Prime-3 Prime, Inc.) and 
precipitated overnight at -20˚C with 2.5 volumes 100 % ethanol. After precipitation, the 
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samples were stored at -20˚C.  Biotinylated antisense cRNA was synthesized from the dsDNA 
template, using T7 RNA polymerase (MEGAscript T7 Kit, Ambion, Inc.).  A 20 µl reaction 
volume contained between 0.3-1.5 µg cDNA, 7.5 mM of both ATP and GTP, 5.6 mM of both 
UTP and CTP and 1.8 mM of both biotinylated Bio-16-UTP and Bio-11-CTP (ENZO 
diagnostics) and 2 µl 10x T7 enzyme mix. The reaction was incubated at 37˚C for 8 hours.  
Thereafter the unincorporated NTPs were removed by putting the sample over an RNeasy 
spin column (Qiagen). Aliquots of the reaction before and after cRNA synthesis were 
analyzed by agarose gel electrophoresis.  Samples were precipitated overnight at -20˚C, taken 
up in 20 µl DEPC treated water and spectrophotometrically quantified. Thereafter, 40 µg of 
the biotinylated antisense cRNA was fragmented by heating the sample to 95˚C for 35 min in 
a volume of 25 µl, containing 40 mM tris-acetate (pH 8.1), 100 mM KOAc, 30 mM MgOAc. 
After the fragmentation, the samples were placed on ice. 
 
High-density oligonucleotide arrays.   
In this study, a custom designed Drosophila oligonucleotide array (Affymetrix Inc., 
ROEZ003A) was used.  The genes represented on the array correspond to 1519 sequenced 
Drosophila genes encoding open reading frames deposited in SWISS-PROT/TrEMBL 
databases as of spring 1998 (a complete list of these genes will be given on our web-site).  
Each gene is represented on the array by a set of 20 oligonucleotide probes (25-mers) 
matching the gene sequence.  To control the specificity of hybridization the same probes are 
synthesized with a single nucleotide mismatch in a central position. As such, each gene is 
represented by 20 probe pairs comprised of a perfect match and a mismatch oligo.  The 
difference between the perfect match hybridization signal and the mismatch signal is 
proportional to the abundance of a given transcript (4). Drosophila genes which were not 
unambiguously represented by a probe set of 20 probe pairs on the array, were excluded from 
further analysis (23 probe sets were not used).  The oligonucleotide probe selection 
corresponding to each Drosophila gene and the array fabrication was performed by 
Affymetrix Inc.   
 
Hybridization and scanning.   
Gene Chips (stored at 4˚C) were allowed to warm up to room temperature and were pre-
hybridized with 220 µl hybridization buffer (1x MES (pH 6.7), 1 M NaCl, 0.01 % triton, 0.5 
µg/µl acetylated BSA, 0.5 µg/µl sonicated herring sperm DNA) for 15 min at 45˚C on a 
rotisserie at 60 rpm.  Hybridization was done in a final volume of 220 µl hybridization buffer, 
containing 40 µg fragmented biotinylated cRNA. The samples were heated to 95˚C for 5 min 
and briefly spun down. Hybridizations were carried out for 16 hours at 45˚C with mixing on a 
rotisserie at 60 rpm.  After hybridization, the solutions were removed, arrays  were briefly 
rinsed with 6x SSPE-T (0.9 M NaCl, 0.06 M NaH2PO4, 6 mM EDTA, 0.01 % triton ) and 
washed on a Fluidics station (Affymetrix Inc.).  Hybridized arrays were stained with 220 µl 
detection solution (1x MES buffer, containing 2.5 µl streptavidin-R phycoerythrin conjugate 
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(1mg/ml) (Molecular Probes)  and 2.0 mg/ml acetylated BSA (Sigma) at 40˚C for 15 min and 
washed again (13). 
 
Data analysis.   
Probe arrays were scanned with a commercial confocal laser scanner (Hewlett-Packard).  
Pixel intensities were measured and expression signals were analyzed with commercial 
software (Genechip 3.1, Affymetrix Inc.).  Detailed data analysis was carried out using 
RACE-A (Roche), Access 97 and Excel 97 (Microsoft) software.  For quantification of 
relative transcript abundance the average difference value (Avg Diff) was used.  Four 
replicates for wildtype (condition 1) as well as heat shock treated wildtype (condition 2) 
embryos were carried out.  All chips were normalized against the mean of the total sums of 
Avg Diff values across all 8 chips.  For the analysis of expression profiling of condition 1 
embryos, two filter operations were combined.  First, all genes with a mean Avg Diff over the 
4 replicate chips that was below 50 were excluded from further analysis.  Second, a transcript 
was judged as present only if the standard deviation of its mean Avg Diff value over the 4 
replicate chips was below 25% of its mean Avg Diff.  For differential transcript imaging, only 
genes with a change factor quality above 1 were considered in this analysis, meaning that the 
difference of the means of the Avg Diff values over the 4 replicates between condition 1 and 
condition 2 was larger than the sum of the standard deviations of the mean Avg Diff values of 
condition 1 and condition 2 (RACE-A software, Neeb and Broger, unpublished results).  In 
addition, for downregulation, the mean Avg Diff value of a gene had to be above or equal to 
50 in condition 1; for upregulation, the mean Avg Diff value of a gene had to be above or 
equal to 50 in condition 2.   
 
Whole mount in situ hybridization.   
Digoxigenin-labeled sense and antisense RNA probes were generated in vitro, with a DIG 
labeling kit (Roche diagnostics), using commercially available templates (Research Genetics, 
Inc) and hybridized to Drosophila  whole mount embryos following standard procedures (14). 
Hybridized transcripts were detected with an alkaline phosphatase conjugated anti-
digoxigenin Fab fragment (Roche diagnostics) using Nitro blue tetrazolium (NBT) and 5-
bromo-4-chloro-3-indolyl phosphate (BCIP) (Sigma) as chromogenic substrates. Embryos 
were mounted in Canada balsam (Serva) and photographed with a Prog/Res/3008 digital 
camera (Kontron Electronic) on a Zeiss Axioskop microscope with differential interference 
contrast optics. 
 
Functional classification.   
The Drosophila genes represented on the high-density oligonucleotide array were classified 
into 14 functional classes according to the function of the gene product and currently 
available genetic data.  For this, notations in Flybase, Interactive Fly, and SWISS-
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PROT/TrEMBL databases were used.  Representative genes for each of the functional classes 
are listed as follows.  Signal transduction: cytoplasmic proteins involved in intracellular 
signalling/ MAP-kinases/ cAMP, cGMP dependent kinases/ small GTP-ases/ ras oncogene-
like proteins/ SH3-SH2-SH3 domain proteins; Transcriptional regulation: Transcription 
factors such as homeodomain proteins, zinc finger proteins, ETS proteins, Pou domain 
proteins/ nuclear hormone and steroid receptors/ Polycomb- and Trithorax group proteins; 
Cell cycle: cyclins/ cyclin dependent  kinases; Cytoskeleton/ structural proteins: proteins 
involved in cytoskeletal  organization such as actin, actin filament-associated proteins, 
microtubule-associated proteins, dynein, kinesin/ proteins involved in muscle contraction such 
as myosin, tropomyosin/ yolk proteins/ chorion proteins/ nuclear envelope proteins; 
Metabolism: general "house-keeping" proteins/ enzymes/ soluble calcium binding proteins/ 
pheromone binding and odorant binding proteins/ ABC transporters/ pigment proteins/ 
antibacterial peptides/  proteins involved in nucleotide synthesis/ cytochromes; Translation: 
ribosomal proteins/ proteins involved in translational regulation/ tRNA synthetases; Heat 
shock proteins: Heat shock proteins and Heat shock cognate proteins; Transcription/ 
replication/ repair: RNA polymerases/ TATA binding factors/  DNA polymerases/ DNA 
helicases/ proteins involved in DNA damage and repair; Proteolytic systems/ apoptosis: 
ubiquitinases/ ubiquitin-activated enzymes/ proteasome subunits/ trypsin/ serine proteases/ 
proteins involved in apoptotic pathways; Cell surface receptors/ CAMs/ ion channels: 
transmembrane signalling receptors/ glutamate receptors/ GABA receptors/ acetylcholine 
receptors/ membrane associated antigens/ transmembrane phosphatases and kinases/ ion 
channel subunits/ cell adhesion molecules/ rhodopsins; Transposable elements: F-, copia-, 
HET-A-, gypsy-, P-elements, transposable element-encoded ORFs; Chromatin structure: 
DNA binding proteins not involved in transcription/ histones/ nucleosome associated proteins/ 
centrosome associated proteins/ proteins involved in chromosomal segregation; RNA binding: 
RNA helicases/ proteins involved in RNA localization/ RNA binding proteins; Secreted 
proteins: secreted signalling proteins/ ligands.   
 
 
 
Results and Discussion 
 
Quantitative transcript imaging of genes expressed in postgastrulation embryogenesis 
under standard conditions. 
The oligonucleotide array used contains probe sets that are complementary to 1519 identified 
sequenced Drosophila genes.  Most of these genes (96%) can be grouped into 14 functional 
categories according to the nature of the encoded protein (Table 1). In a first set of 
experiments, we used this oligonucleotide array to identify transcripts expressed in wildtype 
embryos raised under standard conditions (25˚C).  Transcript imaging revealed a total of 563 
(37%) of the 1519 Drosophila genes as expressed in embryonic stages 10-17.  (Expression 
levels and statistical data on all expressed transcripts will be made available according to 
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editorial policy).  To document the quantitative reproducibility of the relative expression 
levels, average difference intensity values (Avg Diff; see Materials and Methods) and 
corresponding standard deviations for the detected transcripts were determined over four 
experimental replicates (Fig. 1).  Over two thirds of the detected transcript types encode 
proteins involved in metabolism (19.8%), transcriptional regulation (13.1%), cell surface 
receptors/CAMs/ion channels (11.1%), translation (9.2%) cytoskeleton/cell structure (8.5%) 
or signal transduction (7.2%).   
 
Marked differences were observed in the range of relative expression levels for the different 
functional categories (Fig. 2).  Highest expression levels were seen for specific genes 
encoding proteins involved in translation.  Thus, of the 21 transcripts with Avg Diff>5000, 18 
encode ribosomal proteins.  High expression levels with Avg Diff>4000 are also seen for 
specific individual transcripts encoding proteins involved in chromatin structure and protein 
degradation.  For example the highest Avg Diff in the functional class protein degradation/ 
apoptosis is the transcript encoding the Cystatin-like protein (Avg Diff=4792).  Some 
transcripts for proteins involved in signal transduction, DNA transcription/replication/repair, 
metabolism, as well as the transcript encoding the Heat shock cognate protein 70-4 have 
maximal Avg Diff in the 3000-4000 range.  Surprisingly, elevated expression levels are 
observed for transcripts encoded by specific transposable elements; in three cases Avg Diff 
were above 2000, namely for two open reading frames, encoded by the transposon I element 
and a putative reverse transcriptase, encoded by an F element.  Remarkably elevated 
expression levels are also seen for the transcription factor Box B-binding factor 1 (1315); for 
other genes encoding transcription factors such as snail (Avg Diff = 394), glial cells missing 
(237), islet (136), and paired (64) transcript levels were in the intermediate to low range (Avg 
Diff<550).  
 
Quantitative transcript imaging of heat-shocked compared to non heat-shocked 
embryos. 
Oligonucleotide arrays were next used to determine transcript profile changes following heat 
shock exposure.  For this, transcript imaging was carried out on stage 10-17 embryos 
subjected to a 36˚C heat shock for 25 min (see Materials and Methods).  The expression 
profile from embryonically expressed genes after heat shock was quantitatively compared to 
the expression profile from embryos raised under standard conditions.  Comparative transcript 
imaging identified 74 genes, distributed among 12 functional classes, whose relative 
expression level changed in response to heat shock; 36 genes had increased and 38 genes had 
decreased expression levels (Fig. 3).   
 
Heat shock is known to induce the expression of an evolutionary conserved family of genes, 
encoding the heat shock proteins (Hsps) (10, 15, 16). Accordingly, in our comparative screen 
we observed a prominent increase in relative transcript abundances for all genes encoding 
Hsps represented on the chip and which have been reported to be highly upregulated by heat 
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shock. Transcript imaging detected increases above 3-fold in relative expression levels for 9 
genes encoding Drosophila heat shock proteins: Hsp22, 26, 27, 23, DnaJ-1, Hsp67Bc, 83, 
70Ab, 70Bb  (17, 18).  The largest changes (>10-fold) were observed for Hsp22, Hsp26, 
Hsp27, and Hsp23.  This is in accordance with several studies that report that these four small 
Hsps are expressed during normal fly development and are upregulated under heat shock (19, 
20).  For five other genes known to encode heat shock proteins, DnaJ-1, Hsp67Bc, 83, 70Ab, 
70Bb, we detect an increase in expression in the 3-6 fold range.  All of these genes are known 
to be responsive to heat shock (20).  The heat shock cognate genes (Hsc) have been reported 
to be expressed at normal temperatures but are not further induced by heat shock (21, 22).  In 
accordance with this, we observed no marked change in expression level for Hsc70-1, Hsc70-
4 and Hsc70-5 .  We did, however, detect a small increase in expression level for Hsc70-3.   
Two other genes with increases in relative expression levels above 3-fold are Shark, involved 
in a signalling pathway for epithelial cell polarity (23) and anon-23Da, encoding a protein 
with currently unknown function.  25 other genes show increased expression levels in the 1.5 
to 3-fold range.  Heat shock induced expression of these genes in Drosophila has not been 
reported before.  However, Cdc37 is known to interact genetically with Hsp83 in a common 
signalling pathway in Drosophila (24), and in several other cases, homologous genes in other 
eukaryotes are known to be stress-inducible.  The gene kayak (kay) for example is the 
Drosophila homologue of the mammalian c-fos.  c-fos mRNA is induced following exposure 
to noxious stimuli such as heat, arsenite and heavy metals and recently it has been reported 
that the human and rodent c-fos promoters contain heat shock element consensus sequences, 
which enhance transcription in response to heat (25).  A second example is Tenascin major 
(Ten-m), encoding a protein implicated in patterning the early fly embryo. The mammalian 
homologue of Tenascin major is the gene DOC4, which is known to act downstream of 
CHOP, a small nuclear protein that mediates changes in cell phenotype in response to stress 
(26).   
 
 Heat shock induced decreases in relative expression levels greater than 3-fold are seen for 
mus210, the Drosophila homologue of the xeroderma pigmentosum complementation group 
C gene, which is involved in DNA repair, and for anon-X, which encodes a novel WD repeat 
protein of unknown function (27, 28).  The remaining 36 genes with decreased relative 
expression levels are in the 1.5-fold to 3-fold range.  A decrease in relative expression in 
response to heat shock has not been reported previously for any of these genes in Drosophila.   
 
For most of the 74 identified genes, which show differential expression levels in response to 
heat shock, changes are in the 1.5- to 3-fold range.  It was not possible to unambiguously 
reveal these small quantitative changes using qualitative detection techniques such as in situ 
hybridization.  Changes in gene expression that are in higher ranges can, however, be detected 
with in situ hybridization.  To document this, whole mount in situ hybridization was carried 
out for transcripts of Hsp22 (19-fold increase),  Hsp26 (14-fold increase) and DnaJ-1 (6-fold 
increase) (Fig. 4).  In all three cases, in situ hybridization revealed clear increases in 
hybridization signal following heat shock. 
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Taken together, these results demonstrate that oligonucleotide arrays have the potential to 
analyse the relative expression levels of hundreds of known genes in a complex RNA sample 
of the multicellular Drosophila embryo.  In addition, they allow a quantitative assessment of 
differential gene expression under normal versus heat shock conditions.  Thus, the 
oligonucleotide probe arrays used in our study establish highly reproducible transcript images 
of Drosophila embryos and allow accurate comparisons of changes in gene expression under 
different environmental conditions.  In this respect, they complement the DNA microarray 
technique that has recently been used to study gene expression during metamorphosis in 
Drosophila (29).  With the imminence of whole genome sequence data for Drosophila (2) it 
will now be possible to expand quantitative transcript imaging to include all functional genes 
and set the stage for a complete genomic analysis of expression profiles in normal and 
environmentally or genetically manipulated Drosophila embryos. 
 
 
 
Acknowledgements 
We thank Jan Mous, Adrian Roth, Michel Tessier, Monika Seiler and Reto Brem for essential 
contributions and helpful advice.  We are particularly grateful to Clemens Broger and Martin 
Neeb for allowing us to use their RACE-A Chip analysis software, prior to publication.  This 
research was funded by grants from the SNSF and EU Biotech (to H.R.) and by Hoffmann-La 
Roche.   
 - 32 -
References 
 
1. The C. elegans Consortium. (1998) Science 282, 2012-2018. 
2. Burtis, K. C. & Hawley, R. S. (1999) Nature 401, 125, 127. 
3. Granjeaud, S., Bertucci, F. & Jordan, B. R. (1999) Bioessays 21, 781-790. 
4. Lipshutz, R. J., Fodor, S. P., Gingeras, T. R. & Lockhart, D. J. (1999) Nat. Genet. 21, 
20-24. 
5. Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., et al. (1996) 
Nat. Biotechnol. 14, 1675-1680. 
6. Lashkari, D. A., DeRisi, J. L., McCusker, J. H., Namath, A. F., Gentile, C., Hwang, S. 
Y., Brown, P. O. & Davis, R. W. (1997) Proc. Natl. Acad. Sci. USA 94, 13057-13062. 
7. Akam, M. (1987) Development 101, 1-22. 
8. Pankratz, M. J. & Jäckle, H. (1993) in The Development of Drosophila melanogaster, 
eds. Bate, M. & Martinez-Arias, A. (Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, New York), Vol.1, pp. 467-516. 
9. Campos-Ortega, J. & Hartenstein, V. (1997) The embryonic development of 
Drosophila melanogaster (Springer, Heidelberg). 
10. Nover, L. & Scharf, K. D. (1997) Cell. Mol. Life Sci. 53, 80-103. 
11. Walter, M. F., Petersen, N. S. & Biessmann, H. (1990) Dev. Genet. 11, 270-279. 
12. Mahadevappa, M. & Warrington, J. A. (1999) Nat. Biotechnol. 17, 1134-1136. 
13. Certa, U., de Saizieu, A. & Mous, J. (2000) Methods Mol. Biol., in press. 
14. Tautz, D. & Pfeifle, C. (1989) Chromosoma 98, 81-85. 
15. Lindquist, S. & Craig, E. A. (1988) Annu. Rev. Genet. 22, 631-677. 
16. Schlesinger, M. J. (1990) J. Biol. Chem. 265, 12111-12114. 
17. Pauli, D. & Tissières, A. (1990) in Stress Proteins in Biology and Medicine, eds. 
Morimoto, R., Tissières, A. & Georgopoulos, C. (Cold Spring Harbour Laboratory Press, 
New York), pp. 361-378. 
18. Michaud, S., Marin, R. & Tanguay, R. M. (1997) Cell. Mol. Life Sci. 53, 104-113. 
19. Haass, C., Klein, U. & Kloetzel, P. M. (1990) J. Cell. Sci. 96, 413-418. 
20. Vazquez, J., Pauli, D. & Tissières, A. (1993) Chromosoma 102, 233-248. 
21. Craig, E. A., Ingolia, T. D. & Manseau, L. J. (1983) Dev. Biol. 99, 418-426. 
22. Rubin, D. M., Mehta, A. D., Zhu, J., Shoham, S., Chen, X., Wells, Q. R. & Palter, K. 
B. (1993) Gene 128, 155-163. 
23. Ferrante, A. W., Jr., Reinke, R. & Stanley, E. R. (1995) Proc. Natl. Acad. Sci. USA 92, 
1911-1915. 
24. Cutforth, T. & Rubin, G. M. (1994) Cell 77, 1027-1036. 
25. Ishikawa, T., Igarashi, T., Hata, K. & Fujita, T. (1999) Biochem. Biophys. Res.  
Commun. 254, 566-571. 
26. Wang, X. Z., Kuroda, M., Sok, J., Batchvarova, N., Kimmel, R., Chung, P., Zinszner, 
H. & Ron, D. (1998) EMBO J. 17, 3619-3630. 
27. Henning, K. A., Peterson, C., Legerski, R. & Friedberg, E. C. (1994) Nucleic Acids 
Res. 22, 257-261. 
 - 33 -
28. Kraemer, C., Weil, B., Christmann, M. & Schmidt, E. R. (1998) Gene 216, 267-276. 
29. White, K. P., Rifkin, S. A., Hurban, P. & Hogness, D. S. (1999) Science 286, 2179-
2184.
 
 
 
 
 
Fig. 1.  Gene expression monitoring of stage 10-17 wildtype embryos raised under standard conditions 
(25˚C).  Compilation of the 100 genes expressed with the highest Average Difference values (Avg Diff; for 
details see Materials and Methods) and the corresponding standard deviations (SD; indicated by bars) over 
4 experimental replicates.   
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Fig. 2.  Range of Avg Diff values for expressed genes, grouped according to their functional classes.  
Translation (min Avg Diff 56 - max Avg Diff 9394), Chromatin structure (78-5873), Proteolytic systems/ 
apoptosis (53-4792), Signal transduction (52-3791), Tanscription/ replication/ repair (59-3303), 
Metabolism (51-3223), Heat shock proteins (55-3073), Transposable elements (87-2624), Cytoskeleton/ 
structural proteins (52-2419), Secreted proteins (59-1317), Transcriptional regulation (51-1315), Cell 
surface receptors/ CAMs/ ion channels (51-1152), RNA binding (52-1095), Cell cycle (56-405), and 
unknown function (61-1114). 
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Fig. 3.  Differentially expressed genes observed in heat shocked versus non-heat shocked stage 10-17 
wildtype embryos, grouped according to functional classes.  Bars represent the fold-change of differentially 
expressed genes in the heat shock versus standard condition.  Positive values indicate that the relative 
expression level of a gene is increased after heat heat shock and negative values indicate a decrease.  Avg 
Diff values are given for the heat shocked condition as follows: white bars represent Avg Diff<100, grey 
bars represent Avg Diff ranging from 100-1000 and black bars represent Avg Diff>1000. 
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Fig. 4.  Comparison of whole mount in situ hybridizations between non-heat shocked and heat shocked 
wildtype embryos.  (A-F) lateral views, anterior to the left.  (A, C, E) non-heat shocked wildtype, (B, D, F) 
heat shocked wildtype embryos.  (A, B)  at stage 11 Hsp22 expression is confined to metameric ectodermal 
patches in non-heat shocked wildtype embryos (A) whereas Hsp22 is ubiquitously expressed in the 
ectoderm of heat shocked wildtype embryos (B).  (C, D) at stage 12 there is no expression of Hsp26 in the 
ectoderm of non-heat shocked wildtype embryos (C, gut staining out of focal plane) whereas Hsp26 is 
expressed in all ectodermal cells of heat shocked wildtype embryos (D)  (E;F ) at stage 11 DnaJ-1 is not 
detected in non-heat shocked wildtype embryos (E) whereas heat shocked wildtype embryos show strong 
expression in all ectodermal cells (F). 
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Table 1. Drosophila  oligonucleotide array:  expression data for wildtype embryos 
 
 
 
 
 
Genes expressed in stage 10-17 wildtype embryos raised under standard conditions (25˚C), grouped 
according to functional classes.  Number of genes within a functional group present on the chip (N); total 
number of genes represented on the chip ΣN=1519. Number of genes expressed within a functional group 
(n); total number of transcripts detected Σn=563.  (n/N x 100 in %) Distribution of genes expressed within a 
functional group in relation to the total number of identified genes in this group present on the chip.  
Distribution of genes expressed within a functional group, given as percentage of the total number of genes 
expressed. 
Functional class Number of genes on the chip (N) Number of transcripts detected (n) n/N x 100 (%) Transcripts detected (%)
Metabolism 315 112 35.5 19.8
Transcriptional regulation 268 74 27.6 13.1
Cell surface receptors/CAMs/ion channels 181 63 34.8 11.1
Translation 60 52 86.6 9.2
Cytoskeleton/structural proteins 149 48 32.2 8.5
Signal transduction 107 41 38.3 7.2
RNA binding 59 29 49.1 5.1
Transcription/replication/repair 73 28 38.3 4.9
Unknown function 85 23 27.0 4.0
Proteolytic systems/apoptosis 62 22 35.4 3.9
Cell cycle 37 18 48.6 3.1
Transposable elements 35 18 51.4 3.1
Chromatin structure 36 18 50.0 3.1
Heat shock proteins 18 10 55.5 1.7
Secreted proteins 34 7 20.5 1.2
ΣN = 1519 Σn = 563
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Table 2. Comparison of change folds between oligonucleotide arrays and RT-PCR 
 
 
 
 
 
RT-PCR was performed on cDNA derived from heat-shocked embryos and embryos raised under standard conditions. 
Change folds determined by RTPCR are represented as the mean value of eight independent replicates, derived from 
two different cDNA preparations. wt, wild type; HS, heat shock. 
Gene
wt HS-wt Array RT-PCR
Hsp27 347 4646 12.4 20.0
Hsp67Bc 183 944 5.2 8.0
anon-23Da 6 64 3.2 2.6
kay 74 153 2.1 1.4
Ten-m 92 162 1.8 2.1
kiwi 108 199 1.8 4.0
Cdc37 179 286 1.6 3.4
Rac2 424 425 1.0 1.1
FK506-bp2 1918 1248 -1.5 -2.0
Change FoldAvg Diff (Array)
-39-
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Abstract 
 
Background 
Homeotic genes are key developmental regulators that are highly conserved throughout 
evolution.  Their encoded homeoproteins function as transcription factors to control a wide 
range of developmental processes.  Although much is known about homeodomain-DNA 
interactions, only a small number of genes acting downstream of homeoproteins have been 
identified.  Here we use a functional genomic approach to identify candidate target genes of 
the Drosophila homeodomain transcription factor Labial (Lab).   
 
Results 
High density oligonucleotide arrays with probe sets representing 1513 identified and 
sequenced genes were used to analyse differential gene expression following lab 
overexpression in Drosophila embryos.  We find significant expression level changes for 96 
genes belonging to all functional classes represented on the array.  In accordance with our 
experimental procedure, we expect that these genes are either direct or indirect targets of 
labial gene action.  Among these genes, 48 were upregulated and 48 were downregulated 
following lab overexpression.  This corresponds to 6.3% of the genes represented on the 
array.  For a selection of these genes we show that the data obtained with the oligonucleotide 
arrays are consistent with data obtained using quantitative RT-PCR.   
 
Conclusions 
Our results identify a number of novel candidate downstream genes for Labial, suggesting 
that this homeoprotein differentially regulates a limited and distinct set of embryonically 
expressed Drosophila genes.   
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Background 
The homeotic/Hox genes encode a network of evolutionary conserved homeodomain 
transcription factors that are involved in the specification of segmental identity along the 
anterior-posterior body axis of animals as diverse as insects and vertebrates [1-6].  In 
Drosophila, these genes are arranged along the chromosome in two gene clusters known as 
the Antennapedia and Bithorax complexes.  There is a correlation between the relative 
position of the Hox genes within the cluster and their spatial and temporal expression pattern 
in the body,  in that genes located towards the 3’ end are expressed more anterior and earlier 
than genes located towards the 5’ end (spatial and temporal colinearity) [7-11].   
 
Given their central role in developmental processes, it has been proposed that the 
homeoproteins do not act directly to specify morphological differences but rather control a 
battery of subordinate genes encoding cellular functions directly required in differentiation 
[12,13].  In search of these subordinate genes, various strategies such as enhancer trapping, 
immunoprecipitation of chromatin fragments, subtractive hybridization, selection for binding 
sites in yeast, and heat shock induced overexpression have been employed [9,14-21].  
However, only a small number of target genes of homeoproteins have been identified to date; 
most of these encode either transcription factors or cell signalling molecules [9].  In contrast 
to these results, recent studies suggest that homeoproteins may bind at significant levels to the 
majority of genes in the Drosophila embryo and regulate a large number of downstream genes 
[22,23].   
 
Here we focus on the homeotic gene labial (lab) in the Drosophila embryo.  lab is the most 
proximal gene located within the Drosophila Antennapedia complex; it encodes an 
antennapedia-like Q50 homeodomain transcription factor and is one of the most anteriorly 
expressed homeotic genes along the anterior-posterior body axis [24-27].  Genetic studies 
have demonstrated that lab is required for proper head formation [28], for the specification of 
cellular identity in the midgut [29] as well as in the embryonic brain [30].  The lab gene and 
its vertebrate Hox1 orthologs are among the best characterized examples of evolutionary 
conservation of structure, expression and function of Hox genes in animal development [31-
35]. 
 
In order to address the question of which and how many downstream genes are under control 
of lab, we used a combination of in vivo overexpression techniques and quantitative transcript 
imaging with oligonucleotide arrays.  By using transgenic flies carrying the lab gene under 
control of a heat inducible promoter, we ubiquitously overexpressed lab following heat shock 
treatment in Drosophila embryos.  We then used high density oligonucleotide arrays 
representing 1513 identified Drosophila genes for large scale detection and quantification of 
induced gene expression [36-39].  We find significant changes in gene expression for 96 
identified genes following lab overexpression.  Quantitative RT-PCR on a selection of these 
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genes verified the differential expression levels in response to heat shock induced 
overexpression of lab.  Our findings identify a number of novel candidate downstream genes 
for lab and, thus, demonstrate that oligonucleotide arrays are powerful tools for analysing, at a 
genome wide level, the number, identity and quantitative expression level of genes in the 
Drosophila embryo. 
 
 
Results  
In this study, transgenic fly strains carrying the lab coding sequence under control of the heat 
inducible Hsp70 promotor were used [40].  Stage 10-17 embryos were given a 25 min heat 
pulse in order to overexpress lab and allowed to recover for 25 min (see Materials and 
methods for heat shock protocol).  Ubiquitous overexpression of lab was verified by whole 
mount in situ hybridization with a lab specific antisense RNA probe.  Ubiquitous 
overexpression of Labial protein was verified by immunocytochemistry with an anti-Labial 
antibody.  These experiments demonstrated that both lab RNA and Labial protein were 
strongly overexpressed 50 min after the onset of heat shock in these strains (Fig. 1).  Wildtype 
control flies were subjected to the identical heat shock regime.   
 
Following ubiquitous overexpression of lab, transcript profiles were analysed using a high 
density oligonucleotide array and compared to the transcript profiles of heat shock treated 
wildtype control embryos.  For each of the two experimental conditions (hs-wt and hs-lab), 
four replicates were carried out and the data set was analysed with an unpaired t-test (see 
Materials and methods, and [39]).  The genes represented on the oligonucleotide array 
correspond to probe sets that are complementary to 1513 identified and sequenced Drosophila 
genes.  Most of these genes can be grouped into 14 functional categories according to the 
nature of the encoded protein [39].   
 
At a significance level of p≤0.01, a total of 96 genes were found to be differentially regulated 
following lab overexpression, as compared to heat shocked wildtype control embryos.  This 
corresponds to 6.3% of the genes represented on the array.  At a significance level of p≤0.05, 
205 genes were found to be differentially regulated following lab overexpression as compared 
to heat shocked wildtype control embryos (data not shown).  This corresponds to 13.5% of the 
genes represented on the array.  The relative distribution of lab regulated genes in particular 
functional classes as well as the percentage of genes regulated within a given functional class 
were comparable between the p≤0.01 group and the p≤0.05 group.  In the following, only 
genes that were differentially expressed at a significance level of p≤0.01 are considered 
further.  We posit these genes to be potential direct or indirect downstream genes for the 
homeodomain transcription factor Labial.   
 
When ubiquitously expressed in the embryo, lab caused a significant transcriptional response 
among a wide variety of genes belonging to all functional classes represented on the array 
(Table 1).  The functional class with the highest absolute number of differentially regulated 
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genes was transcriptional regulation (n=20).  Other functional classes with high numbers of 
differentially regulated genes were metabolism (n=13), proteolytic systems/apoptosis (n=12), 
cell surface receptors/CAMs/ion channels (n=12), and RNA binding (n=7).  Relative to the 
number of genes represented on the array within a given functional class, the highest relative 
percentage of differentially regulated genes was found in the functional classes proteolytic 
systems/apoptosis (19.4%), cell cycle (13.5%), transposable elements (11.4%), chromatin 
structure (11.1%), RNA binding (11.9%), and transcriptional regulation (7.6%).   
 
Figure 2 shows the lab regulated genes and presents a quantitative representation of the 
change in expression levels for these genes.  Of the 96 genes that were differentially 
regulated, 48 showed increased expression levels and 48 showed decreased expression levels. 
The gene with the highest increase in expression level (26-fold) was lab itself, in accordance 
with our experimental procedure.  Increases in expression levels above 10-fold were also 
observed for the genes Bicaudal C (BicC), swallow (swa) and oskar (osk), all encoding 
proteins involved in RNA binding, as well as for the wings apart-like (wapl) gene belonging 
to the functional class chromatin structure.  The increased expression levels in BicC, swa, and 
osk are surprising since all of these genes are known to function as maternal control genes 
during early embryogenesis [41,42].  Since lab activity is only observed from gastrulation 
onwards [26], this suggests that high levels of widespread ectopic lab expression are able to 
activate genes which under wildtype conditions show non-overlapping spatio-temporal 
expression domains as compared to that of lab.  Increases in the 5-10 fold range were seen for 
6 genes.  One of these encodes the enzyme Ubiquitin carboxy-terminal hydrolase, whose 
mammalian homolog has also been found to be differentially upregulated by ectopic 
overexpression of the lab ortholog Hoxa1 [43].  Increased expression levels in the 1.5-5 fold 
range were prominent in several functional classes.  For example, in the funtional class 
proteolytic systems/apoptosis, 12 of 13 differentially regulated genes were upregulated and 
most of these showed increased expression levels ranging between 1.5 and 5.  Strikingly, in 
the functional class cell cycle and in the functional class transcription/replication/repair all of 
the differentially regulated genes were upregulated.  Thus, differentialy expressed genes such 
as twine (twe), Cyclin B (CycB), and Cyclin D (CycD), belonging to the functional category 
cell cycle, were all upregulated following lab overexpression.  It is noteworthy in this respect 
that recent experiments carried out on mammalian cell lines demonstrated that ectopic 
overexpression of the lab ortholog Hoxa1 also causes differential upregulation of cell cycle 
regulatory proteins [43].   
 
Decreases in expression levels in the 10-fold and above range were not observed and 
decreases in the 5-10 fold range were only seen for the transposable R2 rDNA element gene.  
Decreased expression levels in the 1.5-5 fold range were, however, prominent in the 
functional class transcriptional regulation and in the functional class cell surface 
receptors/CAMs/ion channels.  Thus, almost 3/4 of the differentially regulated genes encoding 
transcription factors showed significant decreases in expression levels following lab 
overexpression.  For example, the genes prospero (pros), Distal-less (Dll), tailup/islet (tup), 
mirror (mirr), huckebein (hkb), and abrupt (ab) were all downregulated.  Interestingly, it has 
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been shown that Distal-less is a direct target of homeotic gene control [9], and recent genetic 
studies demonstrated that tailup/islet expression in the lab-specific territory of the embryonic 
Drosophila brain is dependent on lab gene action [30].  Similar to the situation of the 
functional class transcriptional regulation, 10 out of 12 genes representing the functional 
category cell surface receptors/CAMs/ion channels were downregulated, including the genes 
derailed (drl), frizzled 2 (fz2), Neurotactin (Nrt), Neurexin (Nrx), rhomboid (rho), and 18 
wheeler (18w).  As is the case for tailup/islet, Neurotactin expression in the lab-specific 
territory of the embryonic Drosophila brain is dependent on lab gene action [30].  18 wheeler 
has been identified as a binding site of the homeotic protein UBX in polytene chromosomes 
[18].   
 
To verify the differences in expression level after heat shock induced overexpression of lab as 
compared to heat shocked wildtype embryos, quantitative RT-PCR was performed on selected 
candidate target genes.  Changes in expression levels were determined for eight genes that 
were differentially regulated following lab overexpression, namely labial (lab), swallow 
(swa), Ubiquitin conjugating enzyme 4 (UbcD4), twine (twe), cyclin B (cycB), Ubiquitin 
carboxy-terminal hydrolase (Uch), scratch (scrt) and phosphoenolpyruvate carboxykinase 
(Pepck).  The gene squid (sqd), whose expression level remained unchanged under both 
experimental conditions, served as a control.  As indicated in Table 2, these experiments 
demonstrated that the changes in relative expression level as measured by RT-PCR, are 
consistent with the data obtained with the oligonucleotide arrays.   
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Discussion 
In this report we have used a novel combination of manipulative genetics and functional 
genomics to gain further insight into homeotic gene action in Drosophila from a genomic 
perspective.  Using inducible overexpression and quantitative transcript imaging through 
oligonucleotide arrays, we have identified 96 genes whose expression levels change 
significantly following lab overexpression.  Accordingly, of the 1513 identified genes 
represented on the oligonucleotide array, only 6.3% showed significant differential regulation 
following overexpression of the homeoprotein lab.   
 
These findings suggest a specific differential regulation of a limited and distinct set of 
candidate downstream genes for lab.  As such, this appears to contrast with previous reports 
indicating that in late embryogenesis the majority of Drosophila genes are under control of 
homeoproteins [23,44].  However, it should be stressed, that there are a number of features of 
our functional genomic analysis that impede a direct comparison with these reports, which are 
based on DNA binding studies.  First, although our analysis can quantify gene expression 
accurately and simultaneously for many identified genes, the temporal and spatial resolution 
of our analysis is low.  This is because our experimental design averages gene expression 
throughout the embryo and during several embryonic stages.  In consequence, our analysis 
may fail to detect genes that are only expressed in a small subset of cells or during a very 
restricted time period in embryogenesis.  Second, our overexpression protocol makes it 
difficult to control the level of Lab protein as well as the temporal dynamics and stability of 
this protein.  Since different levels of of a given homeoprotein can have different functional 
consequences in terms of developmental specificity [29,45], the high level of Lab protein may 
bias the set of candidate downstream target genes identified.  Third, in our studies lab 
overexpression is not accompanied by concomittant overexpression of cofactors, which are 
thought to act together with homeotic proteins to determine their in vivo target specificity 
[34,46].  It is noteworthy in this respect, that the gene mirror, which has been proposed to be 
an additional cofactor for homeoprotein specificity [47], was detected as downregulated 
following lab overexpression.   
 
Although the question of the total number of target genes that are regulated by homeoproteins 
in vivo must await further analysis, our genomic perspective of lab gene targets does reveal 
several specific features of homeoprotein action.  First, our results demonstrate that the 
homeodomain transcription factor lab acts on numerous candidate target genes that also 
encode transcription factors.  The category transcriptional regulation comprises one of the 
largest sets of differentially regulated genes following lab overexpression.  This is consistent 
with the idea that homeobox genes establish developmental patterns by acting through a 
cascade of transcription factors which regulate the expression of their own subset of 
downstream genes [1,2,9,15].  Second, our data indicate that upregulation of gene expression 
is prominent in several functional classes.  Thus, virtually all of the lab regulated genes in the 
functional classes cell cycle, transcription/replication/repair, and proteolytic 
systems/apoptosis show increased expression values.  Third, our results show that lab 
 - 47 -
overexpression causes not only widespread activation but also widespread repression of gene 
expression.  Thus, of the 96 genes that are potential targets of lab, one half are downregulated 
by overexpression of this homeobox gene.  This widespread repression is especially 
pronounced in the functional classes of transcriptional regulation and cell surface 
receptors/CAMs/ion channels.  For example, following lab overexpression over 80% of the 
differentially regulated genes encoding cell surface receptors/CAMs/ion channels showed 
decrease in expression level.  
 
 
Conclusions 
Taken together, our results identify a large number of novel candidate downstream genes of 
the homeodomain transcription factor Labial.  To our knowledge, most of these 96 identified 
and sequenced genes have not been previously shown to be lab targets.  At present, we do not 
know which genes are direct targets (regulated directly by Labial protein binding to DNA 
regulatory sequences) or indirect targets of lab gene action.  Furthermore, our results 
demonstrate that oligonucleotide arrays are useful tools for analysing, at a genome wide level, 
the number, identity and quantitative expression levels of candidate downstream genes 
differentially regulated in vivo by developmental control genes.  This confirms the general 
utility of microarrays for studying diverse molecular and cellular processes in Drosophila [48-
50].  Considering the evolutionary conservation of gene structure, expression and function 
[1,35], we posit that these results obtained in Drosophila will also be valid for lab gene 
orthologs in other animal species including vertebrates.  It will now be important to determine 
which of the detected candidate downstream genes in Drosophila are direct targets and how 
they exert the developmental genetic programs imposed by lab gene action.   
 
 
Materials and methods 
Fly strains, embryo collections and heat shock regime 
The wildtype was Drosophila melanogaster Oregon-R.  For ectopic overexpression of lab, we 
used the line p(w+hs-lab) with a heat shock lab construct homozygous on the X chromosome 
[40].  All fly stocks were kept on standard cornmeal/yeast/agar medium at 25°C.  Embryos 
were collected overnight for 12 hours on grape juice plates, further kept for 4 hours at 25°C 
and then subjected to a 36°C heat shock for 25 min, followed by a recovery period of 25 min 
at 25°C before RNA isolation.  Therefore, at the time of RNA isolation these embryos were at 
embryonic stages 10-17 (stages according to [51]).  Embryos younger than embryonic stage 
10 were not used, since heat shock in these earlier stages results in lethality [52].   
 
Whole mount in situ hybridization and immunocytochemistry.   
For in situ hybridization, digoxigenin-labeled sense and antisense lab RNA probes were 
generated in vitro, with a DIG labeling kit (Roche Diagnostics) and hybridized to whole 
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mount embryos following standard procedures [53].  Hybridized transcripts were detected 
with an alkaline phosphatase conjugated anti-digoxigenin Fab fragment (Roche Diagnostics) 
using Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) 
(Sigma) as chromogenic substrates.  For Immunocytochemistry, embryos were dechorionated, 
fixed and labeled according to [54].  The primary antibody was rabbit anti-LAB [55] used 
1:100.  The histochemical staining was performed using the Vectastain Elite ABC Kit (Vector 
Laboratories).  Embryos were mounted in Canada balsam (Serva) and photographed with a 
Prog/Res/3008 digital camera (Kontron Electronic) on a Zeiss Axioskop microscope with 
differential interference contrast optics.  Photographs were arranged and labeled using 
Microsoft PowerPoint, 97.   
 
High-density oligonucleotide arrays 
Gene expression analysis was performed as described [36] using a custom designed 
Drosophila oligonucleotide array (ROEZ003A; Affymetrix Inc).  The genes represented on 
the array and considered in this study correspond to 1513 sequenced Drosophila genes 
encoding open reading frames deposited in SWISS-PROT/TrEMBL databases as of spring 
1998.  (For a complete list of these genes see supplementary data of [39]).  Each gene is 
represented on the array by a set of 20 oligonucleotide probes (25-mers) matching the gene 
sequence.  To control the specificity of hybridization, the same set of probes, containing a 
single nucleotide mismatch in a central position, are represented on the array.  The difference 
between the perfect match hybridization signal and the mismatch signal is proportional to the 
abundance of a given transcript and calculated as its Average Difference value (Avg Diff) 
[37].  Drosophila genes which were not unambiguously represented by a probe set of 20 
probe pairs on the array, were excluded from further analysis (29 probe sets were not used in 
this study). 
 
RNA sample preparation and hybridization 
Initial experiments designed to determine the sensitivity and reproducibility of hybridization 
showed that the use of total RNA versus poly(A)+  RNA as a template for cDNA synthesis 
and subsequent amplification (synthesis of cRNA) gave comparable results, despite the fact 
that we consistently detected 5S RNA and histone genes present on the array with cRNA 
derived from total RNA.  Based on these findings, all experiments were carried out using a 
total RNA protocol [56]. 
Total RNA was isolated from 200 mg of embryonic tissue, using guanidinium isothiocyanate 
in combination with acidic phenol (pH 4.0) (fast RNA tube green kit from BIO101) in a fast 
prep homogenizer FP120 (BIO 101).  After precipitation, the RNA was dissolved in DEPC-
treated water (Ambion) and spectrophotometrically quantified using a GeneQuant RNA/DNA 
calculator (Pharmacia Biotech).  cDNA was synthesized upon total RNA as a template, using 
the SuperScript Choice System for cDNA synthesis (Gibco/BRL) with a T7-(T)24 DNA 
primer.  
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This primer (5'-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(T)24VN-
3') was PAGE-gel purified.  For first strand cDNA synthesis, a typical 40 µl reaction 
contained 25 µg RNA, 200 pmoles T7-(T)24 primer, 500 µM of each dNTPs and 800 units 
reverse transcriptase (AMV Superscript II).  The reaction was incubated for one hour at 42°C.  
Second strand cDNA synthesis was carried out at 18°C for two hours  in a total volume of 340 
µl, using 20 units E. coli DNA ligase, 80 units E. coli DNA polymerase I and 4 units RNase H 
in the presence of 250 µM of each dNTP.  After 2nd strand cDNA synthesis, 0.5 µl RNase A 
(100mg/ml) (Qiagen) was added and the samples were incubated at 37°C for half an hour.  
Thereafter 7.5 µl proteinase K (10mg/ml) (Sigma) was added and the samples were further 
incubated at 37°C for another half hour.  After cDNA synthesis was completed, samples were 
phenol-chloroform extracted, using Phase Lock Gel (5 Prime-3 Prime, Inc.) and ethanol 
precipitated.  Biotinylated antisense cRNA was synthesized from the dsDNA template, using 
T7 RNA polymerase (MEGAscript T7 Kit, Ambion, Inc.).  A 20 µl reaction volume contained 
between 0.3-1.5 µg cDNA, 7.5 mM of both ATP and GTP, 5.6 mM of both UTP and CTP and 
1.8 mM of both biotinylated Bio-16-UTP and Bio-11-CTP (ENZO diagnostics) and 2 µl 10x 
T7 enzyme mix.  The reaction was incubated at 37°C for 8 hours.  Thereafter the 
unincorporated NTPs were removed by putting the sample over an RNeasy spin column 
(Qiagen).  Samples were precipitated, taken up in 20 µl DEPC treated water and 
spectrophotometrically quantified.  Thereafter, 40 µg of the biotinylated antisense cRNA was 
fragmented by heating the sample to 95°C for 35 min in a volume of 25 µl, containing 40 mM 
tris-acetate (pH 8.1), 100 mM KOAc, 30 mM MgOAc. After the fragmentation, the samples 
were placed on ice. 
Gene Chips were pre-hybridized with 220 µl hybridization buffer (1x MES (pH 6.7), 1 M 
NaCl, 0.01 % triton, 0.5 µg/µl acetylated BSA, 0.5 µg/µl sonicated herring sperm DNA) for 
15 min at 45°C on a rotisserie (Heidolph, Schwabach, Germany) at 60 rpm.  Hybridization 
was done in a final volume of 220 µl hybridization buffer, containing 40 µg fragmented 
biotinylated cRNA.  The samples were heated to 95°C for 5 min and briefly spun down.  
Hybridizations were carried out for 16 hours at 45°C with mixing on a rotisserie at 60 rpm.  
After hybridization, the arrays were briefly rinsed with 6x SSPE-T (0.9 M NaCl, 0.06 M 
NaH2PO4, 6 mM EDTA, 0.01 % triton ) and washed on a Fluidics station (Affymetrix Inc.).  
Hybridized arrays were stained with 220 µl detection solution (1x MES buffer, containing 2.5 
µl streptavidin-R phycoerythrin conjugate (1mg/ml) (Molecular Probes)) and 2.0 mg/ml 
acetylated BSA (Sigma) at 40°C for 15 min and washed again.   
 
Data analysis 
Pixel intensities were measured with a commercial confocal laser scanner (Hewlett Packard) 
and expression signals were analyzed with commercial software (Genechip 3.1, Affymetrix 
Inc.).  Detailed data analysis was carried out using Race-A (Roche), Access 97 and Excel 97 
(Microsoft) software.  For quantification of relative transcript abundance the normalized 
Average Difference value (Avg Diff) was used.  For each of the three experimental conditions 
(wt, hs-wt, hs-lab), four replicates were carried out (for the experimental conditions wt and 
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hs-wt see [39], including supplementary data).  For the difference of the means of the Avg 
Diff values over the 4 replicates between condition 1 (hs-wt) and condition 2 (hs-lab) a t-test 
was performed.  Moreover, for downregulation, the mean Avg Diff value of a gene had to be 
above or equal to 50 in condition 1; for upregulation, the mean Avg Diff value of a gene had 
to be above or equal to 50 in condition 2.  Genes which had a normalized Avg Diff below 20 
obtained automatically an Avg Diff of 20 (Race-A protocol).  To obtain a comprehensive 
analysis of the number and identity of genes differentially regulated by lab, candidates that 
were already differentially expressed in heat shock treated wildtype embryos compared to non 
heat shocked wildtype controls, were excluded from further analysis (data not shown; [39]).  
Previously, we have used quantiative RT-PCR to confirm that relative expression level 
changes in the 1.5-fold and above range, as detected on this array, accurately reflect 
differences in mRNA abundance in vivo in Drosophila embryos [39].  In consequence, in this 
report only relative expression level changes in the 1.5-fold and above range are presented. 
 
Reverse Transcriptase PCR (RT-PCR) 
Three hundred ng of poly(A)+ RNA, isolated from heat shocked wild type embryos and heat 
shocked hs-lab embryos (mRNA isolation kit; Roche Diagnostics), was reverse transcribed 
with AMV-RT and random hexamers (first-strand cDNA synthesis kit for RT-PCR; Roche 
Diagnostics).  PCR was performed with 100 pg of  template DNA and gene-specific primers 
(designed, using SEQ WEB, Wisconsin Package Version 10.0, GCG) on a light cycler 
(LightCycler, Roche Diagnostics).  Continuous fluorescence observation of amplifying DNA 
was made possible by using SYBR Green I (LightCycler- FastStart DNA master SYBR 
GreenI; Roche Diagnostics).  After cycling, a melting curve was produced by slow 
denaturation of the PCR end products to check the specificity of amplification.  To compare 
the relative amounts of PCR products, we monitored the amplification profile on a graph, 
displaying the log of the fluorescence against the number of cycles. Relative change folds for 
a given gene under both conditions (heat shock wt vs. heat shock hs-lab) were calculated by 
using the fit point method (LightCycler operator’s manual, version 3.0, Roche Diagnostics). 
Functional classification 
The genes represented on the high-density oligonucleotide array were grouped into 14 
functional classes according to the function of the gene product and currently available 
genetic data [39].  For this, notations in Flybase, Interactive Fly, and SWISS-PROT/TrEMBL 
databases were used.  A comprehensive presentation of all the genes represented on the 
oligonucleotide array as well as their attribution to functional classes is given as 
supplementary data at website (www.pnas.org).  
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Fig. 1. Heat shock driven ubiquitous overexpression of lab monitored by in situ hybridization 
and immunocytochemistry.  (A, B, C, D) RNA in situ hybridization; (E, F, G, H) 
immunocytochemical staining.  lab gene expression is shown in heat shocked wild-type 
embryos (A, C, E, G) and in heat shocked embryos carrying a hs-lab construct (B, D, F, H).  (A, 
B, E, F) Overview of stage 10-17 embryos.  (C, D) Higher magnification of a single stage 15 
embryo and (G, H) a single stage 13 embryo; lateral view and anterior is to the left. Embryos 
were exposed to a heat shock at 36° C for 25 min and were allowed to recover for another 25 
min before fixation. 
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Transcriptional regulation RNA binding
lab labial BicC Bicaudal C
CG11971 CG11971 swa swallow
Gnf1 Germ line transcription factor 1 osk oskar
stc shuttle craft vas vasa
wdn wings down stau staufen
gro groucho how held out wings
Eip75B Ecdysone-induced protein 75B elav embryonic lethal abnormal vision
HLHm7 E(spl) region transcript m7
pros prospero Signal transduction
Pdp1 PAR-domain protein 1 pll pelle
Dll Distal-less Ras85D Ras oncogene at 85D
tup tailup Btk29A Btk family kinase at 29A
CrebA Cyclic-AMP response element binding protein A Gtp-bp GTP-binding protein
HLHm3 E(spl) region transcript m3 Src42A Src oncogene at 42A
mirr mirror
Mef2 Myocyte enhancing factor 2 Cell cycle
vvl ventral veins lacking twe twine
scrt scratch CycB Cyclin B
hkb huckebein Pen Pendulin
ab abrupt polo polo
CycD Cyclin D
Metabolism
SamDC S-adenosylmethionine decarboxylase Cytoskeleton/structural proteins
Cyp4e2 Cytochrome P450-4e2 AnnX Annexin X
awd abnormal wing discs fax failed axon connections
Tpi Triose phosphate isomerase Klp64D Kinesin-like protein at 64D
Pdk Pyruvate dehydrogenase kinase LanB1 Laminin B1
Eno Enolase vkg viking
Pp2A-29B Protein phosphatase 2A at 29B
Crc Calreticulin Transcription/replication/repair
Pi3K59F Phosphotidylinositol 3 kinase 59F mus309 mutagen-sensitive 309
Atpα Na pump α subunit TfIIFB Transcription factor IIFB
Bc Black cells Mcm5 Minichromosome maintenance 5
Mlc-k Myosin light chain kinase TfIIFA Transcription factor IIFA
Pepck Phosphoenolpyruvate carboxykinase
Transposable elements
Proteolytic systems/apoptosis R2-element R2-element
UbcD4 Ubiquitin conjugating enzyme 4 jockey jockey element ORF2
Uch Ubiquitin carboxy-terminal hydrolase 3S18 3S18 element
Pros28 Proteasome 28kD subunit 1 R2-element R2 rDNA element
αTry αTrypsin
Pros35 Proteasome 35kD subunit Chromatin structure
Prosb2 Proteasome b2 subunit wapl wings apart-like
Fur2 Furin 2 thr three rows
ben bendless corto corto (CP-1)
Prosα7 Proteasome α7 subunit corto corto (ccf)
faf fat facets
Dcp-1 Death caspase-1 Secreted proteins
Ubi-p63E Ubiquitin-63E gbb glass bottom boat
mspo  M-spondin
Cell surface receptors/CAMs/ion channels
tor torso Unknown function
smo smoothened Atu Another transcription unit
drl derailed CG4844 CG4844
fz2 frizzled 2
Nrt Neurotactin Translation
Nrx Neurexin Nmda1 Aspartate receptor ass. protein
Gp150 Gp150
Rya-r44F Ryanodine receptor 44F
Hem HEM-protein
rho rhomboid
18w 18 wheeler
trn tartan
Fig. 2. Genes differentially expressed in response to heat shock induced overexpression of lab, grouped according to functional classes. Bars represent the fold-
change between differentially expressed genes in heat shock treated wildtype embryos and heat shocked hs-lab embryos. Positive values indicate that the relative
expression level of a gene is increased (up-regulated) following lab overexpression and negative values indicate a decrease (down-regulated). Absolute Average
Difference (Avg Diff) values are given for the lab overexpression condition as follows: white bars represent Avg Diff < 100, grey bars represent Avg Diff ranging
from 100-1000, and black bars represent Avg Diff >1000. 
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 Genes that are differentially expressed following heat induced ubiquitous overexpression of lab in stage 10-17 hs-lab embryos, 
grouped according to functional classses.  (N) Number of genes within a functional group present on the chip.  (n) Number of 
genes differentially expressed within a functional group following lab overexpression.  (n/N x 100) Number of differentially 
expressed genes within a functional class following lab overexpression, given as % of the total number of genes in this class 
present on the array.  (down-regulated) Total number of genes within each functional class differentially down-regulated following 
lab overexpression.  (up-regulated) Total number of genes within each functional class differentially up-regulated following lab 
overexpression.  (*) The functional class Heat shock proteins was excluded from the analysis (see Materials and methods). 
Table 1. Genes differentially expressed in response to lab overexpression  
 
Functional class 
Genes on the 
array 
(N) 
Differentially 
expressed transcripts 
(n) 
n/N x 100 
(%) 
down- 
regulated 
up- 
regulated 
Signal transduction 107 5 4.7 2 3 
Transcriptional regulation 263 20 7.6 14 6 
Cell cycle 37 5 13.5 0 5 
Cytoskeleton/structural proteins 149 5 3.4 4 1 
Metabolism 315 13 4.1 6 7 
Translation 59 1 1.7 1 0 
Heat shock proteins 18 * * * * 
Transcription/replication/repair 73 4 5.5 0 4 
Proteolytic systems/apoptosis 62 12 19.4 1 11 
Cell surface 
receptors/CAMs/ion channels 181 12 6.6 10 2 
Transposable elements 35 4 11.4 3 1 
Chromatin structure 36 4 11.1 2 2 
RNA binding 59 7 11.9 2 5 
Secreted proteins 34 2 5.9 2 0 
Unknown function 85 2 2.4 1 1 
 ΣN = 1513 Σn = 96  48 48 
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Table 2 - Comparison of change folds between oligonucleotide 
arrays and RT-PCR 
      
 Avg Diff (array)  Change fold 
      
Gene HS-wt HS-lab  Array RT-PCR 
lab  41 1078  26.3 55.7 
swa  20 406  20.3 18.4 
UbcD4  44 423  9.6 6.5 
twe  20 132  6.6 4.9 
cycB  243 1344  5.5 4.6 
Uch  61 312  5.1 12.1 
sqd  373 370  1.0 1.1 
scrt  225 79  -2.9 -3.7 
Pepck  610 171  -3.6 -4.6 
 
RT-PCR was performed on cDNA derived from heat shocked wild type embryos and heat shocked hs-lab 
embryos. Change folds determined by RT-PCR are represented as the mean value of eight independent 
replicates, derived from two different cDNA preparations. 
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Summary 
Hox genes encode evolutionarily conserved transcription factors involved in the specification 
of segmental identity during embryonic development.  This specification of identity is thought 
to be directed by differential Hox gene action, based on differential spatio-temporal 
expression patterns, protein sequence differences, interactions with cofactors, and regulation 
of specific downstream genes.  During embryonic development of the Drosophila brain, the 
Hox gene labial is required for the regionalized specification of the tritocerebral neuromere; in 
the absence of labial the cells in this brain region do not acquire a neuronal identity and major 
axonal pathfinding deficits result.  Here we use genetic rescue experiments to investigate the 
functional equivalence of the Drosophila Hox gene products in the specification of the 
tritocerebral neuromere.  Using the Gal4-UAS system, we first demonstrate that the labial 
mutant brain phenotype can be rescued by targeted expression of the Labial protein under the 
control of CNS-specific labial regulatory elements.  We then show that under the control of 
these CNS-specific regulatory elements all other Drosophila Hox gene products, except 
Abdominal-B, are able to efficiently replace Labial in the specification of the tritocerebral 
neuromere.  We also observe a correlation between the rescue efficiency of the Hox proteins 
and the chromosomal arrangement of their encoding loci.  Our results indicate that, despite 
considerably diverged sequences, most Hox proteins are functionally equivalent in their 
capability to replace Labial in the specification of neuronal identity.  This suggests that in 
embryonic brain development, differences of Hox gene action rely mainly on cis-acting 
regulatory elements and not on Hox protein specificity.   
 
 
Introduction 
The homeotic/Hox genes encode a network of evolutionarily conserved transcription factors 
that are involved in the specification of segmental identity along the anterior-posterior body 
axis of animals as diverse as insects and vertebrates.  This specification of identity is thought 
to be directed by differential Hox gene action, based on differential spatio-temporal 
expression patterns, protein sequence differences, interactions with cofactors, and regulation 
of specific downstream genes (Carroll, 1995; Graba et al., 1997; Gellon and McGinnis, 1998; 
Mann and Morata, 2000).  The functional roles of Hox genes in insect development have been 
studied extensively in Drosophila.  In Drosophila, these genes are arranged along the 
chromosome in two gene clusters known as the Antennapedia and Bithorax complexes.  There 
is a correlation between the relative position of the Hox genes in the clusters and their spatial 
and temporal expression pattern in the body; genes located towards the 3’ end are expressed 
more anteriorly and earlier than genes towards the 5’ end (spatial and temporal colinearity) 
(Manak and Scott, 1994; Duboule and Morata, 1994; Maconochie et al., 1996).   
 
Hox genes are expressed in the developing brain and ventral nerve cord of Drosophila in an 
ordered set of domains.  In the embryonic brain, specific Hox genes are expressed in the 
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posterior half of the tritocerebrum (and to a small extent in the deutocerebrum) as well as in 
the three subesophageal neuromeres.  The tritocerebrum is the posterior neuromere of the 
supraesophageal ganglion and consists of two bilaterally symmetric hemiganglia that are 
bounded anteriorly by the deutocerebrum and are linked by the tritocerebral commissure that 
runs across the midline beneath the gut (Burrows, 1996; Reichert and Boyan, 1997).  The 
tritocerebrum is connected to more posterior parts of the brain through longitudinal 
connectives and forms projections to the frontal ganglion via the frontal connectives.  The 
Hox gene that is specifically expressed in the posterior half of the tritocerebral neuromere is 
labial (lab).  Loss-of-function lab mutations cause profound defects in the establishment of 
the tritocerebral neuromere (Hirth et al., 1998).  In lab mutants, the tritocerebral commissure 
is missing and the longitudinal connectives are reduced or absent.  Moreover, the cells in the 
lab mutant domain do not acquire a neuronal identity as exemplified by the lack of expression 
of neuronal markers indicating that lab is required for the specification of neuronal identity in 
the tritocerebrum.  Comparable effects are seen in Deformed mutants, the only major 
difference being that these effects were observed in the mandibular and anterior maxillary 
brain neuromere which is the expression domain of Deformed.  None of the other Hox gene 
mutants show comparable brain defects (Hirth et al., 1998). 
 
Here we use genetic rescue experiments to investigate the functional equivalence of all of the 
Drosophila Hox genes in specifying the neuronal identity in the tritocerebral neuromere.  For 
this we use the Gal4-UAS system (Brand and Perrimon, 1993) for targeted misexpression of 
Hox genes in the posterior tritocerebral domain (in which lab is normally expressed) of lab 
null mutants.  As expected, we find that the lab mutant brain phenotype can be rescued by 
targeted expression of the Lab protein under the control of CNS-specific lab regulatory 
elements.  We then demonstrate that under the control of these CNS-specific regulatory 
elements most of the other Drosophila Hox gene products are also able to replace the Lab 
protein in the specification of the tritocerebral neuromere.  Only the Abdominal-B protein 
does not efficiently rescue the lab mutant phenotype in the brain.  For the other Hox proteins, 
we observe a correlation between their efficiency of rescue the lab mutant brain phenotype 
and the chromosomal arrangement of their encoding loci.  Our results indicate that, despite 
considerably diverged sequences, most Hox proteins are functionally equivalent in their 
capability to replace Labial in the specification of neuronal identity in the brain.  This 
suggests that differences of Hox gene action in brain development rely mainly on cis-acting 
regulatory elements and not on Hox protein specificity. 
 
Materials and Methods 
Fly Strains and Genetics   
The P{w+ lab::Gal4}K5J2 driver was generated by cloning a genomic fragment from labial 
that extends from the HindIII site 3.6 Kb upstream of the transcriptional start site downstream 
to the BssHII site at +10 bp (Chouinard and Kaufman, 1991).  The downstream site was 
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converted using a HindIII linker creating a 3.6 Kb HindIII fragment that was cloned into this 
site in pGaTN (Brand and Perrimon, 1993).  This plasmid was then cut with NotI to remove 
the lab::Gal4 cassette, cloned into pCosperNot (supplied by John Tamkun) and used to 
generate the transgenic line P{w+ lab::Gal4}K5J2. 
 
For lab::Gal4 specific targeted misexpression of proboscipedia (pb), Deformed (Dfd), 
abdominal-A (abd-A), and Abdominal-B (Abd-B) in lab mutant embryos, the following 
UAS::Hox responder lines were used: p[UAS::pb 49.1] homozygous on chromosome II (Aplin 
and Kaufman, 1997); p[UAS::Dfd] homozygous on chromosome II (Brown et al.,1999); 
p[UAS::abd-A 21.6] homozygous on chromosome I (Greig and Akam, 1993), supplied by M. 
Akam; p[UAS::Abd-Bm] homozygous on chromosome II (Castelli-Gair et al., 1994) driving 
the expression of the Abd-Bm form (Casanova et al. 1986; Zavortink and Sakonju 1989), 
supplied by M. Akam.   
 
For lab::Gal4 specific targeted misexpression of labial (lab), Sex combs reduced (Scr), 
Antennapedia (Antp), and Ultrabithorax (Ubx) in lab mutant embryos, p[UAS::lab], 
p[UAS::Scr], p[UAS::Antp], and p[UAS::Ubx] responder lines were generated (see also Miller 
et al., in press).  The respective Hox cDNAs were cloned into a polylinker downstream from a 
minimal hsp70 promoter of the Gal4 responder plasmid pUAST (Brand and Perrimon, 1993) 
which contains a P-element with the white mini-gene as a marker.  The hsp70 promoter is 
activated in the presence of Gal4 due to five upstream Gal4 binding sites (UAS).  For 
generating p[UAS::lab], a 2.1 kb cDNA derived from a 2.4a minigene (including the second 
intron; Chouinard and Kaufman, 1991) encompassing the entire lab coding region, was 
digested with the SspI to generate the 2.1Kb cDNA which was inserted into pBlueScriptKS+ 
(Stratagene) at the EcoRV site.  The cDNA was subsequently removed with EcoRI(5') and 
KpnI(3') for insertion into pUAST at the same sites.  For generating p[UAS::Scr], the 1.2 Kb 
BamHI(5') and MluI(3') truncated Scr L3 cDNA (Mahaffey and Kaufman, 1987) was inserted 
into pSE280 (Invitrogen) using the same sites.  A partial Scr cDNA was then removed from 
pSE280 with NcoI(5'), blunted with Klenow, and then released with XhoI.  This modified 
cDNA was inserted into pUAST at the Klenow blunted EcoRI and XhoI sites.  For generating 
p[UAS::Antp], the entire Antp G1100 cDNA (Scott et al., 1983) was inserted into pUAST at 
the EcoRI site.  For generating p[UAS::Ubx], the previously reported Ubx NAB3 cDNA 
containing isoform 1S, which is the predominant embryonic cDNA (O'Connor et al., 1988), 
was inserted into pUAST at the EcoRI site.  All strains as well as all experimental genotypes 
were maintained in standard laboratory cultures at 25°C.   
 
Control experiments verified that the P{w+ lab::Gal4}K5J2 driver is expressed in a spatial 
pattern, which corresponds to that of endogenous lab in the procephalon, and in the 
tritocerebral neuromere.  UAS::transgene activation in the procephalon is delayed for 2.5hrs 
as compared to earliest presence of endogenous Lab protein (Kaufman et al., 1990), thus 
under the control of P{w+ lab::Gal4}K5J2, UAS::responder activation starts at late stage 10 
(5h-5.5h AEL; Campos-Ortega and Hartenstein, 1997).  Phenotypic penetrance of the lab 
mutant brain phenotype was 88.6% (n =209) as determined with the lab null allele labvd1 
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(Merrill et al., 1989; Hirth et al., 1998) using flies of the genotype labvd1/TM6B-UbxlacZ.  
The ability of the Hox proteins to rescue the lab mutant brain phenotype was determined by 
crossing P{w+ lab::Gal4}K5J2; labvd1/TM6B-UbxlacZ to either P{UAS::lab}, labvd1/TM3-
AntplacZ or to flies of genotype P{UAS::Hox}, labvd1/ TM6B-UbxlacZ where Hox = pb, Dfd, 
Antp, and Abd-B; or to flies of genotype, P{UAS::Hox}/+; labvd1/+ for Hox = Scr , Ubx and 
abd-A.  All rescue experiments reported here were carried out at 25°C; no significant 
differences in rescue efficency were obtained when rescue experiments were carried out at 
28°C.   To identify rescued lab-/- cells and their axonal projection pattern, UAS::tau-lacZ 
located on the X chromosome (Callahan and Thomas, 1994) was additionally crossed in. 
 
Immunocytochemistry and Genetic Rescue Analysis   
Whole-mount immunocytochemistry and laser confocal microscopy was performed as 
previously described (Hirth et al., 1998).  In genetic rescue experiments, P{w+ 
lab::Gal4}K5J2 driven P{UAS::Hox} activity in homozygous lab null mutants (labvd1/labvd1) 
was confirmed by the absence of balancer-specific (TM6B-UbxlacZ; TM3-AntplacZ) β−gal 
and/or Labial immunoreactivity as well as by the presence of corresponding Hox 
immunoreactivity in the tritocerebral lab domain.  The criteria used to judge lab-/- embryos as 
fully rescued were (1) the presence of the tritocerebral commissure linking the two 
tritocerebral hemiganglia, (2) the restoration of the longitudinal pathways between the supra- 
and subesophageal ganglia, and (3) the expression of neuron-specific molecular labels as 
assayed by anti-HRP and anti-Elav immunoreactivity (Hirth et al., 1998).  Only when all three 
criteria were fulfilled, the tritocerebrum of a lab-/- mutant embryo was scored as rescued.  
Additionally, in embryos of the genotype UAS::tau-lacZ/+; lab::Gal4/UAS::Hox; lab-/-, the 
specificity of rescue was also determined by the presence of correct axonal projections of 
rescued lab-/-cells along the rescued tritocerebral commissure. 
 
Laser Confocal Microscopy 
For laser confocal microscopy, a Leica TCS SP was used.  Optical sections ranged from 0.4 to 
2 µm recorded in line average mode with picture size of 512 x 512 pixels.  Captured images 
from optical sections were arranged and processed using IMARIS (Bitplane).  Figures were 
arranged and labeled using Adobe Photoshop. 
 
 
Results 
In the embryonic brain of Drosophila, the labial (lab) gene is expressed in the posterior half 
of the tritocerebral neuromere (Fig. 1A-D).  In lab loss-of-function mutants, regionalized 
axonal patterning defects occur in the lab domain which are due to both cell-autonomous 
effects and non cell-autonomous effects.  Thus, in the absence of lab, mutant cells are 
generated and positioned corrrectly in the brain, but these cells do not extend axons.  
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Moreover, extending axons from other neighboring wild-type neurons stop at the mutant 
domains or project ectopically.  As a result, dramatic defects in commissural and longitudinal 
axon pathways occur (Hirth et al., 1998); the tritocerebral commissure, which links the two 
tritocerebral hemiganglia, is absent and the longitudinal pathways between the 
supraesophageal and subesophageal ganglia are reduced or absent (Fig. 1E, F).  
Immunocytochemical analysis demonstrates that cells in the mutant domain do not express 
any of the numerous neuronal markers such as ELAV that positionally equivalent cells 
express in the wildtype, indicating a complete lack of neuronal identity in the lab mutant brain 
domain (Hirth et al., 1998).  This strong mutant phenotype is apparent in 88.6% of the cases 
(n = 209).  These data indicate that lab is involved in the specification of tritocerebral 
neuronal identity in the Drosophila brain. 
 
In order to carry out a genetic rescue of the mutant brain phenotype in lab mutant embryos, 
we made use of the Gal4-UAS system (Brand and Perrimon, 1993).  For this, a transgenic fly 
line carrying a Gal4 transcriptional activator under the control of the lab promoter together 
with CNS-specific upstream enhancer elements of the lab gene was used (see Methods).  By 
crossing this lab::Gal4 line to different UAS–responders it is possible to express the 
responder constructs in a pattern that corresponds to that of the endogenous lab gene.  To 
verify this we first crossed the lab::Gal4 line to transgenic lines carrying a UAS::taulacZ 
(Callahan and Thomas, 1994) reporter construct.  The spatial expression domain of this 
reporter construct in the embryonic brain mimicked the endogeneous labial expression 
domain (Fig 2. A, B).  Spatially localized expression domains were seen in the posterior parts 
of the tritocerebral neuromere. (Ectopic reporter expression was seen in a small number of 
individual cells in the deutocerebral and mandibular neuromeres.)  Double immunostaining 
experiments using anti-lacZ and anti-Lab antibodies confirmed that lacZ expression occurred 
in the axons and cortical cytoskeleton of those cells that showed nuclear Lab expression (Fig. 
2 C, D). 
 
We next determined whether the labial mutant brain phenotype could be rescued by 
transgenic expression of the Lab protein in a labial null mutant background.  For this a 
UAS::lab responder was driven by the lab::Gal4 driver in the tritocerebral lab mutant 
domain.  Using this approach, we obtained efficient rescue of all of the tritocerebral defects in 
the lab mutants.  Thus, in these rescued embryonic brains the tritocerebral commissure was 
present, the longitudinal pathways between the supra- and subesophageal ganglia were 
restored, and cells in the mutant domain showed correct neuron-specific molecular labels as 
revealed by anti-Elav (not shown) and anti-HRP immunoreactivity (Fig. 3 A, B).  A 
quantification of the rescue efficiency for Lab in these experiments is given in table 1.  The 
fact that in these experiments Lab protein was indeed expressed specifically in the 
tritocerebral domain was demonstrated by carrying out anti-Lab immunostaining on these 
rescued brains (Fig. 3 C, D).  
 
To determine whether other members of the Hox gene complex might also be able to rescue 
the lab mutant brain defects and, thus, be functionally equivalent to Lab in determining the 
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segmental identity of the tritocerebral neuromere, transgenic lines were used in which the 
coding sequence of each of the remaining 7 Hox genes was placed under UAS control (see 
Methods and Miller et al., 2001).  As a control, we first determined whether lab::Gal4 driven 
misexpression of any of the 8 Hox proteins in a lab+ background had any effects on the 
development and specification of the tritocerebral lab domain.  In none of these experiments 
did we detect any sign of morphological abnormalities in the tritocerebrum or in any other 
part of the embryonic brain.  Thus, in lab::Gal4/UAS::Hox; lab+ embryos, all labeled 
structures in the tritocerebral lab domain were normal.  Moreover, lab::Gal4 driven 
UAS::taulacZ reporter gene expression in conjunction with Hox gene misexpression in a 
labial+ background revealed that the tritocerebral lab+ cells showed a wildtype-like axonal 
projection pattern. 
 
Next, we expressed each of the remaining 7 UAS::Hox responders under the control of the 
lab::Gal4 driver in the lab mutant domain.  We first investigated the Hox proteins of the 
Antennapedia-Complex, since in the wildtype, all five proteins of this complex are expressed 
in specific domains of the developing brain (Hirth et al., 1998).  Surprisingly, all of the 
Antennapedia-Complex Hox proteins were able to rescue the lab mutant brain defects in these 
experiments.  Examples of the ability of these Hox proteins to rescue the labial mutant brain 
phenotype are shown for Sex combs reduced (Scr) and Antennapedia (Antp) (Fig. 4).  In both 
cases, an efficient rescue of the tritocerebral defects in the lab mutants was obtained; the 
tritocerebral commissure was present, the longitudinal pathways were restored, and cells in 
the mutant domain showed correct neuron-specific molecular labels.  In addition to the 
lab::Gal4 driven ectopic expression of Scr and Antp in the tritocerebral labial mutant domain, 
the large endogenous expression domains of these genes were observed unchanged in the 
subesophageal ganglion for Scr, and in the subesophageal ganglion and ventral nerve cord for 
Antp (Fig. 4 C, F) (Hirth et al., 1998).  A quantification of the rescue efficiency for all of the 
Antennapedia-Complex Hox proteins in these experiments is given in table 1. 
 
We next investigated the rescue potential of the Hox proteins of the Bithorax-Complex in 
comparable experiments.  In contrast to the Hox proteins of the Antennapedia-Complex, the 
Bithorax-Complex Hox proteins are not expressed in the developing brain of the wildtype, 
rather their expression domains are restricted to the ganglia of the ventral nerve cord (Hirth et 
al., 1998).  Remarkably, as was the case for the Antennapedia-Complex proteins, both the 
Ultrabithorax (Ubx) and the Abdominal-A (Abd-A) gene products of the Bithorax-Complex 
were able to rescue the lab mutant brain defects in these experiments.  Once again, an 
efficient rescue of the tritocerebral brain defects in the lab mutants was obtained; the 
tritocerebral commissure was present, the longitudinal pathways were restored, and cells in 
the mutant domain showed correct neuron-specific molecular labels. An example of the 
ability of these Hox proteins to rescue the labial mutant brain phenotype is shown for Ubx 
(Fig. 5 A-C).  Note that, in addition to the lab::Gal4 driven ectopic expression of Ubx in the 
tritocerebral labial mutant domain, the endogenous Ubx expression domain in the ventral 
nerve cord is also seen (Fig. 5 C) (Hirth et al., 1998).  In contrast to the other two Bithorax-
Complex Hox proteins, use of the Abdominal-B (Abd-B) gene product did not result in an 
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efficient rescue of the tritocerebral defects in the lab mutants.  In over 90% of the 
lab::Gal4/UAS::Abd-B; lab-/- mutant embryos, profound axonal projection deficits were 
observed in the brain; the tritocerebral brain commissure was absent, the longitudinal brain 
pathways were reduced or lacking, and cells in the mutant domain lacked correct neuron-
specific molecular labels (Fig. 5 D-F).  A quantification of the rescue efficiency for all of the 
Bithorax-Complex Hox proteins in these experiments is given in table 1.  
 
The efficient rescue of the tritocerebral defects in the lab mutants, which is achieved by 
targeted misexpression of 7 out of 8 Hox genes is striking; in the rescued embryonic brains 
the tritocerebral commissure was present, the longitudinal pathways between the supra- and 
subesophageal ganglia were restored, and cells in the mutant domain showed correct neuron-
specific molecular labels.  However, it is conceivable, that the rescue of all of these neuronal 
structures might be due to a restoration of generic neuronal properties in the cells of the lab 
mutant domain and not due to the rescue of specific neuronal identities in these cells.  To 
investigate this, we determined whether the rescued cells in the lab-/- domain project their 
axons correctly accross the rescued tritocerebral commissure, as is the case for lab-expressing 
neurons in the wildtype brain.  For this, we coexpressed a UAS::taulacZ reporter gene with 
each UAS::Hox responder in the tritocerebral lab mutant domain using the lab::Gal4 driver.  
This coexpression makes it possible to visualize both the cell bodies and the axonal 
projections of the rescued lab-/- cells.  For all of the Hox gene products except AbdB these 
experiments demonstrated that the rescued tritocerebral lab-/- cells were again able to extend 
axons that projected correctly along the rescued tritocerebral commissure (Fig. 6).  
 
As is indicated in Table 1, the relative efficiency of rescue of the brain phenotype in lab 
mutants varied systematically for the different Hox proteins.  The lab responder achieved the 
best rescue efficiency while the other Hox responders had slightly lower rescue efficiencies.  
Figure 7 shows the rescue efficiency of all other Hox proteins relative to the rescue efficiency 
of Lab, which was taken as 100%.  Interestingly, the decline in relative rescue efficiency for 
these other Hox proteins appears to be co-linear (Lab>Pb>Dfd>Scr>Antp>Ubx>Abd-A) in 
that it reflects the proximal to distal arrangement of their encoding loci on the chromosome.   
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Discussion 
Our findings indicate that Proboscipedia (Pb), Deformed (Dfd), Sex combs reduced (Scr), 
Antennapedia (Antp), Ultrabithorax (Ubx), and Abdominal-A (Abd-A), but not Abdominal-B 
(Abd-B), are able to efficiently substitute for Lab in determining the segmental identity of the 
Drosophila brain.  Morphological evidence for a homeotic transformation of the tritocerebral 
neuromere into one of a different segmental identity was not observed in any of these rescue 
experiments.  This suggests, that all of the Hox proteins, with the exception of Abd-B, are to a 
large degree functionally equivalent to Lab in this aspect of embryonic brain development.  
This surprising functional equivalence contrasts with the general notion, derived from 
experiments on the specification of other body parts in Drosophila, that Hox proteins assign 
different identities along the anterior-posterior body axis by acting as specific selectors of 
different, alternative developmental pathways (Garcia-Bellido, 1975; Lawrence and Morata, 
1994; Gellon and McGinnis, 1998; Mann and Morata, 2000).  
 
There are several possible explanations for this discrepancy.  First, the functional role of Lab 
in the specification of neuronal identity in the brain may differ from the role of other Hox 
proteins in other parts of the CNS.  For example, Hirth et al. (1998) find that the loss-of-
function phenotype of lab (and Dfd) in the embryonic CNS differs from that of the remaining 
Hox genes.  Moreover, in contrast to other domains in the embryonic CNS, there is an 
absence of overlapping expression with other Hox proteins, so that there is no genetic 
“backup” in the tritocerebrum.  Similar oberservations on Lab have been made in epidermal 
structures (reviewed by Kaufman et al., 1990; McGinnis and Krumlauf, 1992; Morata, 1993).  
Second, it is conceivable that all Hox proteins can specify neuronal identity and the generic 
formation of commissural and longitudinal connections in the CNS.  However, this seems 
unlikely, since the morphology and innervation of the triocerebral neuromere is unique and 
highly specific and unlike that of any other neuromere in the CNS (Burrows, 1996).  
Similarly, the morphology, mode of formation and gut-specific association of the developing 
tritocerebral commissure is clearly different from that of the other ganglionic commissures in 
the embryonic CNS (e.g. Wildemann et al, 1997).  Third, Hox proteins may indeed be to a 
larger degree functionally interchangable in the CNS than hitherto expected.  In this respect, 
two sets of recent functional complementation experiments carried out on mammalian 
Hoxa3/Hoxd3 genes and on mammalian Hox11a/Hox11d genes are noteworthy since they 
indicate that paralogous gene products can carry out identical biological functions if they are 
placed unter the control of the appropriate cis-acting regulatory elements (Zakany et al., 1996; 
Greer et al., 2000).  Our results extend this notion of functional equivalance of Hox genes 
from the level of paralogous genes to the level of the entire Hox gene cluster, excepting Abd-
B.   This, in turn, suggests that almost all of the Hox proteins can carry out identical biological 
functions in the Drosophila brain, if they are under the control of the same cis-acting 
regulatory elements. 
 
In our experiments, all of the Hox responders were expressed in the lab mutant under the 
control of the identical, lab-specific regulatory elements.  Under these circumstances, the Lab 
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responder achieved the best rescue efficiency, while the other Hox responders (with the 
exception of Abd-B) had somewhat lower rescue efficiencies which ranged from 86%-59% of 
the rescue values achieved by Lab (see Fig. 7).  Interestingly, the relative rescue efficiency of 
the Hox gene products Lab, Pb, Dfd, Scr, Antp, Ubx and Abd-A reflect their proximal to 
distal arrangement of their encoding loci on the chromosome.  It is conceivable, that this co-
linear correlation of rescue efficiency among theses Hox gene products is due to the 
variability in the Gal4-UAS system, to positional effects of transgene insertions, or to 
differences in transgene expression levels.  However, a more reasonable explanation is, that 
the decline in relative rescue efficiency among these Hox proteins, as well as the qualitative 
difference between Abd-B and the other Hox proteins in their ability to rescue the lab mutant 
brain phenotpye, is due primarily to Hox protein sequence differences.  Hox proteins do 
indeed show sequence differences in several respects.  The most notable differences reside in 
the homeodomain, the hexapeptide motif (lacking in Abd-B), and the linker lengths between 
the homeodomain and the hexapeptide motif (Gehring et al., 1994; Duboule, 1994; Mann, 
1995; Chan et al., 1996; Mann and Chan, 1996; Piper et al., 1999; Passner et al., 1999).  
 
We posit that the findings reported here have implications for understanding Hox gene 
function and evolution.  The functional equivalence of almost all of the Hox proteins in brain 
neuromere specification implies that the specificity of Hox gene action is achieved mainly 
through regulatory elements that control position, timing and level of Hox gene expression 
and only to a lesser degree through Hox protein sequence differences.  Similar findings have 
been obtained in studies on Pax gene interchangeability in Drosophila (Li and Noll, 1994).  
Thus, the genes paired and gooseberry, which have distinct developmental roles in 
embryogenesis and which have considerably diverged coding sequences, can exert the same 
conserved function in genetic rescue experiments.  Comparable findings have recently been 
reported in mammals (Bouchard et al., 2000), corroborating the notion put forward by Noll 
that the essential difference among these developmental regulatory genes of the same family 
may reside in their cis-regulatory regions.   
 
The fact that the expression of different Hox genes in the lab mutant domain does not cause 
homeotic transformation of tritocerebral identity, suggests that Hox proteins act as 
“mediators” rather than as “selectors” within the developmental pathway that specifies 
segmental neuronal identity in the Drosophila brain.  Recent experiments using both loss- and 
gain-of-function mutations suggest that this also applies to the specification of other structures 
along the antero-posterior body axis of Drosophila.  For example, in haltere development, 
abd-A and to some extent Abd-B can substitute for Ubx gene action (Casares et al., 1996).  
Moreover, a comparable lack of Hox gene specificity has been observed in gonad 
development (Greig and Akam, 1995). 
 
Finally, the high degree of functional interchangeability of Lab and all of the other 
Drosophila Hox proteins, with the exception of Abd-B, is consistent with evolutionary studies 
which propose a common origin of all of the Hox genes from a single ancestral progenitor and 
an early singularity of Abd-B-like genes in the ancestral Hox gene cluster (Schubert et al., 
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1993).  Given the striking evolutionary conservation of structure, expression and brain-
specific function of lab and its mammalian Hox1 orthologs (Hirth and Reichert, 1999; 
Reichert and Simeone, 1999), it will now be important to determine whether functional 
equivalence among non-paralogous Hox gene products is also valid for vertebrate hindbrain 
development.  
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Table 1   
Rescue of brain defects in lab mutants by Hox transgene expression 
 
Hox protein  Lab Pb Dfd Scr Antp Ubx AbdA AbdB 
N examined  132 145 145 142 149 134 138 165 
N rescued  79 77 73 68 69 59 55 12 
% rescued  59.8 53.1 50.3 47.8 46.3 44 39.8 7.2 
% corrected  48.4 41.7 38.9 36.4 34.9 32.6 28.4   0 
 
Quantitative rescue efficiency of lab mutant brain defects by the Hox gene products Lab, Pb, 
Dfd, Scr, Antp, Ubx, Abd-A, and Abd-B expressed in the lab mutant under the control of the 
same lab-specific cis-acting regulatory elements.  The number of embryos examined (N 
examined), the number of examined embryos showing a complete rescue of the tritocerebral 
brain defects (N rescued), the percentage of embryos showing a complete rescue of the 
tritocerebral brain defects (% rescued), and the corrected percentage values for a rescue of the 
tritocerebral brain defects (% corrected) are shown.  Percentage values were corrected in 
order to take account of the phenotypic penetrance of the lab mutation in tritocerebral 
development (88.6%).  Thus, the corrected percentage values were calculated by substracting 
11.4% from the uncorrected percentage values. 
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Figure 7
Relative rescue efficiency of Hox gene products as related to Lab. The relative efficiency of rescue of the
tritocerebral brain defects in lab null mutants is shown for the Hox gene products Lab, Pb, Dfd, Scr, Antp, Ubx,
Abd-A, and Abd-B expressed in the lab mutant under the control of the same lab -specific cis-acting regulatory
elements (see Table 1). The rescue efficiency for Lab is taken as 100% and the rescue values (the relative
percentage of embryos showing a complete rescue of the tritocerebral brain defects) of the other Hox gene
products are shown in percentage relative to this. The relative rescue efficiency of the Hox gene products
(Lab>Pb>Dfd>Scr>Antp>Ubx>Abd-A) reflects the proximal to distal arrangement of their encoding loci on the
chromosome.  
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Abstract 
Background:  The homeobox genes of the orthodenticle (otd)/Otx family play conserved 
roles in embryogenesis of the head and brain.  Gene replacement experiments show that the 
Drosophila otd gene and orthologous mammalian Otx genes are functionally equivalent, in 
that overexpression of either gene in null mutants of Drosophila or mouse can restore defects 
in cephalic and brain development. This suggests that otd and Otx genes can control a 
comparable subset of downstream target genes in either organism.  Here we use quantitative 
transcript imaging to analyze this equivalence of Drosophila otd and human Otx gene action 
at a genomic level.   
 
Results:  Oligonucleotide arrays representing 13,400 annotated Drosophila genes were used 
to study differential gene expression in flies in which either the Drosophila otd gene or the 
human Otx2 gene was overexpressed. 287 identified transcripts showed highly significant 
changes in expression levels in response to otd overexpression, and 682 identified transcripts 
showed highly significant changes in expression levels in response to Otx2 overexpression.  
Among these, 93 identified showed differential expression changes following overexpression 
of either otd or Otx2, and for 90 of these, comparable changes were observed under both 
experimental conditions.  We postulate that these transcripts are common downstream targets 
of the fly otd gene and the human Otx2 gene in Drosophila. 
 
Conclusions: Our experiments indicate that approximately one third of the otd-regulated 
transcripts also respond to overexpression of the human Otx2 gene in Drosophila. These 
common otd/Otx2 downstream genes are likely to represent the molecular basis for the 
functional equivalence of otd and Otx2 gene action in Drosophila. 
 
 
Background 
Studies on developmental control genes involved in anterior patterning have revealed a set of 
homologous genes encoding transcription factors that are required for the development of the 
head and brain in diverse animal phyla[1-5].  A striking example for the evolutionary 
conservation of expression and function of such genes between invertebrates and vertebrates 
are the homeobox genes of the orthodenticle gene family, which includes the Drosophila 
orthodenticle (otd) and the murine Otx1 and Otx2 genes[6-9]. The Drosophila otd gene is 
expressed in the anterior region of the early embryo in a domain that includes the precursors 
of the procephalic regions of the head, and it is also expressed in anterior brain regions and in 
midline CNS structures[6, 10-15]. Mutational inactivation of otd in Drosophila results in 
defects in head structures and in deletions in anterior parts of the brain as well as in ventral 
nerve cord defects[6, 14, 16]. The two otd-related genes in the mouse, Otx1 and Otx2, are also 
expressed anteriorly in the embryo in nested domains that include the embryonic forebrain 
and midbrain[17]. Mutational inactivation of these genes result in specific defects in the head 
and anterior CNS; Otx2 null mice die early in development and fail in specification of the 
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rostral neuroectoderm and proper gastrulation[18-21]. Otx1 null mice are viable but show 
spontaneous epileptic seizures and abnormalities affecting the dorsal telencephalic cortex 
[22]. 
 
In addition to the remarkable similarities in expression patterns and mutant phenotypes of the 
otd/Otx gene family, in vivo gene replacement experiments provide further evidence for 
conservation of functional properties [3, 23-25]. In these cross-phylum rescue experiments, 
human Otx1 or Otx2 genes were overexpressed in Drosophila otd mutants and, conversely, 
murine Otx1 or Otx2 genes were replaced with the Drosophila otd gene in the mouse.  Human 
Otx1 and Otx2 genes were able to partially rescue the brain and cephalic defects in 
Drosophila although Otx2 rescues at a lower frequency than otd, and Otx1 rescues less 
efficiently still[24, 25].  Similarly, the Drosophila otd gene coding sequence introduced into 
the mice Otx1 locus was able to rescue most of the brain pattering defects in Otx1 mouse 
mutants and, when provided with the appropriate Otx2 posttranslational control elements, also 
in Otx2 mouse mutants[23, 26].  
 
Drosophila and vertebrate otd/Otx gene products share structural homology that is confined 
mainly to the homeodomain. The 60 amino acid residues of the fly otd homeodomain differ 
from the homeodomains of the human Otx1 and Otx2 protein in only three and two amino 
acids, respectively.  It, thus, seems likely that most of the conserved functional action of the 
otd/Otx genes is mediated by the evolutionarily highly conserved homeodomain of the 
encoded transcription factor protein[25, 27]. Given this highly conserved homeodomain, one 
might predict that the in vivo functional equivalence of otd/Otx genes, as demonstrated in the 
cross-phylum rescue experiments, is due to the fact that both otd and Otx genes can control a 
comparable set of downstream target genes irrespective of whether the otd/Otx genes are 
expressed in flies or in mammals[27].  However, currently, little is known about the 
downstream targets of either otd or Otx genes in flies or in mammals, and no information on 
common targets of otd and Otx genes is available in any species context[27, 28]. 
 
In order to address this issue at a genome-wide level we have combined cross-phylum 
overexpression experiments with expression profiling using oligonucleotide arrays. We 
sought to identify the common downstream target genes of fly otd and human Otx2 in 
Drosophila. To this end, we used transgenic flies which carried either the fly otd gene or the 
human Otx2 gene under the control of a heat-inducible promoter [29-33].  These experiments 
identified 287 annotated genes that showed highly significant (p≤0.001) changes in 
expression levels in response to otd overexpression in Drosophila.  Among these genes, 93 
also showed highly significant differential expression changes in response to Otx2 
overexpression.  Moreover the expression levels of 90 of these 93 genes were influenced in 
the same direction, either upregulated or downregulated, by otd and by Otx2 overexpression. 
In summary, approximately one third of the candidate otd downstream target genes in 
Drosophila also respond to overexpression of the human Otx2 gene homolog and nearly all of 
them display identical patterns of either up- or downregulation under both experimental 
conditions.  From a genome-wide perspective, it is likely that the conserved genetic control of 
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these common otd/Otx2 downstream genes forms the molecular genetic basis for the striking 
in vivo functional similarity of otd and Otx gene action in Drosophila.  
 
 
Results 
In vivo overexpression and microarray analysis 
In this study, transgenic fly strains carrying the otd coding sequence or the human Otx2 
coding sequence under control of the heat inducible Hsp70 promoter were used[24].  Stage 
10-17 embryos were given a 25-min heat pulse in order to overexpress the otd or Otx2 genes 
and allowed to recover for 25 min (see Material and Method).  Ubiquitous overexpression of 
otd and Otx2 was verified by whole mount in situ hybridization with otd- or Otx2-specific 
antisense RNA probes.  These experiments demonstrated that RNA was strongly 
overexpressed 50 min after the onset of heat shock in these strains (data not shown).  
Wildtype control flies were subjected to the identical heat shock conditions.   
 
Following ubiquitous overexpression of otd or Otx2, transcript profiles were analyzed using a 
genome-wide high-density oligonucleotide array and compared to the transcript profiles of 
heat shock treated wildtype control embryos. The transcripts represented on the 
oligonucleotide array correspond to probe sets that are complementary to approximately 
13,400 annotated Drosophila genes according to Release 1.0 of the Drosophila genome[34]. 
For each experimental condition, several replicates were carried out (see Materials and 
Methods). The degree of reproducibility within individual replicates is shown in scatter plots 
for four experimental conditions in figure 1.  A complete description of the microarray 
content as well as all primary data obtained in each individual microarray experiment are 
given as supplementary data (linked according to genome-biology). 
 
Overview of differentially expressed transcripts 
An overview of the total number of transcripts that were differentially regulated following otd 
or Otx2 overexpression is given in Table 1.  Two levels of significance for the experimental 
data are considered in this overview.  At a significance level of p≤0.001, a total of 287 genes 
were found to be differentially regulated following otd overexpression, as compared to heat 
shocked wildtype control embryos.  This corresponds to 2.1% of the genes represented on the 
array.  At a significance level of p≤0.01, a total of 762 genes were found to be differentially 
regulated following otd overexpression as compared to heat shocked wildtype control 
embryos.  This corresponds to 5.7% of the genes represented on the array.  In both cases, 
approximately one fourth of the differentially regulated transcripts corresponded to known 
genes, and the rest corresponded to genes that are currently characterized only by sequence 
information and predicted function, CG-transcripts (CG: Celera Genomics) 
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Overexpression of the human Otx2 gene in Drosophila embryos resulted in a larger number of 
differentially expressed transcripts than did overexpression of the Drosophila otd gene.  At a 
significance level of p≤0.001, a total of 682 genes were found to be differentially expressed 
following Otx2 overexpression, as compared to heat shocked wildtype control embryos.  This 
corresponds to 5.1% of the genes represented on the array.  At a significance level of p≤0.01, 
1395 genes were found to be differentially expressed following Otx2 overexpression as 
compared to heat shocked wildtype control embryos.  This corresponds to 10.4% of the genes 
represented on the array.  Again, in both cases, approximately one fourth of the differentially 
regulated transcripts corresponded to known genes, and the rest were CG-transcripts. 
 
A subset of the transcripts found to be differentially regulated following otd overexpression 
were also differentially regulated following Otx2 overexpression. Among the transcripts that 
were differentially expressed at the significance level of p≤0.001, 93 transcripts were found to 
be differentially regulated following overexpression of either gene. This implies that 32% of 
the otd-regulated transcripts were also regulated by Otx2. Among the transcripts that were 
differentially expressed at the significance level of p≤0.01, 351 transcripts were found to be 
differentially regulated following overexpression of either gene. This implies that 46% of the 
otd-regulated transcripts were also regulated by Otx2. In the following, only genes that were 
differentially expressed at the significance level of p≤0.001 are considered further.  We 
propose these genes to be potential direct or indirect downstream targets for the homeodomain 
transcription factors otd and Otx2. 
 
Functional classification of differentially expressed transcripts  
When ubiquitously expressed in the embryo, both otd and Otx2 caused a significant 
transcriptional response of genes encoding a wide variety of functionally different gene 
products.  A detailed classification of the otd- and Otx2-regulated transcripts into different 
functional classes was carried out according to Gene Ontology (GO) and is presented in Table 
2.  (In the GO classification scheme, a given gene can be grouped into more than one 
functional class; [35])  The otd- and Otx2-regulated transcripts fall into 92 GO classes, but 
only about half of these classes are characterized by more than one regulated transcript.  
 
In terms of known function, the two classes with the highest absolute and relative numbers of 
regulated transcripts were ‘enzymes’ and ‘transcription factors’; this was the case for both 
otd-regulated and Otx2-regulated transcripts. Other functional classes with high numbers of 
differentially regulated genes were ‘signal transduction’, ‘DNA binding’, ‘transporter’, 
‘protein kinase’, ‘motor’, ‘ligand binding or carrier’, and ‘endopeptidase’; again this was the 
case for both otd- and Otx2-regulated transcripts.  Indeed, in most cases in which a functional 
class was characterized by both otd- and Otx2-regulated transcripts, the relative number (n/M; 
see table 2) of otd-regulated transcripts was similar to that of Otx2-regulated transcripts.  For 
example, 2.79% of the otd-regulated transcripts versus 2.20% of the Otx2-regulated 
transcripts were classified under ‘cell adhesion’, and 3.48% of the otd-regulated transcripts 
versus 3.67% of the Otx2-regulated transcripts were classified under ‘signal transduction’.  
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Approximately half of both the otd-regulated and the Otx2-regulated transcripts belong to the 
class ‘function unknown’. 
  
Quantitative profiling of differentially expressed transcripts 
Figure 2 shows the otd-regulated transcripts that correspond to known Drosophila transcripts 
and presents a quantitative representation of the change in expression levels for these 
transcripts.  For clarity, these transcripts are only grouped into mother classes and not into the 
detailed GO classes.  Most of the 63 known transcripts that were differentially expressed 
following otd overexpression showed increased expression levels; less than 20% of these 
transcripts were downregulated. The gene with the highest increase in expression level (78-
fold) was otd itself, in accordance with our experimental overexpression protocol.  Increases 
in expression levels above 10-fold were also observed for forkhead domain 96cb (fd96Cb) 
which encodes a nuclear binding protein, for patched (ptc) which encodes a protein involved 
in signal transduction, for picot, which encodes a transporter, and for cortactin and Regulator 
of cyclin A1 (Rca1), which encode gene products of currently unknown molecular function.  
Only two transcripts showed increases in the 5-10-fold range, namely sugar transporter1 
(sut1) encoding a protein involved in sugar transportation, and scraps (scra) encoding an actin 
binding protein. The majority of the upregulated transcripts had increases in the 2-5-fold 
range.  The transcript with the most marked decrease in expression was eyegone (eyg), 
encoding a transcription factor known to be involved in eye development. 
 
Figure 3 shows the Otx2-regulated transcripts that correspond to known Drosophila genes and 
presents a quantitative representation of their expression level changes.  Again, these 
transcripts are grouped into mother classes and not into detailed GO classes.  As was the case 
for otd overexpression, most of the known transcripts that were differentially expressed 
following Otx2 overexpression showed increased expression levels.  For example, in the 
functional class of  ‘enzyme’, 45 out of 49 transcripts were upregulated.  In total, less than 
13% of the 184 Otx2-regulated known transcripts were downregulated.  Increases in 
expression levels above 10-fold were observed for 23 genes and for 6 of these genes, retained 
(retn), SMC2, licorne (lic), Rtc1, Hairless (H) and deadhea (dhd), the increases were greater 
than 50-fold.  22 transcripts showed increases in the 5-10-fold range, and, similar to the otd 
overexpression situation, increases of 2-5-fold dominated in most of the functional classes.  
The transcript with the most marked decrease in expression was once again eyg. 
 
Common candidate downstream genes of otd and Otx2 
93 transcripts were differentially expressed both in response to otd overexpression and in 
response to Otx2 overexpression. This indicates that approximately one third of the otd-
regulated genes in Drosophila also respond to overexpression of the human Otx2 gene 
homolog.  Figure 4 shows the expression levels for these transcripts which are, thus, likely to 
represent the common downstream target genes for otd and Otx2.  21 of these transcripts 
correspond to known Drosophila genes and 72 correspond to annotated CG-transcripts. The 
expression levels of all of the known transcripts were influenced in the same manner by 
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overexpression of otd and Otx2, in that a given downstream target gene was either 
upregulated in both cases or downregulated in both cases.  Moreover, for most of these 
transcripts the absolute expression levels were similar in response to otd and to Otx2.  Two 
marked exceptions were pimple (pim), which was upregulated 12.4-fold following Otx2 
overexpression and 2.1-fold following otd overexpression, and eyg, which was downregulated 
77.6-fold following Otx2 overexpression (but see PCR data below) and downregulated 6.8 
fold following otd overexpression.  Similarly, the expression levels of 68 of the CG 
transcripts were influenced in the same manner by overexpression of otd and Otx2.  Only in 
the three remaining cases were transcripts upregulated by overexpression of one of the 
otd/Otx transgenes and downregulated by overexpression of the other. Thus, approximately 
one third of the candidate otd downstream target genes in Drosophila are controlled in a 
comparable manner by the human Otx2 gene homolog. 
 
There are a number of interesting genes among these common candidate genes.  The four 
known transcripts in class ‘ligand binding or carrier’, scra, Kinesin-like protein at 61F 
(Klp61F), alpha-Spectrin (alpha-spec) and Centrosomal protein 190kD  (Cen190), are all 
involved in actin or microtubule binding or movement[36-39]. This finding is intriguing since 
one of the Otx2 downstream genes identified in the mouse is a tropomyosin gene, which also 
encodes actin binding protein[40].  Among the four known transcripts in the class ‘nucleic 
acid binding’ are the genes Minichromosome maintenance 7 (Mcm7) and Suppressor of 
variegation 205 (Su(var)205) [41, 42] which encode chromatin binding proteins and the genes 
eyg and HLH54F which encode transcription factors[43, 44].  The four known transcripts in 
the functional class ‘enzymes’ are Lysozyme D (LysD), cdc2, Rpd3, and 
BcDNA:LD08534[45-48].  Although the cdc2 gene product is classified as ‘enzyme’, it also 
acts at the G2/M transition of mitotic cell cycle[47].  Moreover, Rpd3 encodes a histone 
deacetylase which is involved in the chromatin structure[46]. In the class “transporter” the 
SNAP receptor encoding n-synaptobrevin (n-syb) gene is involved in synaptic vesicle docking 
and fusion and is expressed in the embryonic CNS[49].  In the class ‘signal transducer’, the 
gene EG: 30B8.6 encodes a putative GABA-B receptor[50].  Finally, the gene Segregation 
distorter (Sd) classified as ‘enzyme regulator’ encodes a RAN GTPase activator[51]. Among 
the transcripts of known genes are several genes, whose precise functional role is not well 
defined at the molecular level.  These are the Bx34 and MRG15 genes[52, 53] which encode 
components of the nucleus and the gluon, Bub3 and pim genes which are all involved in 
mitosis. gluon encodes a putative component of the condensin, and gluon mutants show PNS 
defects during embryogenesis [54]. The gene product of Bub3 is localized to the kinetochore 
and may function in the mitotic check point[55].  pim  is expressed in the embryonic CNS and 
encodes a protein implicated in mitotic sister chromatid separation[56]. 
 
Verification of microarray expression data with RT-PCR 
To confirm the differences in gene expression levels after heat-shock induced overexpression 
of otd and human Otx2 as compared to heat-shocked wildtype embryos, quantitative RT-PCR 
was performed on selected candidate target genes. Changes in expression levels were 
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determined for eight genes that were differentially regulated by otd or human Otx2, namely 
scra, LysD, glu, Rpd3, pim, n-syb, eyg  and otd. The genes wunen (wun) and Scc1, whose 
expression levels remained unchanged in response to otd or Otx2 overexpression, were used 
as controls. As indicated in Table 3, these experiments showed that the changes in relative 
expression level, as measured by RT-PCR, are generally consistent with the data obtained 
with the oligonucleotide arrays.  An exception is data on the response of the eyg gene to Otx2 
overexpression; RT-PCR data indicate a weak downregulation (-1.62) whereas 
oligonucleotide array data indicate a strong downregulation (-77.6).   
 
 
Discussion
Common downstream target genes for otd and Otx 
Cross-phylum gene replacement experiments have shown that the fly otd gene and the 
homologous human Otx genes are functionally equivalent in vivo, in that overexpression of 
either gene in Drosophila otd null mutants can lead to the restoration of defects in cephalic 
and brain development[23-26].  We have used a combination of transgenic overexpression 
genetics and functional genomics to gain insight into the equivalence of otd and Otx gene 
expression in Drosophila at a comprehensive, genome-wide level.  Using inducible 
overexpression and quantitative transcript imaging through oligonucleotide arrays 
representing the total number of 13,400 currently annotated Drosophila genes, we have 
identified hundreds of candidate downstream genes both for the fly otd gene and for the 
human Otx2 gene.  A comparison of these candidate downstream genes reveals that both otd 
and Otx genes appear to control an overlapping set of genes; we refer to these genes as 
common downstream genes.  The number of identified common downstream genes for otd 
and Otx2 depends on the statistical level of significance used to determine if a given gene 
showed differential expression in response to transgene overexpression.  If the analysis is 
restricted to highly significant (p≤0.001) data sets, we find 93 common downstream genes, 
equivalent to 32% of the candidate otd downstream genes or approximately 1% of transcripts 
in the annotated fly genome.  If, in contrast, the analysis is based on significant (p≤0.01) data 
sets, we find 351 common downstream genes, equivalent to 46% of the candidate otd 
downstream genes or approximately 3% of transcripts in the annotated fly genome.  In either 
case, a substantial, but far from complete, set of the otd regulated genes are common 
downstream targets of both fly and human transgenes.  
 
It is interesting that, at the genome-wide transcript level, the Otx2 gene does not appear to be 
able to replace otd action in full; over half of the transcripts that are influenced by otd 
overexpression are not influenced by Otx2 overexpression.  Given the pronounced differences 
in amino acid sequence between the OTD and OTX2 proteins, this may not be altogether 
surprising.  The OTD and OTX2 proteins consist of 548 and 289 amino acids, respectively. 
Shared homology between them is restricted to the homeodomain and to a short domain 
immediately upstream of the homeodomain as well as a tripeptide at the amino terminus[25].  
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Moreover, since Otx genes cannot completely replace the otd gene in cross-phylum rescue 
experiments in vivo, a complete correspondence of otd downstream genes and common 
otd/Otx downstream genes might not be expected [3, 24, 25]. However, more than one third of 
the otd-regulated genes do respond also to Otx2 overexpression.  We suggest that these 
common downstream genes are likely to explain the overlapping roles of the otd/Otx genes in 
cross-phylum rescue experiments in vivo.  These target genes reflect the evolutionarily 
conserved roles of the members of the otd/Otx gene family in Drosophila.  To investigate this 
further, it will now be important and interesting to carry out similar functional genomic 
analyses of otd and Otx gene action in a mammalian system such as the mouse [27]. 
 
 
otd overexpression: a genomic perspective of candidate downstream genes 
The experiments reported here identify approximately 300 genes that showed highly 
significant (p≤0.001) changes in expression levels in response to otd overexpression in 
Drosophila.  The genomic perspective of these identified otd downstream target genes reveals 
several features of otd action at a higher level of insight.  First, this finding indicates that the 
otd gene product, a homeodomain transcription factor, regulates a limited and distinct set of 
candidate downstream genes.  At a significance level of p<0.001, 287 genes were found to be 
differentially regulated, corresponding to approximately 2.1% of the transcripts in the 
annotated fly genome. At a significance level of p<0.01, 762 genes were found to be 
differentially regulated, corresponding to approximately 5.7% of the transcripts in the 
annotated fly genome.  This is further evidence for the notion, that homeoproteins in 
Drosophila control only a subset and not the majority of the genes in the genome [30].  
Indeed, in similar experiments in which the homeobox gene labial was overexpressed using 
the same heat shock protocol as described here, 6.4% of the genes represented on the array 
used were shown to be differentially regulated at a significance level of p<0.01 [30].  (It 
should however, be noted that the array used in these labial overexpression experiments 
represents only 10% of the genes in the fly genome.)  Thus the relative number of putative otd 
targets appears to be in the same range as the number of putative labial targets.   
 
Second, these experiments show that the OTD homeodomain transcription factor acts on 
numerous candidate target genes that also encode transcription factors, consistent with the 
idea that homeodomain proteins act through a cascade of transcription factors which regulate 
the expression of their own subset of downstream genes [57]. Currently, we do not know 
which of the downstream target genes are direct OTD targets and are, thus regulated directly 
by OTD protein binding to DNA regulatory sequences, and which are indirect targets. At 
present, little is known about temporal response of putative target genes following pulsed 
expression of a transcription factor. Some studies have been carried out, based on the 
assumption that direct targets respond immediately, while indirect targets respond with a 
delay due to the time required for intermediary gene expression.  Nasiadka and Krause used a 
kinetic approach to identify direct and indirect targets of the ectopically expressed 
homeodomain transcription factor fushi tarazu (ftz) [58].  Their results show that target genes 
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respond to pulses of ftz expression within two distinct temporal windows. Direct responses 
(no intermediary gene transcription is required) are 50% complete within about 18 minutes 
post heat shock.  Indirect responses do not reach the same level of response until 26 minutes 
post heat shock. Assuming that otd expression follows a similar kinetic profile as ftz, it is 
likely that we have identified primary targets as well as genes whose response was caused by 
indirect effects requiring intermediate transcription. 
 
Third, these results show that the primary consequence of otd overexpression in Drosophila is 
the upregulation of its downstream target genes.  Indeed more than 80% of the genes that 
were differentially expressed following otd overexpression showed increased expression 
levels.  This contrasts with the action of the homeotic gene lab; overexpression of lab under 
comparable conditions resulted in an approximately equal number of upregulated and 
downregulated target genes [30]. 
 
The majority of potential downstream target genes of otd are annotated CG transcripts and, 
hence, correspond to predicted genes which have not yet been studied in detail in an in vivo 
context.  This is surprising given the fact that numerous classical genetic screens for genes 
involved in cephalic and CNS embryogenesis have been carried out [59].  This may indicate 
that many of the genes involved in those aspects of cephalic and CNS embryogenesis that are 
under the control of otd in Drosophila have not yet been identified.  Alternatively, this finding 
may reflect specific constraints of the overexpression experiment.  For example, the 
overexpression protocol used makes it difficult to control the level of the OTD protein 
concentration and stability.  As different levels of a homeoprotein may have different 
developmental consequences, the relatively high level of OTD protein attained may influence 
target genes that are not affected by the endogenously attained protein level [60, 61].  
Moreover, the fact that otd overexpression is not accompanied by simultaneous 
overexpression of cofactors, which can act together with homeodomain transcription factors 
to determine their in vivo target specificity, may also lead to unspecific activation of target 
genes[62]. 
 
 
Functional genomics of a human transgene overexpressed in Drosophila  
In several cases, human transgenes have been overexpressed in Drosophila in order to gain 
insight into the evolutionary conservation of developmental control gene action[24, 25, 63-
66].  This has also been the primary goal of the overexpression of human Otx2 in Drosophila 
carried out in this report.  In addition to the identification of common otd/Otx downstream 
genes, the genomic level of analysis reported here has uncovered remarkable similarities in 
the activity of the human transgene in the fly as compared to that of its fly homolog.  Thus, 
otd and Otx2 both upregulate most of their target genes upon overexpression.  Moreover, the 
target genes of both transcription factors fall into the same functional categories.  For 
example, the classes ‘enzymes‘ and ‘transcription factors‘ had the highest absolute and 
relative transcript number.   
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The striking difference in the action of the two transgenes is that overexpression of human 
Otx2 causes expression changes in much more downstream genes than does overexpression of 
the fly otd gene. The experiments reported here identify approximately 700 genes that showed 
highly significant (p≤0.001) changes in expression levels in response to Otx2; this is over two 
times more than that observed in response to otd.  It is unlikely that this difference is due to 
corresponding differences in the expression levels attained for Otx2 versus otd transcripts. 
Indeed the transcript abundance of otd was higher than that of Otx2 in these experiments (see 
Materials and Methods). Nevertheless, these data should be interpreted with caution, since 
several explanations, not mutually exclusive, are possible for the observation that more genes 
respond to overexpression of Otx2. First, only one single transgenic strain of otd and only one 
single transgenic strain of Otx2 were used.  Thus, strain differences or insertion effects might 
account for the fact that more genes show differential expression following overexpression of 
Otx2 compared to overexpression of otd. Second, it is conceivable that overexpression of the 
Otx2 gene affects more downstream genes in Drosophila than otd because the OTX2 
transcription factor binds to many more DNA regulatory regions than does OTD.  The smaller 
OTX2 protein might, therefore, have a lower specificity for target gene regulatory regions.  
Similarly, the OTX2 protein might be more promiscuous than OTD in its interactions with the 
numerous cofactors that determine target specificity. Third, it has been shown that the DNA 
binding specificity of homeoproteins is low in vitro.  But given that the homeodomain is 
conserved and Otx2 rescues the otd phenotype, this suggests that they should recruit a similar 
subset of cofactors and regulate a common subset of downstream genes at least in those 
tissues where otd is endogenously expressed. Furthermore, the Otx2 product, which is not a 
fly protein, could influence the expression of a small number of transcription factors, which 
are not affected by OTD and which then regulate the expression of their own subset of 
downstream genes.  Whatever the molecular basis for this unexpected difference in the result 
of Otx2 versus otd overexpression may be, its discovery is a further demonstration of the 
novel level of insight that can be attained from a genome-wide functional perspective.  
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Materials and methods 
Embryos   
The wildtype was Drosophila melanogaster Oregon-R. For overexpression of otd, we used 
the hsp-otd line 5A generated by Royet and Finkelstein [67]. For overexpression of human 
Otx2, we used the hsp-Otx2 line generated by Leuzinger et al [24]. All fly stocks were kept on 
standard cornmeal/yeast/agar medium at 25˚C.  Embryos were collected overnight for 12 
hours on grape juice plates, further kept for 4 hours at 25 ˚C and then subjected to a 37 ˚C 
heat shock for 25 min, followed by a recovery period of 25 min at 25 ˚C before RNA 
isolation.  Therefore, at the time of RNA isolation these embryos were at embryonic stages 
10-17[29].  Embryos younger than embryonic stage 10 were not used, since heat shock in 
these earlier stages results in lethality[68].  Embryos used for in situ hybridization studies 
were collected and heat shock treated in the same way.   
 
Whole mount in situ hybridization 
For in situ hybridization, digoxigenin-labeled sense and antisense lab RNA probes were 
generated in vitro, with a DIG labeling kit (Roche Diagnostics) and hybridized to whole 
mount embryos following standard procedure [69].  Hybridized transcripts were detected with 
an alkaline phosphatase conjugated anti-digoxigenin Fab fragment (Roche Diagnostics) using 
Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Sigma) as 
chromogenic substrates. 
 
High density oligonucleotide arrays and hybridization 
In this study, a custom-designed Drosophila oligonucleotide array (roDROMEGAa, 
Affymetrix, Santa Clara, CA) was used.  It contains 14,090 sequences representing 
Drosophila specific transcripts, prokaryotic control sequences and custom chosen sequences 
for transgenes such as gal4, gfp, and lacZ. 13,998 sequences correspond to Drosophila 
specific transcripts that were annotated by Celera Genome Release 1 [34] and deposited in 
SWISS-PROT/TrEMBL databases. These 13,998 sequences represent approximately 13,400 
genes in the Drosophila genome and therefore some genes are represented by more than one 
probe set. Each sequence is represented on the array by a set of 14 oligonucleotide probes (25-
mers) matching the sequence.  To control the specificity of hybridization, the same probes are 
represented on the array with a single nucleotide mismatch in a central position.  As such, 
each sequence is represented by 14 perfect match and 14 mismatch probes.  The Average 
Difference (Avg Diff) between the perfect match hybridization signal and the mismatch signal 
is proportional to the abundance of a given transcript [32].  RNA was isolated, labeled and 
hybridized to the arrays as described [29, 30] with minor modifications. 
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Data Analysis 
Probe arrays were scanned with a commercial confocal laser scanner (Hewlett-Packard). Pixel 
intensities were measured, and expression signals were analyzed with commercial software 
(GENECHIP 3.1, Affymetrix).  Data processing was carried out using RACE-A (F. 
Hoffmann-La Roche), Access 97 and Excel 97 (Microsoft) software.  Scatter plots were 
prepared using GeneSpringTM software version 4.1 (Silicon Genetics, Redwood City, CA).  
For quantification of relative transcript abundance, the Average Difference value (Avg Diff) 
was used[32]. Four replicates were performed for hsotd and hsOtx2. Three and five replicates 
were performed for hswt and wt respectively.  All arrays were normalized against the mean of 
the total sums of Avg Diff values across all 16 arrays. In order to avoid huge fold changes 
(FC), genes with a normalized Avg Diff below 20 were automatically assigned an Avg Diff of 
20 (RACE-A protocol). An unpaired t-test for each individual gene was performed for the 
following pairwise comparisons: hswt vs. wt, hswt vs. hsotd and hswt vs. hsOtx2. For 
differential transcript imaging, only transcripts that had highly significant or significant 
changes in Avg Diff (p≤ 0.001 and p≤0.01, respectively) and whose changes were in the 2-
fold and above range are presented.  Additionally, the higher mean Avg Diff of a pairwise 
comparison for a given transcript had to be above or equal to 50.  For a comprehensive list of 
all genes with fold changes and significance level, see supplements (Details depend on the 
editorial policy). 
 
Reverse Transcription Polymerase Chain Reaction 
300 ng poly(A)+ RNA was isolated from embryos of wt, hswt, hsotd and hsOtx2 (mRNA 
isolation kit; Roche Diagnostics) and reverse transcribed with AMV-RT and random 
hexamers (RT-PCR kit; Roche Diagnostics).  PCR was performed with 100 pg template DNA 
and gene specific primers (Seq Web, Winsconsin Package Version 10.0, GCG) on a light 
cycler (LightCycler, Roche Diagnostics). Continuous fluorescence observation of amplifying 
DNA was possible using SYBR Green I (Roche Diagnostics).  After cycling, a melting curve 
was produced by slow denaturation of the PCR end products, to validate the specificity of 
amplification.  To compare the relative amounts of PCR products we monitored the 
amplification profile on a graph, displaying the log of the fluorescence against the number of 
cycles. Relative change folds for a given gene under both conditions (hsotd vs. hswt or hsOtx2 
vs. hswt) were calculated using the fit point method (Light Cycler Manufacturer, Roche). 
 
Quantification of otd and human Otx2 transcripts by RT-PCR 
Plasmids containing fly otd or human Otx2 cDNA were linearized with appropriate restriction 
enzymes and purified. The concentrations of the linearized plasmids were 
spectrophotometrically quantified using a GeneQuant RNA/DNA calculator (Pharmacia 
Biotech) and serial dilutions were made. To quantify the concentration of the otd and Otx2 
transcripts from heat shocked hsotd and hsOtx2 embryos, standard curve was established 
using the serial dilution of the corresponding linearized plasmid on a light cycler 
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(LightCycler, Roche Diagnostics). RT-PCR was performed when the standard curve was 
established. Thereafter, the steady state concentrations of the otd and human Otx2 were 
calculated in relation to their standard curves, using the second derivative maximum method 
(Light Cycler Manufacturer, Roche). This showed that the concentrations of otd and Otx2 
transcripts were 1.5 x 10-6 µg/µl and 3.6 x 10-7 µg/µl, respectively.  
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Fig. 1. Normalized Average Difference (Avg Diff) of one pair of replicate arrays for 
each experimental condition in a log(base 10) scale. A. hsOtx2; B. hsotd; C. hswt; D. wt. 
Only probe sets with positive values in both arrays are used. The central line is y = x, 
and the flanking lines indicate the difference of a factor of two.
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Fig.3  Known transcripts differentially expressed in response to overexpression of human Otx2 
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Fig.4   Transcripts differentially expressed in response to overexpression of  otd  and human Otx2 
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Fig. 4. Transcripts differentially expressed in response to overexpression of otd and in response to overexpression of human Otx2 , grouped according to functional
classes. Bars represent the fold change between differentially expressed transcripts in hswt embryos and hsotd or hsOtx2 embryos. The upper bars represent the fold
change of differentially expressed transcripts following overexpression of Otx2 and the lower bars represent the fold change of differentially expressed transcripts
following overexpression of otd . Positive values indicate that the relative expression level of a gene is increased (up-regulated) following otd overexpression and
negative values indicate a decrease (down-regulated). Absolute Average Difference (Avg Diff) values are given for the otd overexpression condition as follows: white
bars represent Avg Diff < 100, gray bars represent Avg Diff ranging from 100-1000, and black bars represent Avg Diff >1000.
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Table 1. Numbers of transcripts differentially regulated by hsotd or hsOtx2 
 
Differentially expression in 
response to 
Total Named 
transcripts 
CG 
transcripts 
hsotd 287 63 224 
hsOtx2 682 184 498 
hsotd and hsOtx2 93 21 72 
 
 
Differentially expression in 
response to 
Total Named 
transcripts 
CG 
transcripts 
hsotd 762 165 597 
hsOtx2 1395 331 1064 
hsotd and hsOtx2 351 69 282 
 
 
Table 1. Numbers of transcripts differentially regulated by HS-otd or HS-Otx2 
Overview of the numbers of transcripts that were differentially expressed following overexpression of otd 
or human Otx2. A. Number of transcripts that were differentially expressed at the significance level of 
p≤0.001.  B. Number of transcripts that were differentially expressed at the significance level of p≤0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
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Table 2. Classification of Transcripts differentially expressed in response to Otx2 and otd  
Overexpression 
 
Functional class notd notd/N 
(%) 
notd/M 
(%) 
nOtx2 
 
nOtx2/N
(%) 
nOtx2/M 
(%) 
Function unknown (7108) 143 2.01 49.83 311 4.38 45.60 
Enzyme (1872) 34 1.82 11.85 88 4.70 12.90 
Transcription factor (940) 23 2.45 8.01 69 7.34 10.12 
Signal transduction (462) 17 3.68 5.92 24 5.19 3.52 
DNA binding (306) 14 4.58 4.88 27 8.82 3.96 
Transporter (498) 12 2.41 4.18 19 3.82 2.79 
Motor (406) 11 2.71 3.83 22 5.42 3.23 
Protein kinase (365) 10 2.74 3.48 25 6.85 3.67 
Ligand binding or carrier (581) 9 1.55 3.14 28 4.82 4.11 
Endopeptidase (413) 8 1.94 2.79 25 6.05 3.67 
Nucleic acid binding (369) 8 2.17 2.79 21 5.69 3.08 
Cell adhesion (328) 8 2.44 2.79 15 4.57 2.20 
Structural protein (335) 7 2.09 2.44 18 5.37 2.64 
Actin binding (157) 6 3.82 2.09 10 6.37 1.47 
RNA binding (292) 4 1.37 1.39 13 4.45 1.91 
Transmembrane receptor (251) 4 1.59 1.39 9 3.59 1.32 
Chaperone (195) 3 1.54 1.05 14 7.18 2.05 
Cell cycle regulator (190) 3 1.58 1.05 12 6.32 1.76 
Ion channel (214) 3 1.40 1.05 7 3.27 1.03 
Protein phosphatase (91) 3 3.30 1.05 6 6.59 0.88 
DNA repair protein (65) 3 4.62 1.05 4 6.15 0.59 
Transcription factor binding 
(64) 
2 3.13 0.70 11 17.19 1.61 
Cytoskeletal structural protein 
(121) 
2 1.65 0.70 6 4.96 0.88 
DNA replication factor (42) 2 4.76 0.70 5 11.90 0.73 
Defense/immunity protein (64) 2 3.13 0.70 4 6.25 0.59 
G-protein linked receptor (103) 2 1.94 0.70 3 2.91 0.44 
Receptor (97) 2 2.06 0.70 2 2.06 0.29 
Cytochrome P450 2 14.29 0.70 0 0 0 
Storage protein (25) 1 4.00 0.35 3 12.00 0.44 
Peptidase (97) 1 1.03 0.35 3 3.09 0.44 
Lysozyme (8) 1 12.50 0.35 2 25.00 0.29 
Cyclin-dependent protein 
kinase (11) 
1 9.09 0.35 2 18.18 0.29 
GABA-B receptor (1) 1 100.0
0 
0.35 1 100.00 0.15 
Enzyme inhibitor (121) 1 0.83 0.35 1 0.83 0.15 
Ecdysteroid hormone receptor 
(2) 
1 50.00 0.35 0 0 0 
3',5'-cyclic-nucleotide 
phosphodiesterase (1) 
1 100.0
0 
0.35 0 0 0 
FK506 binding (2) 1 50.00 0.35 0 0 0 
Peptidylprolyl isomerase (3) 1 33.33 0.35 0 0 0 
Neurotransmitter transporter 
(29) 
1 3.45 0.35 0 0 0 
Steroid hormone receptor (16) 1 6.25 0.35 0 0 0 
Acid phosphatase (5) 1 20.00 0.35 0 0 0 
Arginine-tRNA ligase (2) 1 50.00 0.35 0 0 0 
Carboxypeptidase (1) 1 100.0
0 
0.35 0 0 0 
Caspase activator(1) 1 100.0
0 
0.35 0 0 0 
Protein tyrosine phosphatase (9) 0 0.00 0.00 4 44.44 0.59 
Protein serine/threonine kinase 
(43) 
0 0.00 0.00 4 9.30 0.59 
Chromatin binding (16) 0 0.00 0.00 4 25.00 0.59 
Ubiquitin conjugating enzyme 
(12) 
0 0.00 0.00 3 25.00 0.44 
Structural protein of ribosome 
(136) 
0 0.00 0.00 3 2.21 0.44 
Casein kinase I (6) 0 0.00 0.00 3 50.00 0.44 
Calcium binding (18) 0 0.00 0.00 3 16.67 0.44 
Ubiquitin (14) 0 0.00 0.00 2 14.29 0.29 
Translation factor (70) 0 0.00 0.00 2 2.86 0.29 
Transcription co-repressor (3) 0 0.00 0.00 2 66.67 0.29 
GTP binding (14) 0 0.00 0.00 2 14.29 0.29 
Glutathione transferase (7) 0 0.00 0.00 2 28.57 0.29 
Furin  (2) 0 0.00 0.00 2 100.00 0.29 
Electron transfer (35) 0 0.00 0.00 2 5.71 0.29 
Ubiquitinyl hydrolase 1 (2) 0 0.00 0.00 1 50.00 0.15 
Ubiquitin-specific protease (5) 0 0.00 0.00 1 20.00 0.15 
Ubiquitin-like conjugating 
enzyme (1) 
0 0.00 0.00 1 100.00 0.15 
Tubulin-tyrosine ligase (7) 0 0.00 0.00 1 14.29 0.15 
Functional class notd notd/N 
(%) 
notd/M 
(%) 
nOtx2 
 
nOtx2/N 
(%) 
nOtx2/M 
(%) 
Transmembrane receptor 
protein tyrosine phosphatase (4)
0 0.00 0.00 1 25.00 0.15 
Transmembrane receptor 
protein tyrosine kinase (7) 
0 0.00 0.00 1 14.29 0.15 
Transcription factor, 
cytoplasmic sequestering (1) 
0 0.00 0.00 1 100.00 0.15 
Transcription co-activator (2) 0 0.00 0.00 1 50.00 0.15 
Thioredoxin (4) 0 0.00 0.00 1 25.00 0.15 
Spermidine synthase (1) 0 0.00 0.00 1 100.00 0.15 
SNF1A/AMP-activated protein 
kinase (1) 
0 0.00 0.00 1 100.00 0.15 
SH3/SH2 adaptor protein (2) 0 0.00 0.00 1 50.00 0.15 
Sarcosine oxidase (2) 0 0.00 0.00 1 50.00 0.15 
Ribulose-phosphate 3-
epimerase (1) 
0 0.00 0.00 1 100.00 0.15 
Receptor signalling protein 
tyrosine phosphatase (1) 
0 0.00 0.00 1 100.00 0.15 
Protein tagging (2) 0 0.00 0.00 1 50.00 0.15 
Prenylated protein tyrosine 
phosphatase (1) 
0 0.00 0.00 1 100.00 0.15 
Phosphoserine  phosphatase (1) 0 0.00 0.00 1 100.00 0.15 
Multicatalytic  endopeptidase 
(4) 
0 0.00 0.00 1 25.00 0.15 
mRNA (guanine-N7)-
methyltransferase (1) 
0 0.00 0.00 1 100.00 0.15 
Mitochondrial processing 
peptidase(1) 
0 0.00 0.00 1 100.00 0.15 
MAP kinase kinase (3) 0 0.00 0.00 1 33.33 0.15 
Inositol-1,4,5-triphosphate 
receptor (1) 
0 0.00 0.00 1 100.00 0.15 
Electron transfer flavoprotein 
(1) 
0 0.00 0.00 1 100.00 0.15 
Effector caspase (3) 0 0.00 0.00 1 33.33 0.15 
DNA-directed RNA 
polymerase III (7) 
0 0.00 0.00 1 14.29 0.15 
Cyclin (5) 0 0.00 0.00 1 20.00 0.15 
CDP-diacylglycerol-serine O-
phosphatidyltransferase (1) 
0 0.00 0.00 1 100.00 0.15 
Caspase (5) 0 0.00 0.00 1 20.00 0.15 
cAMP-dependent protein 
kinase regulator (1) 
0 0.00 0.00 1 100.00 0.15 
cAMP-dependent protein 
kinase catalyst (3) 
0 0.00 0.00 1 33.33 0.15 
cAMP-dependent protein 
kinase (1) 
0 0.00 0.00 1 100.00 0.15 
Amine oxidase (flavin-
containing) (7) 
0 0.00 0.00 1 14.29 0.15 
3-oxo-5-alpha-steroid 4-
dehydrogenase (1) 
0 0.00 0.00 1 100.00 0.15 
 
 
 
Table 2. Classification of Transcripts differentially expressed 
in response to Otx2 and otd overexpression. Genes that were 
differentially expressed following ubiquitous overexpression of 
otd or human Otx2, grouped according to Gene Ontology (GO) 
functional classes. (n) Number of transcripts detected that 
belong to an individual class. (N) Number of the transcripts 
represented on the chip for each functional class; the value of N 
for each for each functional class is given in the parenthesis 
following the class name. (n/N x 100) Percentage of transcripts 
that were differentially regulated for each functional class 
relative to the total number of transcripts in that class 
represented on the chip. (M) Total number of differentially 
expressed transcripts (of all classes) following overexpression 
of otd or human Otx2 (p ≤ 0.001); for otd and Otx2, M is 287 
and 682 respectively. (n/M x 100) Percentage of transcripts that 
were differentially regulated in each functional class relative to 
the the total number of differentially regulated transcripts for 
otd and Otx2. 
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Table 3. Comparison of change folds between oligonucleotide arrays and RT-PCR 
 
                                              Change fold 
                                               Avg diff                                           hsotd                                hsOtx2   
Transcript hswt hsotd hsOtx2 Array RT-PCR Array RT-PCR
scra 251 1375 1229 5.5 1.3 4.9 1.6
LysD 525 1646 2436 3.1 1.6 4.6 4.0
glu 479 1196 1991 2.5 1.8 4.2 10.9
Rpd3 1170 2562 2673 2.2 2.0 2.3 2.5
pim 118 246 1467 2.1 1.4 12.4 8.0
n-syb 612 293 296 -2.1 -1.5 -2.1 -1.5
eyg 1552 229 10 -6.7 -1.4 -77.6 -1.6
wun 885 / 884 / / 1 1.00
Scc1 724 723 / 1 1.0 / /
otd 84 6555 108 78.0 119.4 1.3 1.5
 
Table 3.  Comparison of change folds between oligonucleotide arrays and RT-PCR RT-PCR was 
performed on cDNA derived from hswt, hsotd or hsOtx2 embryos. Change folds determined by RT-PCR 
are represented as the mean value of eight independent replicates, derived from two different cDNA 
preparations. wun is used as a control for the comparison of the RT-PCR data between hswt an hsOtx2. 
Scc1 is used as a control for the comparison of the RT-PCR data between hswt an hsotd. 
-110-
 - 111 -
7. Gliogenesis in Drosophila: Genome-Wide Analysis of Downstream Genes 
of glial cells missing in the Embryonic Nervous System 
 
Boris Egger1, Ronny Leemans1, Thomas Loop1, Lars Kammermeier1, Yun Fan1, Tanja 
Radimerski1, Martin C. Strahm2, Ulrich Certa3, and Heinrich Reichert1,4
 
 
 
 
 
 
1Biozentrum/Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland.  
2Roche Bioinformatics and 3Genetics Pharmaceuticals Division, F. Hoffmann-La Roche, Ltd, 
CH-4070 Basel, Switzerland. 
 
4Corresponding author:  
Heinrich Reichert, Institute of Zoology, Biozentrum/Pharmazentrum 
University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland. 
Tel.: 0041-61-267 16 12   Fax: 0041-61-267 16 13   e-mail: Heinrich.Reichert@unibas.ch 
 - 112 -
Summary 
 
In Drosophila, the glial cells missing (gcm) gene encodes a transcription factor that 
controls the determination of glial versus neuronal fate. In gcm mutants, presumptive 
glial cells are transformed into neurons and, conversely, when gcm is ectopically 
misexpressed, presumptive neurons become glia.  Although gcm is thought to initiate 
glial cell development through its action on downstream genes which execute the glial 
differentiation program, little is known about the identity of these genes.  To identify 
gcm downstream genes in a comprehensive manner, we used genome-wide 
oligonucleotide arrays to analyse differential gene expression in wild-type embryos 
versus embryos in which gcm is misexpressed throughout the neuroectoderm.  
Transcripts were analysed at two defined temporal windows during embryogenesis.  
During a first period of initial gcm action on determination of glial cell precursors, over 
400 genes were differentially regulated.  Among these are numerous genes that encode 
other transcription factors, underscoring the master regulatory role of gcm in 
gliogenesis.  During a second later period when glial cells had already differentiated, 
over 1200 genes were differentially regulated.  Most of these genes, including many 
genes for chromatin remodeling factors, and cell cycle regulators, were not differentially 
expressed at the early stage indicating that the genetic control of glial fate determination 
is largely different from that involved in maintenance of differentiated cells.  At both 
stages, glial-specific genes were upregulated and neuron-specific genes were 
downregulated supporting a model whereby gcm promotes glial development by 
activating glial genes while simultaneously repressing neuronal genes.  Also at both 
stages, numerous genes that were not previously known to be involved in glial 
development were differentially regulated and, thus, identified as potential new 
downstream targets of gcm.  For a subset of the differentially regulated genes, tissue-
specific in vivo expression data were obtained which confirmed the transcript profiling 
results.  This first genome-wide analysis of gene expression events downstream of a key 
developmental transcription factor presents a novel level of insight into the repertoire of 
genes that initiate and maintain cell fate choices in CNS development.   
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Introduction 
 
During CNS development, two major cell types are generated, namely neurons and glial cells.  
These can be generated either by common precursors (neuroglioblasts) or by precursors that 
are specialized to produce either neurons (neuroblasts) or glial cells (glioblasts) (Akiyama-
Oda et al., 1999; Bernardoni et al., 1999; Gage, 2000; Malatesta et al., 2000; Qian et al., 
2000).  Neuroglial development has been studied in detail in Drosophila, where each 
embryonic neuromere consists of approximately 60 glial cells and 700 neurons (Klämbt and 
Goodman, 1991; Ito et al., 1995; Schmidt et al., 1997; Jones, 2001).  In Drosophila, 
neuroblasts divide asymmetrically to produce ganglion mother cells, which divide once to 
produce two neurons (Doe and Skeath, 1996), whereas glioblasts produce only glial cells.  
Glial and neuronal cell lineages in Drosophila also derive from neuroglioblasts, which divide 
asymmetrically to produce a neuroblast and a glioblast.   
 
In Drosophila, the glial cells missing (gcm) gene encodes a transcription factor that controls 
the determination of glial versus neuronal fate in neuroectodermally derived cells (Hosoya et 
al., 1995; Jones et al., 1995; Vincent et al., 1996; Wegner and Riethmacher, 2001).  In gcm 
mutants, cells that normally develop into glia enter a neuronal differentiation pathway leading 
to a loss of glia and a gain of neurons.  In contrast, targeted gcm misexpression in neural 
progenitors leads to an increase of glial cells at the expense of neurons.  Neither a specific 
embryonic stage nor a neural “ground state” appear necessary for gcm action since 
misexpression of gcm in epidermis or mesoderm suppresses normal cell fate and causes cells 
to adopt a glial fate (Akiyama-Oda et al., 1998; Bernardoni et al., 1998). Mesectodermal 
midline glial cells do not require gcm function (Granderath and Klämbt, 1999).   
 
The molecular mechanisms of gcm action in glial development are poorly understood.  
Clearly, gcm transcription factor action depends on its target genes, however, relatively few 
genes, such as the reversed polarity (repo) gene, are known to act downstream of gcm 
(Akiyama et al., 1996).  To identify gcm downstream genes in a comprehensive manner, we 
carried out a novel functional genomic approach using genome-wide oligonucleotide arrays.  
These arrays are used to analyze the transcripts in wild-type embryos versus embryos in 
which gcm is misexpressed throughout the CNS.  Tissue-specific misexpression was achieved 
by using a scabrous-GAL4 (sca-GAL4) line (Klaes et al., 1994) to drive gcm expression 
throughout the embryonic neuroectoderm.  Transcripts were analysed at two defined temporal 
windows during embryogenesis.  First, during a period of initial gcm action on determination 
of glial cell precursors and second during a later period when glial cells have already 
differentiated.  In both cases, we find significant changes in transcript abundance for hundreds 
of identified genes following gcm misexpression.  Remarkably, over half of these genes has 
not yet been studied in any in vivo context in Drosophila. All of these identified genes are 
potential direct or indirect downstream targets of gcm and may, thus, be involved in 
regulating glial cell fate.   
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Materials and methods 
 
Flies 
The wild-type was Oregon-R.  For targeted misexpression of gcm, virgin females from 
scabrous-GAL4 (Klaes et al., 1994) were crossed to yw; UAS-gcm; UAS-gcm males (Jones et 
al., 1995).  For gcm loss-of-function studies the null allele gcm∆P1 (Jones et al., 1995) was 
used balanced over CyO-wglacZ.  Homozygous mutants were identified by absence of either 
anti-RK2/REPO or anti-βGAL staining.  Stocks were kept on standard medium at 25°C.  
After a 1 hr pre-collection, wild-type and sca-gcm embryos were collected in parallel for 1 hr 
and staged to 6-7 hrs AEL (stage 11) or to 13-14 hrs AEL (late stage 15/early stage 16). 
Stages are according to (Campos-Ortega and Hartenstein, 1997).   
 
Arrays and hybridization 
A custom-designed Drosophila oligonucleotide array (roDROMEGAa, Affymetrix, Santa 
Clara, CA) was used (Montalta-He et al., 2002).  It contains 14,090 sequences representing 
13,369 single transcripts encoding Drosophila proteins deposited in SWISS-PROT/TrEMBL 
databases (Celera Genome/BDGP Release no. 1) (Adams et al., 2000) as well as prokaryotic 
and custom chosen control sequences.  Each sequence is represented on the array by a set of 
14 oligonucleotide probes of matching sequence and 14 probes with a single nucleotide 
mismatch.  The Average Difference (Avg Diff) between the perfect match hybridization 
signal and the mismatch signal is proportional to the abundance of a given transcript 
(Lipshutz et al., 1999).  RNA was isolated, labeled and hybridized to the array as described in 
(Leemans et al., 2001).  Four replicates were performed for each experimental condition.   
 
Data analysis 
Data acquisition and processing was as described in (Leemans et al., 2001).  For 
quantification of relative transcript abundance, the Average Difference value (Avg Diff) was 
used.  All arrays were normalized against the mean of the total sums of Avg Diff values 
across all 16 arrays.  For differential transcript imaging, only transcripts that had significant 
changes in Avg Diff (p≤ 0.01; unpaired t-test) in the 1.5-fold and above range were 
considered, and then only if the mean Avg Diff for the transcript was ≥ 50 in at least one 
condition.   
 
In situ hybridization and immunocytochemistry 
In situ hybridization was according to (Tautz and Pfeifle, 1989).  Embryos were mounted in 
Canada balsam (Serva) and photographed with a Prog/Res/3008 digital camera (Kontron, 
Zürich) on a Zeiss Axioskop microscope with differential interference contrast optics.  
Immunocytochemical experiments were done according to (Therianos et al., 1995; Leemans 
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et al., 2001).  The primary antibodies were rat anti-RK2/REPO 1:1000 (Campbell et al., 
1994), mouse anti-TEN-M 1:250 (Baumgartner et al., 1994), rabbit anti-EY 1:500 
(Kammermeier et al., 2001), mouse anti-WRAPPER 1:5 (Noordermeer et al., 1998) and goat 
anti-HRP (FITC-conjugated) 1:20 (Jackson Immunoresearch). For fluorescent labellings 
secondary antibodies were Alexa568 and Alexa488 conjugated, all 1:150 (Molecular Probes).  
For laser confocal microscopy, a Leica TCS SP was used.   
 
 
Results 
 
Targeted misexpression of gcm in the embryonic neuroectoderm results in a switch from 
neuronal to glial fate. 
For targeted misexpression of gcm in the neuroectoderm of Drosophila embryos, a scaGAL4 
enhancer trap line (Klaes et al., 1994) was crossed with an UAS-gcm responder line (sca-gcm) 
(Jones et al., 1995).  This resulted in ectopic gcm expression in the embryonic CNS starting 
from embryonic stage 9 and diminishing, similar to endogenous gcm expression, at embryonic 
stage 15.  Although misexpression of gcm starts at stage 9 in sca-gcm embryos, ectopic 
expression of the repo gene, a known direct target of gcm, was not seen before stage 11, 
similar to endogenous repo expression.   
 
In order to identify genes that are either direct gcm target genes or among the initial set of 
downstream genes of gcm, we carried out a first genome-wide analysis of differential gene 
expression at embryonic stage 11 when the first glial marker, the direct gcm target gene repo, 
is expressed.  In the wild-type during stages 10-11, two small groups of neuroectodermal cells 
per hemisegment transiently express gcm, and a single gcm-expressing glial precursor 
delaminates from each of these groups and expresses the repo gene (Fig. 1A,C) (Hosoya et 
al., 1995; Jones et al., 1995).  In contrast, in sca-gcm embryos during stages 10-11, all of the 
cells in the neuroectoderm express gcm (Fig. 1B) and, in consequence, most of the neural 
precursor cells become REPO positive (Fig. 1D).   With the exception of altered gene 
expression in cells of the neuroectoderm, neither gene expression changes outside of the 
neural lineage nor any obvious morphological changes are seen in these stage 11 sca-gcm 
embryos.   
 
In order to identify also additional indirect downstream genes of gcm that act further along in 
the genetic cascade of gcm action, we carried out a second genome-wide transcriptional 
analysis at embryonic stage 15/16 when glial cells are differentiated.  In the wild-type at stage 
15/16, approximately 700 neurons and 60 glial cells per neuromere have differentiated, and 
the glial cells (with the exception of midline glia) are REPO positive (Fig. 1E) (Ito et al., 
1995).  In contrast, in stage 15/16 sca-gcm embryos, 80%-90% of the cells in the CNS express 
REPO protein (Fig. 1F) and have a glial morphology (Hosoya et al., 1995).  Correspondingly, 
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the number of cells expressing the neuronal marker embryonic lethal abnormal vision (elav) 
in these sca-gcm embryos is reduced by approximately 90% (data not shown) (Hosoya et al., 
1995), and a striking reduction of the CNS axon scaffold is observed.  In addition to the 
pronounced changes in the number of glial versus neuronal cells, stage 15/16 sca-gcm 
embryos also show defects in ventral nerve cord condensation and in peripheral innervation.  
No other gross morphological changes were seen in these stage 15/16 sca-gcm embryos.   
 
Overview of differential gene expression following gcm misexpression 
Analysis of differential gene expression in stage 11 and stage 15/16 sca-gcm versus wild-type 
embryos was carried out with oligonucleotide arrays representing 13,369 annotated 
Drosophila genes.  This corresponds to virtually all of the currently annotated genes of the 
Drosophila genome sequence (Adams et al., 2000).  For each embryonic stage, 2 x 4 replicate 
oligonucleotide arrays were used to detect transcript levels in sca-gcm embryos as compared 
to wild-type controls.  Only transcripts which show an expression level fold change (FC) ≥ 
1.5 or ≤ –1.5 at significance values of p≤ 0.01 (t-test) were considered as differentially 
expressed (see materials and methods).  A complete list of all of these genes, as well as their 
quantitative fold change values is given at www.ncbi.nlm.nih.gov/geo/.   
 
At stage 11, we detected 417 transcripts with differential expression values in sca-gcm 
embryos as compared to wild-type.  This corresponds to ~3% of the transcripts on the array.  
Approximately the same number of transcripts have increased (n=219) and decreased (n=198) 
abundance levels, indicating that gcm causes both activation and repression of downstream 
gene transcription.  At stage 15/16, we detected 1259 genes with differential expression 
values in sca-gcm embryos compared to wild-type.  This corresponds to ~9% of the 
transcripts on the array. Thus, markedly more transcripts are differentially expressed at stage 
15/16 than at stage 11.  Again, approximately the same number of transcripts are upregulated 
(n=609) and downregulated (n=650).  
 
For an overview, all differentially expressed genes of known or predicted molecular function 
were grouped into functional classes.  At stage 11, 199 transcripts of known function 
belonging to 13 functional classes are differentially expressed in sca-gcm embryos (Table 1).  
The two functional classes with the largest number of differentially regulated transcripts are 
enzymes (78) and nucleic acid binding proteins (44) including 26 transcription factors.  At 
stage 15/16, 614 transcripts of known function belonging to 15 functional classes are 
differentially expressed in sca-gcm embryos (Table 1).  The two functional classes with the 
largest number of differentially regulated transcripts are again enzymes (249) and nucleic acid 
binding proteins (96) including 38 transcription factors. Strikingly, however, at both stages, 
the majority of the differentially expressed transcripts are of (currently) unknown function; 
218 (52%) at stage 11 and 645 (51%) at stage 15/16.   
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Differential expression of genes encoding transcription factors 
The fact that gcm acts as a fate switch and key regulator of gliogenesis suggests that gcm 
might control a number of other transcription factors which in turn would regulate the 
expression of their own downstream genes.  Transcript profiling of gcm misexpression 
indicated that gcm does indeed control the expression of numerous other transcription factors.  
These transcription factor encoding genes and a quantification of their changes in expression 
level are shown in figure 2.   
 
In stage 11 embryos, 26 genes encoding transcription factors are differentially regulated by 
targeted gcm misexpression (11 upregulated, 15 downregulated).  The gcm gene has the 
highest expression level increase (8.6 fold), in accordance with our experimental procedure.  
(The gcm gene also has a high absolute level of expression at this stage; see color coding in 
figure. 2).  The repo gene, a known direct target of gcm (Akiyama et al., 1996), has the 
second highest increase in expression level (4.8-fold).  Many of the other upregulated 
transcription factor genes such as zinc finger homeobox-2 (zhf-2), u-shaped (ush) and the 
Enhancer of Split complex-member HLHm3 are known to act in different aspects of 
embryonic nervous system development (Delidakis and Artavanis-Tsakonas, 1992; Lundell 
and Hirsh, 1992; Cubadda et al., 1997).  Genes of the Enhancer of split complex, for example, 
act during neural versus epidermal cell fate decision (Jennings et al., 1994), and in the mouse, 
Enhancer of split members Hes1 and Hes5 have been shown to enhance glial cell fate 
(Furukawa et al., 2000; Hojo et al., 2000).  Among the transcription factors with decreased 
expression levels are engrailed (en) and ventral veins lacking/drifter (vvl/drf) which are 
expressed in a subset of neuronal precursor cells and are also involved in midline glial cell 
development, but not in lateral glial cell development (Condron et al., 1994; Anderson et al., 
1995).  Other genes encoding transcription factors with decreased expression levels are sloppy 
paired 1 (slp1), goosecoid (gsc), and forkhead domain 96Cb (fd96Cb), which are expressed in 
subsets of neural precursor cells (Hacker et al., 1992; Hahn and Jäckle, 1996; Bhat et al., 
2000).  Moreover, the scratch (scrt) transcription factor, a pan-neuronal gene encoding a zinc 
finger protein that promotes neuronal development and can induce additional neurons when 
ectopically expressed (Roark et al., 1995), also shows decreased expression levels.   
 
In stage 15/16 embryos, 38 genes encoding transcription factors are differentially regulated by 
targeted gcm misexpression  (18 upregulated, 20 downregulated).  As expected, gcm has the 
highest expression level increase (18.2 fold).  (The absolute level of expression of the gcm 
gene is now an order of magnitude lower at this stage than at stage 11; see color coding in 
figure 2.)  In contrast to high REPO protein levels in stage 15/16 sca-gcm embryos (Fig 1F), 
significant expression of repo transcripts is not detected at this stage.  Several genes encoding 
transcription factors, which are expressed in specific neurons, such as eyeless (ey) and 
Ultrabithorax (Ubx) (Hirth et al., 1998; Kammermeier et al., 2001), are downregulated.  
Moreover, several members of the Enhancer of split complex such as HLHmbeta, HLHm7, 
and E(spl), are downregulated at stage 15/16, in contrast to stage 11; in addition to a role in 
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early neurogenesis, these genes continue to be expressed in the normal developing nervous 
system of the wild-type at later embryonic stages (Wech et al., 1999).   
 
The marked increase in the number of affected transcripts at stage15/16 is due in part to the 
fact that numerous genes encoding transcription factors belonging to the basal transcription 
machinery are differentially regulated at this stage.  Among these are TfIIFbeta, Taf55, TfIIB, 
Taf60, Taf80, and Taf150 (Frank et al., 1995; Lee et al., 1997; Aoyagi and Wassarman, 2000).  
Moreover, among the upregulated genes encoding transcription factors several are involved in 
chromatin remodeling such as the brahma complex or associated genes, dalao (dalao), 
Brahma associated protein 60 kp (Bap60) Snf5-related 1(Snr1) and absent, small or homeotic 
disc 2 (ash2) (Francis and Kingston, 2001).  This suggests that the maintenance of glial cell 
differentiation at later embryonic stages involves chromatin remodeling as well as the 
regulation of global transcriptional processes.   
 
In addition to the above mentioned genes for transcription factors involved in chromatin 
remodeling, a number of genes encoding other proteins which bind to DNA/chromatin are 
influenced by gcm misexpression.  These genes and a quantification of their expression level 
changes are shown in figure 4A.  In stage 11 embryos, 7 genes encoding chromatin binding 
proteins are differentially regulated (3 upregulated, 4 downregulated), and at stage 15/16 
embryos, 26 genes encoding chromatin binding proteins are differentially regulated (17 
upregulated, 9 downregulated).  Prominent among the upregulated genes thought to be 
involved in chromatin condensation and segregation are gluon (glu) (Steffensen et al., 2001) 
and the two DNA replication factor genes Mini chromosome maintenance 6 and 7 (Mcm6) 
and (Mcm7) (Ohno et al., 1998).  Among the genes with downregulated expression are the 
three Sox-related genes sox-like (sox-like), Sox box protein 14 (Sox 14) and Dichaete (D) 
which encode DNA bending proteins.  D is known to be expressed in neural precursor cells 
and in midline glial cells (Soriano and Russell, 1998; Sanchez-Soriano and Russell, 2000).   
 
Only 4 genes encoding DNA binding proteins, including 2 that encode transcription factors, 
are differentially expressed in both early and late stage sca-gcm embryos.  This represents 
only 4% of the genes for DNA binding proteins that are differentially expressed in these 
embryos.  This finding, which in qualitative terms holds for all other functional classes of 
differentially expressed genes, indicates that the molecular genetic mechanisms of early glial 
fate determination are largely different from those involved in the later maintenance of 
differentiated glial cells.   
 
Differential expression of genes encoding kinases and phosphatases  
Cell-cell interactions between neuronal and glial cells are crucial for key cellular processes 
such as metabolic exchange, extrinsic signaling and electrical insulation.  The switch from 
neuronal to glial fate caused by gcm misexpression is, therefore, likely to affect genes that 
encode proteins involved in cell-cell signaling.  Transcript imaging analysis of gcm 
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misexpression indicates that gcm does indeed control numerous genes that encode kinases and 
phosphatases involved in signaling pathways.  A list of these genes as well as a quantitative 
representation of their changes in expression levels is shown in figure 3.  Once again, a 
marked increase in the number of affected transcripts was observed at stage 15/16 as 
compared to stage 11.   
 
In stage 11 embryos, 13 genes encoding kinases or phosphatases are differentially regulated 
by gcm misexpression (8 upregulated, 5 downregulated).  Among the genes with increases in 
transcript abundance is heartless (htl) which encodes a fibroblast growth factor (FGF) 
receptor expressed in lateral glial cells (Shishido et al., 1997).  Conversely the Epidermal 
growth factor receptor (Egfr) shows a decrease in transcript abundance; the Egfr pathway is 
implicated in midline glial cell development (Scholz et al., 1997).  Decreased expression is 
also observed for shaggy (sgg), which encodes a protein kinase, and for skittles (sktl), which 
encodes a putative phosphatidylinositol-4-phosphate 5-kinase.  Cells in sgg mutant embryos 
cannot adopt early epidermal fates and instead develop characteristics of CNS cells (Bourouis 
et al., 1989).  Mutations in sktl cause abnormal development in the PNS (Prokopenko et al., 
2000).   
 
In stage 15/16 embryos, 59 genes encoding kinases or phosphatases are differentially 
regulated by gcm misexpression (29 upregulated, 30 downregulated).  A number of genes 
involved in cell proliferation and mitotic division are upregulated.  These included polo 
(polo), discs overgrown (dco), smallminded (smid) and Nek2 (Nek2) (Llamazares et al., 1991; 
Schultz et al., 1994; Long et al., 1998; Zilian et al., 1999).  In contrast, genes involved in 
aspects of neuronal development such as axogenesis and synaptogenesis are downregulated.  
Among these are derailed (drl), Neuron-specific kinase (Nrk), and Cdk5 activator-like protein 
(Cdk5alpha).  The drl gene is involved in axonal guidance including routing across the 
midline (Bonkowsky et al., 1999).  Nrk is specifically expressed in the embryonic CNS (Oishi 
et al., 1997).  Cdk5alpha controls multiple aspects of axon patterning (Connell-Crowley et al., 
2000).  The only gene in this class that is known to be involved in glial differentiation is htl, 
which is upregulated at stage 11, and remains upregulated in stage 15/16 embryos albeit at a 
lower level.   
 
Differential expression of genes involved in cell cycle regulation  
As mentioned above, a number of chromatin binding protein and kinase/phosphatase 
encoding genes involved in cellular proliferation and in mitotic division are upregulated by 
gcm misexpression.  This suggests that other genes involved in proliferation and division may 
also be affected by gcm misexpression.  Transcript profiling of gcm misexpression indicates 
that gcm does indeed influence genes that encode cell cycle regulators.  These genes and a 
quantitative representation of their changes in expression levels are shown in figure 4B.   
 
10 genes encoding cell cycle regulators are differentially regulated by gcm misexpression (7 
upregulated, 3 downregulated) in stage 15/16 embryos.  For example, increases in transcript 
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abundance are found for Cyclin B (CycB), Cyclin A (CycA), and Cyclin D (CycD).  These 
genes encode regulators of cyclin dependent kinases that act in different phases during mitotic 
cell cycles (Follette and O'Farrell, 1997).  In contrast, and rather unexpectedly, a marked 
decrease in transcript abundance is found for Cyclin E (CycE).  Cyc E is essential for S-phase 
progression and its downregulation leads to the arrest of cell proliferation (Knoblich et al., 
1994).  Remarkably, in the earlier embryonic stage 11, none of the genes in the class of cell 
cycle regulators are influenced by gcm misexpression.   
 
Differential expression of genes encoding cell adhesion molecules 
Several cases for gcm-dependent regulation of genes encoding cell adhesion molecules were 
observed.  These genes as well as a quantitative representation of their expression level 
changes is shown in figure 4C.  At stage 11, 4 genes encoding cell adhesion molecules are 
differentially regulated by gcm misexpression (2 upregulated, 2 downregulated).  At stage 
15/16, 19 genes encoding cell adhesion molecules are differentially regulated by gcm 
misexpression (4 upregulated, 15 downregulated).   
 
A striking example for a gene with a marked increased transcript level (13.6 fold) in stage 
15/16 embryos is wrapper.  wrapper encodes a cell adhesion molecule that is expressed in 
midline glial cells and in late stages also in lateral glial cells (Noordermeer et al., 1998).  
Genes with decreased transcript levels in stage 15/16 embryos that are mainly expressed in 
neurons are Tenascin major (Ten-m), Cadherin-N (CadN) and neuromusculin (nrm).  All 
three act during axogenesis and synaptogenesis (Kania et al., 1993; Baumgartner et al., 1994; 
Levine et al., 1994; Iwai et al., 1997).  The fact that most of the affected genes in the cell 
adhesion class show gcm-dependent decreased transcript levels could reflect the large 
diversity of cell adhesion molecules expressed by neurons.   
 
gcm misexpression may influence genes that act in the hemocyte lineage  
In addition to its key role in gliogenesis, gcm also functions in a mesodermal lineage that 
gives rise to hematopoietic cells (Bernardoni et al., 1997; Lebestky et al., 2000). When 
ectopically expressed in the early mesoderm, gcm can induce expression of Peroxidasin (Pxn) 
which is a marker for macrophage cells.  Misexpression of gcm in cells of the neural lineage 
also gives rise to a few cells that express hemocyte markers although most cells differentiate 
into glia (Bernardoni et al., 1997).  In accordance with these findings, transcript profiling of 
gcm misexpression embryos indicates that several genes encoding marker proteins for cells of 
the hemocyte lineage are differentially regulated.   
 
In stage 15/16 embryos, differential expression levels are detected for Pxn, serpent (srp), and 
the Scavenger receptor class C (type I) gene (Pearson et al., 1995), all of which are expressed 
in hemocytes.  Scavenger receptors play a crucial role in the phagocytosis of apoptotic cells 
and might also be able to mediate the direct recognition of microbial pathogens (Platt et al., 
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1998).  It is noteworthy that the genes encoding Lysozyme B, Lysozyme C, Lysozyme D, and 
Lysozyme E are all upregulated by gcm misexpression in stage 11 embryos.  These four 
closely related lysozyme genes, clustered at locus 61F on the third chromosome, function as 
part of a system of inducible antibacterial immunity (Daffre et al., 1994).  These findings 
support the notion that the glial cell lineage and the hemocyte lineage, which gives rise to 
cells involved in defense and immunity, may be molecularly related (Bernardoni et al., 1997).   
 
Analysis of spatial expression of candidate gcm downstream genes by in situ 
hybridization and immunocytochemistry 
To complement the quantitative transcript profiling analysis with tissue-specific spatial 
expression data, in situ hybridization and immunostaining was carried out on a subset of the 
genes that are differentially regulated by gcm misexpression (Fig. 5).  In all cases, the 
qualitative changes in tissue-specific gene expression revealed by in situ hybridization and 
immunocytochemistry reflect and confirm the changes in gene expression determined by 
transcript profiling.   
 
Expression of the transcripts for htl, scrt, bangles-and-beads (bnb) and elav was examined by 
in situ hybridization.  In stage 11 wild-type embryos, the htl gene is expressed in a distinct set 
of neural precursors in the CNS (Fig. 5A).  Outside of the CNS, htl is also expressed in 
elements of the mesodermal lineage (Shishido et al., 1997).  Following targeted misexpression 
of gcm in cells of the neuroectoderm in stage 11 sca-gcm embryos, the expression of htl is 
expanded in the CNS region to include virtually all neural precursors (Fig. 5B).  No changes 
in the expression of htl are seen outside of the CNS in these embryos.  In stage 11 embryos, 
the pan-neural scrt gene is expressed in most or all neural precursors (Fig. 5C) (Roark et al., 
1995).  Following targeted misexpression of gcm in cells of the neuroectoderm in stage 11 
sca-gcm embryos, the expression of scrt is diminished in most of the neural precursors, but is 
still apparent in a subset of these cells (Fig. 5D).   
 
In stage 15/16 wild-type embryos, the bnb gene is expressed in lateral glial cells (Ng et al., 
1989) (Fig. 5E,G).  With the exception of a small group of cells near the anterior and posterior 
ends of the embryo, no other bnb expression is seen outside of the nervous system at this 
stage.  In stage 15/16 sca-gcm embryos, the expression of bnb increases markedly and appears 
in virtually all of the cells of the nervous system (Fig. 5F,H).  Expression of bnb outside of the 
nervous system does not appear to be influenced in these sca-gcm embryos.  In stage 15/16 
wild-type embryos, the elav gene is expressed in all neurons (Fig. 5I).  In stage 15/16 in sca-
gcm embryos, expression of elav is strongly reduced, but is still visible in some neurons of the 
brain as well as in some of the neurons that occupy the ventral-most cell layer in the ventral 
nerve cord  (Fig. 5J).   
 
Given that transcript abundance is not always reflected on the protein level (Keene, 2001), 
expression of three further candidate gcm downstream genes, ey, Ten-m, and wrapper was 
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investigated at the protein level by immunostaining in wild-type and sca-gcm embryos.  In 
stage 15/16 wild-type embyos the EY protein is expressed in a segmentally reiterated subset 
of neurons in the CNS (Fig 5K).  In stage 15/16 sca-gcm embryos the number of cells in the 
CNS that express the EY protein is dramatically reduced (Fig. 5L).  In stage 15/16 wild-type 
embryos, the TEN-M protein is expressed on the axons that make up the longitudinal and 
commissural tracts of the CNS (Fig. 5M).  This well defined axonal expression pattern of 
TEN-M protein is virtually abolished in stage 15/16 sca-gcm embryos (Fig. 5N).  The TEN-M 
protein is also expressed outside of the nervous system (Baumgartner et al., 1994), but there is 
no obvious change in this non-neuronal expression of TEN-M in sca-gcm as compared to 
wild-type embryos.  In stage 15/16 wild-type embryos, the WRAPPER protein is expressed in 
the midline and in some of the lateral glial cells, as well as in glial cells that support the 
chordotonal sensory organs in the PNS (Fig 5O)(Noordermeer et al., 1998). In stage 15/16 
sca-gcm embryos a substantial increase of WRAPPER expression is seen in the CNS (Fig. 
5P).   
 
To control for possible effects of transgene insertion or of differences in genetic background, 
we repeated the tissue-specific spatial expression analysis for all of the above mentioned 
genes on embryos that contain either only the sca-GAL4 construct or only the UAS-gcm 
constructs.  In all cases, in situ hybridization and immunostaining results on these embryos 
were indistinguishable from results obtained on wild-type embryos (data not shown). 
 
To determine if genes, that are influenced by gcm gain-of-function, might be influenced in an 
inverse way in gcm loss-of-function mutants, we studied tissue-specific spatial expression 
data of the candidate gcm downstream genes repo, bnb, wrapper, elav, ey and Ten-m in gcm 
null mutants using in situ hybridization and immunostaining.  Expression of the genes repo, 
bnb and wrapper is upregulated in gcm gain-of-function embryos.  In stage 15/16 gcm null 
mutant embryos, the expression of the repo gene in lateral glial cells, which is seen in the 
wild-type CNS, is strongly reduced (Fig. 5Q,R) (Hosoya et al., 1995; Jones et al., 1995; 
Vincent et al., 1996). Comparable findings are obtained for bnb; the expression of the bnb 
gene in lateral glial cells, which is seen in the wild-type CNS, disappears (Fig. 5Q,R).  These 
findings contrast with stage 15/16 sca-gcm embryos, where the expression of repo and bnb 
appears in virtually all of the cells of the CNS.  In stage 15/16 gcm null mutant embryos, the 
expression of wrapper in the lateral glial cells and in PNS glial cells (but not the midline glial 
cell expression), which is observed in wild-type embryos, disappears (Fig. 5S,T).  This 
contrasts with stage 15/16 sca-gcm embryos, where the expression of wrapper becomes more 
widespread in the CNS.  Expression of the genes elav, ey and Ten-m is downregulated in gcm 
gain-of-function embryos.  Expression of elav in gcm null mutants is seen in additional 
neuronal cells as compared to the wild-type (data not shown) (Hosoya et al., 1995; Jones et 
al., 1995; Vincent et al., 1996).  In contrast, the number of CNS cells that express either ey or 
Ten-m is not altered in gcm null mutants as compared to the wild-type (data not shown).  This 
is not unexpected since ey and Ten-m are not pan-neuronally expressed as is elav but are 
expressed only in a subset of neuronal cells in the wild-type CNS (Baumgartner et al., 1994; 
Kammermeier et al., 2001).   
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Discussion 
 
Candidate gene identification through genome-wide transcript imaging 
By analysing gene expression profiles following gcm misexpression in the embryonic CNS, 
genome-wide transcript images were obtained for two phases of glial development.  The first 
transcript image reflects an embryonic CNS in which precursor cells that normally give rise to 
neurons have been genetically reprogrammed to give rise to glial cells.  It was obtained at an 
early embryonic stage when the first glial-specific genes, such as the repo gene (which is a 
direct target of gcm), start to become expressed.  This transcript image is therefore likely to 
identify genes that act in CNS precursors and are involved in the determination of glial versus 
neuronal cell lineage.  Approximately 400 genes were found to be differentially expressed at 
this developmental stage, corresponding to 3% of the annotated genes in the fly genome.  We 
posit that the genes that are differentially regulated at this early stage are either direct gcm 
target genes, such as repo, or among the initial set of downstream genes of gcm.   
 
The second transcript image, obtained at a later embryonic stage when glial and neuronal cells 
are normally differentiated, reflects an embryonic CNS in which 80-90% of the normal 
number of neuronal cells have been genetically replaced by glial cells due to gcm action 
(Hosoya et al., 1995).  This transcript image is therefore likely to identify genes that are 
involved in the maintenance of differentiated glial versus neuronal cells.  Approximately 1300 
genes were differentially expressed at this stage, corresponding to 9% of the annotated genes 
in the fly genome.  We postulate that most of these differentially expressed genes are no 
longer direct or initial downstream targets of gcm, but are rather indirect downstream genes 
that act further along in the genetic cascade of gcm action.   
 
The difference in total number of differentially expressed genes at the early stage versus the 
late stage is striking and, in qualitative terms, also holds for each of the major functional gene 
classes.  Moreover, the overlap between the genes that are expressed at the two stages is 
restricted; only 93 (7%) of the 1259 genes that are differentially expressed at the late stage, 
are also differentially expressed at the early embryonic stage (Fig. 6).  This suggests that the 
gene regulatory elements that control determination of glial cell fate are largely different from 
those required for maintenance of glial cell differentiation.   
 
The expression profiles presented here derive from gain-of-function experiments in which the 
gcm gene is misexpressed in the embryonic CNS.  A comparison of these findings with 
expression profiles derived from loss-of-function experiments involving gcm null mutants 
will be an important step in the further analysis of gcm downstream genes.  However, in gcm 
null mutants only about 60 presumptive glial cells per segment are transformed into neurons; 
the 700 neurons of each segment are not affected.  With the current sensitivity of 
oligonucleotide microarrays, it is unlikely that significant measurements of gene expression 
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changes in such a small number of cells can be obtained using whole-mount embryos.  Thus, 
these complementary gcm loss-of-function experiments must await the development of single-
cell isolation techniques for the embryonic nervous system of Drosophila.   
 
Candidate genes implicated in the determination of glial versus neuronal cell lineage 
Although gcm expression is necessary and sufficient to induce glial cell fate in and outside of 
the nervous system, it normally acts in glial precursors in the wild-type (Hosoya et al., 1995; 
Jones et al., 1995; Vincent et al., 1996; Akiyama-Oda et al., 1998; Bernardoni et al., 1998).  A 
current model of this action is that gcm controls the determination of glial cell fate in glial 
precursors by activating both genes that promote glial differentiation and genes that repress 
neuronal differentiation (Giesen et al., 1997).  Application of this model to our experimental 
paradigm leads to the prediction that expression of glial precursor-specific genes should be 
upregulated and expression of neuron precursor-specific genes should be downregulated in 
stage 11 sca-gcm embryos.  Our genome-wide expression data verifies this prediction.   
 
We find upregulation of genes that are known to be expressed in glial precursor cells.  
Prominent among these is repo, which contains 11 GCM consensus binding sites in its 
upstream regulatory region and is the first identified direct target of gcm (Akiyama et al., 
1996).  Another upregulated gene that is first expressed in the CNS in glial precursors is htl, 
which encodes a FGF-receptor (Shishido et al., 1997).  Downregulation is found for several 
genes that are known to be expressed in neuronal precursors.  Prominent among these is the 
pan-neuronal gene scratch (scrt) which promotes neurogenesis and can induce additional 
neurons when ectopically expressed (Roark et al., 1995).  Interestingly, we also observe 
downregulation for several genes that are involved in midline glial cell development such as 
Egfr, vvl, en and D (Condron et al., 1994; Anderson et al., 1995; Scholz et al., 1997; Soriano 
and Russell, 1998).  This suggests that midline glial development may be suppressed in sca-
gcm embryos and might also explain the otherwise unexpected downregulation of tramtrack 
(ttk) and pointed (pnt), since these genes are not only expressed in lateral glial cells but also in 
midline glial cells (Granderath and Klämbt, 1999). 
 
In addition to genes that are known to be involved in the gliogenesis/neurogenesis decision, 
we find a large number of genes that have not previously been implicated in this aspect of 
CNS development.  Indeed, for the majority of the known differentially regulated genes 
identified here, this report represents the first indication for an involvement in gliogenesis 
and/or neurogenesis.  This is also the case for the annotated genes of unknown function, 
which have not been studied in any in vivo context, and which make up the majority of the 
differentially expressed genes identified.   
 
The effects of targeted misexpression of gcm in stage 11 sca-gcm embryos appear to be 
restricted to cells of the neuroectoderm.  Moreover, these effects manifest themselves 
primarily in altered gene expression in cells of the neuroectoderm.  No morphological 
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changes are seen in stage 11 sca-gcm embryos as compared to wild-type, and non-specific 
side effects of gcm misexpression such as growth abnormalities, defective morphogenesis, or 
increased apoptosis are not observed in these embryos.  We therefore assume that the 
observed differential gene expression specifically reflects activation or repression of gcm 
downstream genes.  It is, nevertheless, unlikely that our study uncovers all of the genes that 
act downstream of gcm to induce glial cell fate.  This is because our early transcript image is 
restricted to a specific time point in early gliogenesis development, and gcm may influence 
other targets at other stages.  Moreover, the genetic overexpression of gcm may create an 
artificial situation in vivo, in which not all of the candidate downstream genes show changes 
in magnitude and direction of expression that correspond to their responses to gcm action 
under normal conditions.  For example, whereas gcm expression in a mesodermal lineage 
induces genes involved in hemocyte cell development, overexpression of gcm in 
neuroectodermal cells causes a downregulation of the hemocyte marker genes Pxn and srp.  
(Downregulation of Pxn may, however, also be due to the fact that this gene is also expressed 
in the nervous system.)  Finally, it is conceivable that some of the gene expression changes 
seen in sca-gcm embryos as compared to wild-type are due to insertional effects of the 
transgenes or to differences in genetic background.  While we find no evidence for such 
effects among the 10 gcm candidate genes that we characterized by in situ and 
immunocytochemical experiments, we cannot rule out such effects for all of the candidate 
genes identified in this report.  In consequence, a full appreciation and verification of all of 
these candidate gcm downstream genes and a comprehensive understanding of their roles in 
determination of glial versus neuronal cell lineage will require a careful gene-by-gene 
analysis in mutant embryos.  This also applies to the genes that are differentially expressed in 
stage 15/16 embryos.   
 
Candidate genes implicated in the maintenance of differentiated glial versus neuronal 
cells 
In stage 15/16 sca-gcm embryos most of the neurons in the embryonic nervous system are 
genetically replaced by glial cells, and differential gene expression in these embryos as 
compared to wild-type embryos reflects this fact.  While the transcript image obtained at this 
stage will, therefore, identify genes that are involved in the maintenance of differentiated glial 
versus neuronal cells, non-specific side effects of gcm misexpression on differential gene 
expression cannot be ruled out. This is because the marked loss of neurons in stage 15/16 sca-
gcm embryos results in morphological changes such as defective condensation of the CNS or 
reduction of peripheral innervation, and these morphological alterations may be accompanied 
by changes in gene expression.   
 
Nevertheless, given that the strongest phenotype of stage 15/16 sca-gcm embryos is the gain 
of glial cells at the expense of neurons, we postulate that most of the observed differential 
gene expression at this stage is directly related to the replacement of differentiated neurons by 
differentiated glial cells.  This is supported by the fact that a number of genes that are known 
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to be expressed in differentiated neurons such as elav, lark, Ten-m and CadN are 
downregulated while genes that are expressed in differentiated glial cells such as htl, wrapper 
and bnb are upregulated in stage 15/16 sca-gcm embryos.  In several cases, however, genes 
encoding markers for lateral or peripheral glia were not judged to be upregulated by our data 
analysis.  For example, for the genes repo, locomotion defects (loco), and gliotactin (gli), the 
normalized expression levels, the fold change levels or the statistical significance levels were 
below our threshold filter values, so that these genes were not considered to be upregulated in 
our microarray experiments.   
 
Cell fate determination is often controlled at the transcriptional level by key regulatory factors 
that are expressed transiently, whereas the gene expression patterns that they establish persist.  
Maintenance of the transcriptional state in differentiated cells is then achieved by control 
elements involved in chromatin remodeling and modification (Francis and Kingston, 2001).  
Accordingly, in our analysis of stage 15/16 sca-gcm versus wild-type embryos, we identified 
several differentially expressed genes that are involved in chromatin remodeling such as 
Bap60, dalao, Snr1 and ash2.  In specific glial lineages, the onset of differentiation is thought 
to require cell cycle progression (Akiyama-Oda et al., 2000).  In our analysis, differential 
expression of genes encoding cell cycle regulators or proteins involved in chromatin 
condensation and segregation during mitosis was also observed. Examples of this are cyclin 
encoding genes such as CycB, CycA, CycD and CycE which are differentially expressed in 
stage 15/16 embryos. The differential expression of these genes following gcm misexpression 
provides further support for the general notion that cell cycle regulators are key elements in 
cellular differentiation processes (Ohnuma et al., 2001).   
 
In summary, this study combines in vivo transgenic analysis with genome-wide expression 
analysis based on oligonucleotide arrays to identify genes that are downstream of gcm, a key 
transcriptional control element in gliogenesis.  The results of this study should be helpful in 
obtaining a comprehensive view of the molecular mechanisms of cell fate specification and 
cell type maintenance in the developing nervous system.   
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Transcription factor
stage 11
gcm transcription factor
repo transcription factor
mor non-specific RNA polymerase II transcription factor 
zfh2 RNA polymerase II transcription factor
ush ligand-dependent nuclear receptor
HLHm3 transcription factor
CG3459 transcription factor
grh transcription factor 
dei specific RNA polymerase II transcription factor
CG11710 ligand-dependent nuclear receptor interactor 
fu2 RNA polymerase II transcription factor 
CG4976 transcription co-factor
en specific RNA polymerase II transcription factor 
vvl RNA polymerase II transcription factor
Tbp general RNA polymerase II transcription factor
HLH54F transcription factor 
CG6443 transcription factor
mod(mdg4) RNA polymerase II transcription factor 
grau specific RNA polymerase II transcription factor 
NC2alpha general transcriptional repressor 
Arc70 transcription factor 
CG4575 transcription factor
slp1 RNA polymerase II transcription factor 
scrt transcription factor 
Gsc specific RNA polymerase II transcription factor
fd96Cb transcription factor 
stage 15/16
gcm transcription factor
apt RNA polymerase II transcription factor 
ash2 RNA polymerase II transcription factor
dalao non-specific RNA polymerase II transcription factor 
CG3891 transcription factor
CG6751 general RNA polymerase II transcription factor 
TfIIFbeta general RNA polymerase II transcription factor
l(2)35Ea transcription factor
Taf55 general RNA polymerase II transcription factor 
CG11375 transcription factor
TfIIB general RNA polymerase II transcription factor 
Usf transcription factor 
cact transcription factor, cytoplasmic sequestering
Bap60 non-specific RNA polymerase II transcription factor 
Snr1 RNA polymerase II transcription factor
Taf60 general RNA polymerase II transcription factor 
Taf80 general RNA polymerase II transcription factor 
HLH106 transcription factor 
maf-S transcription factor
HLHmbeta transcription factor 
ttkp69 specific RNA polymerase II transcription factor
Taf150 general RNA polymerase II transcription factor
Pdp1 transcription factor
srp non-specific RNA polymerase II transcription factor 
grau specific RNA polymerase II transcription factor
pnt(P1+P2) specific RNA polymerase II transcription factor 
dei specific RNA polymerase II transcription factor 
Mef2 RNA polymerase II transcription factor 
CG9207 general RNA polymerase II transcription factor
Ubx specific RNA polymerase II transcription factor 
mirr transcription factor
E2f2 RNA polymerase II transcription factor 
bi transcription factor
lola RNA polymerase II transcription factor 
ey specific RNA polymerase II transcription factor 
Oli transcription factor
HLHm7 specific RNA polymerase II transcription factor 
E(spl) specific RNA polymerase II transcription factor
<100 100-1000 >1000
Fig. 2. Changes in transcript levels of the genes encoding transcription factors following gcm 
misexpression. Bars represent the fold changes in gene expression levels between wild-type embryos
and sca -gcm embryos. Positive values indicate that the relative expression level of a gene is increased
(upregulation) and negative values indicate a decrease (downregulation). Normalized average
difference (Avg Diff) values are given for the wild-type condition as follows: yellow bars represent
Avg Diff <100, orange bars represent Avg Diff ranging from 100-1000, and red bars represent Avg
Diff >1000.  
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Kinase/phosphatase
stage 11
htl protein tyrosine kinase
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CG1271 glycerol kinase 
Pka-R1 protein kinase 
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Argk arginine kinase 
EG:52C10.5 1-phosphatidylinositol-4-phosphate 5-kinase
CG8485 protein kinase 
KP78b protein serine/threonine kinase
sgg protein serine/threonine kinase
sktl 1-phosphatidylinositol-4-phosphate 5-kinase
Egfr protein tyrosine kinase
CG3101 protein phosphatase 
stage 15/16
polo protein serine/threonine kinase 
tor protein kinase
fu protein serine/threonine kinase
mbt protein serine/threonine kinase
CG10522 protein serine/threonine kinase 
CG11228 receptor signaling protein serine/threonine kinase
CG8311 dolichol kinase 
smid adenosinetriphosphatase
PEK protein kinase 
Nek2 protein serine/threonine kinase 
CG1271 glycerol kinase 
CG14226 protein tyrosine phosphatase 
dco protein serine/threonine kinase 
CG5026 protein phosphatase 
Pp4-19C protein serine/threonine phosphatase
CG6767 ribose-phosphate pyrophosphokinase 
pll protein serine/threonine kinase 
CG7597 cyclin-dependent protein kinase 
CG14217 receptor signaling protein serine/threonine kinase
Pdk pyruvate dehydrogenase (lipoamide) kinase 
Ptp61F protein tyrosine phosphatase 
Bub1 protein serine/threonine kinase
htl protein tyrosine kinase 
Src64B protein tyrosine kinase 
CG1637 acid phosphatase 
MAPk-Ak2 protein serine/threonine kinase 
CG8173 protein serine/threonine kinase
Pp2A-29B protein phosphatase 
wun2 phosphatidate phosphatase
CG1216 glycerol kinase
HD-14 protein tyrosine kinase 
CG16804 mevalonate kinase 
BcDNA:LD34343 protein serine/threonine phosphatase 
bt protein kinase 
aay phosphoserine phosphatase 
Paps adenylsulfate kinase 
rdgC protein serine/threonine phosphatase 
CG5171 trehalose phosphatase 
CG1216 glycerol kinase 
CG3980 protein phosphatase 
CG17471 1-phosphatidylinositol-4-phosphate 5-kinase 
CkIIbeta protein kinase 
CG1809 alkaline phosphatase 
nmdyn-D7 nucleoside-diphosphate kinase 
ik2 protein kinase 
par-1 protein serine/threonine kinase
bsk protein kinase 
BEST:CK01209 protein kinase
Cdk5alpha cyclin-dependent protein kinase 
Caki calcium/calmodulin-dependent protein kinase 
drl protein tyrosine kinase 
Pkc98E protein kinase 
CG17026 myo-inositol-1(or 4)-monophosphatase 
Nrk protein tyrosine kinase 
CG3101 protein phosphatase 
Ror protein tyrosine kinase 
Pkc53E protein kinase 
PP2A-B' protein phosphatase 
CG5875 diacylglycerol kinase
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Fig. 3. Changes in transcript levels for the genes encoding protein kinases and phosphatases following
gcm  misexpression.  Data presentation as in figure 2.  
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A DNA binding/chromatin binding
stage 11
Mcm6 chromatin binding 
Mlh1 DNA repair protein
phr DNA repair protein 
sox-like DNA bending
Orc2 DNA replication factor 
EG:EG0003.3 DNA repair protein
Sox14 DNA bending
stage 15/16
msl-3 chromatin binding
glu DNA binding 
phr DNA repair protein
CG10898 DNA repair protein 
Bj1 chromatin binding 
spt4 chromatin binding 
Mcm6 chromatin binding
Nopp140 DNA binding 
BcDNA:LD08534 DNA repair protein 
Mcm7 chromatin binding 
mod DNA binding
mus210 DNA repair protein
dup DNA replication factor 
CG15220 DNA replication factor 
Nlp DNA binding 
Su(var)205 chromatin binding 
His2Av DNA binding 
SMC1 DNA binding
HmgZ DNA binding
CG9135 DNA binding 
ewg DNA binding 
ph-p DNA binding 
CG7229 DNA binding 
D DNA bending
Ercc1 DNA repair protein 
CG7233 DNA binding
B Cell cycle regulator
stage 15/16
CycB cyclin
CG3183 cell cycle regulator
CG7683 cyclin 
CycA cyclin 
lin19 cell cycle regulator 
CycD cyclin
CG17498 cell cycle regulator
CycT cyclin
CG4050 cell cycle regulator 
CycE G1/S-specific cyclin 
C Cell adhesion
stage 11
CG5046 cell adhesion
BcDNA:GH03529 cell adhesion
CG8434 cell adhesion; immunoglobulin C-2 type domain
sns cell adhesion; immunoglobulin C-2 type domain
stage 15/16
wrapper cell adhesion; immunoglobulin C-2 type domain
Lac cell adhesion; immunoglobulin C-2 type domain
Sema-5c cell adhesion; semaphorin
Fas1 cell adhesion
mew cell adhesion; integrin alpha chain domain
vkg cell adhesion; collagen
Ten-m cell adhesion
CG5639 cell adhesion; trypsin inhibitor domain 
BM-40/SPARC cell adhesion
LanB1 cell adhesion; laminin
CG10323 cell adhesion
kek1 cell adhesion; immunoglobulin C-2 type domain
CG7709 cell adhesion
BG:DS00180.8 cell adhesion
CadN cell adhesion; cadherin
Pxn cell adhesion; immunoglobulin C-2 type domain
SP2353 cell adhesion
nrm cell adhesion; immunoglobulin subtype domain
CG5308 cell adhesion; immunoglobulin C-2 type domain
<100 100-1000 >1000
Fig. 4. Changes in transcript levels for the genes encoding DNA/chromatin binding proteins, cell
cycle regulators or cell adhesion molecules following gcm  misexpression.  
(A) Genes encoding DNA/chromatin binding proteins. (B) Genes encoding cell cycle regulators.
(C) Genes encoding cell adhesion molecules. Data presentation as in figure 2. 
2.4
1.6
-1.6
-1.5
2.3
1.6
-1.6
-1.8
-2.0
-3.7
1.6
3.5
1.6
-1.5
-1.6
-1.6
-1.7
-1.7
-1.7
-2.0
-2.2
-2.4
-2.6
-2.7
-2.8
-3.0
-3.2
-3.3
13.6
2.0
6.0
3.0
2.7
2.6
2.1
1.8
-1.7
-2.5
-4.9
3.0
9.1
5.8
3.1
3.1
3.0
3.0
2.2
2.1
2.0
2.0
1.9
1.7
1.6
1.6
1.6
1.5
-1.5
-1.5
-2.3
-2.5
-2.5
-2.6
-2.7
-3.5
-6.2
4.8
-135-
-136-
 - 137 -
Fig. 5. Spatial expression of selected candidate gcm downstream genes by in situ 
hybridization and immunocytochemistry. Whole mount in situ hybridization (A-J,Q,R) and 
immunostaining (K-T) show expression of differentially regulated genes in wild-type, sca-
gcm and gcm mutant embryos.  Ventral views of stage 11 (A-D) and stage 15/16 (E,F,I,J,K-P) 
embryos and lateral views of stage 15/16 embryos (G,H,Q-T), anterior is to the left.  Fold 
changes and p-values are indicated to the right.  (A,B) Expression of htl in stage 11 wild-type 
embryos is visible in a distinct set of neural precursors; in sca-gcm embryos, htl is expressed 
throughout the neurogenic region.  (C,D) In stage 11 embryos, the scrt gene is expressed in 
neural precursors; in stage 11 sca-gcm embryos, the expression of scrt is diminished in most 
of the neural precursors, but is still apparent in a subset of these cells.  (E-H) In stage 15/16 
wild-type embryos, bnb gene is expressed in lateral glial cells; in stage 15/16 sca-gcm 
embryos, the expression of bnb increases markedly and appears virtually in all of the cells of 
the nervous system.  (I,J) In stage 15/16 wild-type embryos, the elav gene is expressed in all 
neurons; in stage 15/16 in sca-gcm embryos, expression of elav is strongly reduced in most of 
the neurons.  (K,L)  In stage 15/16 wild-type embyos the EY protein is expressed in a 
segmentally reiterated subset of neurons in the CNS; in stage 15/16 sca-gcm embryos the 
number of EY expressing cells in the CNS is dramatically reduced.  (M,N) In stage 15/16 
wild-type embryos, the TEN-M protein is expressed on the axons that make up the 
longitudinal and commissural tracts of the CNS; this axonal expression of TEN-M is virtually 
abolished in stage 15/16 sca-gcm embryos. (O,P) In stage 15/16 wild-type embryos, the 
WRAPPER protein is expressed in midline glial cells, in some lateral glial cells and in glial 
cells supporting the chordotonal sensory organs; this expression has spread to the complete 
CNS region in stage 15/16 sca-gcm embryos.  (Q,R) In late stage embryos REPO (brown) is 
expressed in all and bnb (blue) is expressed in a subset of lateral glial cells; in gcm mutants 
REPO expression is reduced to a few cells, and bnb expression is completely absent in the 
CNS.  (S,T) In late stage embryos WRAPPER is expressed in midline glial cells, in some 
lateral glial cells and in glial cells supporting chordotonal sensory organs (arrowheads); in 
gcm mutant embryos WRAPPER expression in lateral glia (CNS) and in chordotonal sensory 
organs (PNS) is absent whereas expression in midline glial cells remains.   
DNA binding Chaperone
Mcm6 Caf1
phr CG9906
CG2947
Transcription factor Hsp60
Hsc70-2
gcm Hsp23
dei
grau Function unknown
Transporter CG13913
CG1648
w CG13639
nAcRalpha-80B CG14326
Cyp4p2 CG6218
nAcRbeta-96A CG7330
CG6070 CG17124
Cyp6a8 CG7456
Cyp4e2 CG9186
CG8799 rost
BcDNA:GH07269
Translation factor CG10102
EG:BACN32G11.1
eIF3-S8 CG10671
CG8335 CG3849
c12.1
Structural protein CG13599
CG15561
RpL3 CG5174
egh
Signal transducer CG4364
CG8370
SrpRbeta CG11127
CG9662
Ligand binding or carrier CG9489
BG:DS05899.3
MtnA CG18600
CG17271 CG12797
CG6891 BcDNA:GH12504
CG6783 CG9298
bnk CG11604
CG1943
Enzyme and enzyme inhibitor CG12487
CG3941
serpin-27A CG15428
EG:BACR37P7.9 Cdc27
htl CG9924
CG8563 CG3773
CG1271 CG13912
CG7090 cmp44E
sgl CG18158
CG9953 CG5272
Sodh-2 CG9987
Fdh Ocho
RpII15 CG14988
CG8036 CG10936
CG10682 CG7105
CG5028
Eip71CD
CG12256
CG17524
CG3101 stage 11 stage 15/16
Fig. 6. Changes in transcript levels of the genes with differential expression in both early and late embryonic stages
following gcm misexpression. 93 genes show significant changes in expression levels in response to gcm misexpression at
stage 11 (yellow) as well as at stage 15/16 (red). Bars represent the fold changes in gene expression levels between wild-
type embryos and sca-gcm embryos. Positive values indicate that the relative expression level of a gene is increased
(upregulation) and negative values indicate a decrease (downregulation).
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-1.7
-1.6
-6.2
2.6
1.8
-1.8
-1.7
-1.6
-1.5
1.6
1.6
1.7
1.8
2.1
2.1
2.1
2.5
3.0
-21.5
-17.9
-1.6
6.5
4.0
5.0
5.6
7.3
13.5
3.8
-1.7
-1.9
-1.9
-2.3
3.9
1.9
1.6
1.9
1.6
1.8
4.1
1.8
1.9
3.0
1.7
2.6
3.9
-3.5
-1.7
-6.8
-2.8
-2.5
3.4
-7.5
-1.9
-1.5
-2.4
3.0
3.3
21.0
-1.8
5.2
1.7
3.8
1.9
2.5
2.1
1.8
-6.4
-4.2
1.8
3.0
6.3
1.7
3.5
2.1
10.8
-6.8
-1.6
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Table.1 Differential gene expression in functional 
classes following gcm misexpression 
   
Molecular Function Number of transcripts 
 stage 11 stage 15/16 
   
Nucleic acid binding 44 96 
DNA binding 33 64 
Transcription factor 26 38 
RNA binding 6 27 
Translation factor 5 4 
Ribonucleoprotein / 1 
Cell cycle regulator / 10 
Chaperone 7 13 
Motor protein 4 7 
Defense/immunity protein 4 3 
Enzyme 78 249 
Kinase/phosphatase 13 59 
Enzyme activator / 3 
Enzyme inhibitor 3 7 
Apoptosis regulator / 2 
Signal transducer 12 50 
Cell adhesion 4 19 
Structural protein 3 39 
Transporter 25 51 
Ligand binding or carrier 13 63 
Antioxidant 1 2 
Tumor suppressor 1 / 
Function unknown 218 645 
   
Total 417 1259 
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Abstract 
Background 
Mutations and gene expression alterations in brain tumors have been extensively investigated, 
however the causes of brain tumorigenesis are largely unknown. Animal models are necessary 
to correlate altered transcriptional activity and tumor phenotype and to better understand how 
these alterations cause malignant growth. In order to gain insights into the in vivo 
transcriptional activity associated with a brain tumor, we carried out genome-wide microarray 
expression analyses of an adult brain tumor in Drosophila caused by homozygous mutation in 
the tumor suppressor gene brain tumor (brat). 
Results 
Two independent genome-wide gene expression studies using two different oligonucleotide 
microarray platforms were used to compare the transcriptome of adult wildtype flies with 
mutants displaying the adult bratk06028 mutant brain tumor. Cross-validation and stringent 
statistical criteria identified a core transcriptional signature of bratk06028 neoplastic tissue. We 
find significant expression level changes for 321 annotated genes associated with the adult 
neoplastic bratk06028 tissue indicating elevated and aberrant metabolic and cell cycle activity, 
upregulation of the basal transcriptional machinery, as well as elevated and aberrant activity 
of ribosome synthesis and translation control. One fifth of these genes show homology to 
known mammalian genes involved in cancer formation. 
Conclusion 
Our results identify for the first time the genome-wide transcriptional alterations associated 
with an adult brain tumor in Drosophila and reveal insights into the possible mechanisms of 
tumor formation caused by homozygous mutation of the translational repressor brat.  
 
 
Background  
Cancer is a multistep process, which involves loss of cell proliferation control, resistance to 
cell death, and invasion as well as metastasis. This process is often associated with multiple 
and progressive genetic alterations. Proto-oncogenes are activated in a dominant fashion by 
mutation, chromosome translocation or gene amplification, whereas tumor suppressor genes 
are inactivated or lost by mutation, chromosome loss, mitotic recombination or gene 
conversion [1-3]. 
 
Mutations and gene expression alterations in brain tumors have been extensively  
investigated. For example, data has been accumulated for the cerebellar tumor 
medulloblastoma which is the most common malignant brain tumor in children [4]. In 
addition to chromosome loss, medulloblastomas overexpress certain genes, including c-myc, 
pax5, and zic, all of which encode transcription factors [5-7]. Thus, animal models of brain 
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tumors are required to gain insights into the correlation of genetic alterations and tumor 
phenotype and to better understand how genetic alterations cause malignant neoplasm [4, 8]. 
To better understand the genetic alterations associated with brain tumors in vivo, the fruitfly 
Drosophila melanogaster is an excellent model system for which unprecedented genetic and 
transgenic technologies as well as entire genome sequence information are available [9, 10]. 
Indeed, more than two thirds of the known human cancer genes are thought to have 
Drosophila homologs [11, 12], and various studies have shown that genetic inactivation or 
misregulation of Drosophila oncogenes or tumor suppressor genes lead to neoplasms that 
display characteristic features of malignant growth like in human cancer [13-15]. The level of 
gene and pathway conservation, the similarity of cellular processes, and the emerging 
evidence of functional conservation of Drosophila genes that are homologous to mammalian 
oncogenes or tumor suppressor genes, indicate that studies of tumorigenesis in flies can 
directly contribute to the understanding of human brain tumors [16, 17].  
One of the earlier studies on mutations causing malignant neoplasms in Drosophila examined 
12 recessive lethal mutations affecting the optic neuroblasts and ganglion mother cells in the 
larval brain, the imaginal discs, and the hematopoietic organs [13]. Among others, it could be 
shown, that a mutation in the lethal (2) giant larvae (lgl) gene leads to a failure of the optic 
neuroblasts of the inner and outer formation centers and the ganglion mother cells (GMCs) to 
generate adult neurons. The neuroblasts and GMCs proliferated extensively, causing a  
dramatic enlargement of the larval brain hemispheres. Upon transplantation of neoplastic 
tissue into wildtype hosts, the transplanted tissues invaded the body cavities, the abdomen, the 
thorax, the ovaries, the gut, and the thoracic muscles [13]. 
Further investigation of mutations in the dlg1 and lgl genes revealed that the resulting 
phenotypes exhibited most of the characteristics defining neoplastic growth in vertebrates, 
including rapid growth both  in situ and in culture, defective intercellular junctions, low 
adhesiveness in between cells, defective intercellular communication, absence of terminal 
differentiation, lack of response to ecdysone, invasiveness, and lethality to the host ([13], 
reviewed in [18]). 
Furthermore, it is known that expression of an activated form of RAS1 (RAS1V12) in 
Drosophila imaginal discs is leading to ectopic cell proliferation and hyperplastic tissue 
growth [19]. The mutational activation of the human homolog of Ras is associated with a 
wide variety of human tumors (reviewed in [20]). When RASV12  expression is combined 
with inactivation of scribbled (scrib), lethal (2) giant larvae (lgl), discs large 1 (dlg1), bazooka 
(baz), stardust(sdt) and Cdc42 in Drosophila larvae, migration, invasion of tumor tissue and 
secondary tumor foundation can be found [15]. Another Dosophila gene possessing tumor 
suppressor properties is warts (wts).  Flies homozygous for strong wts alleles show 
overproliferation in the imaginal discs and the central nervous system leading to pupal 
lethality. The observed cellular clones where irregular in shape, unpatterned and formed 
folded lobes. The cells to be found in wts mutant clones were larger than neighboring 
wildtype cells [21]. The mammalian homolog of wts, LATS1, is also known for causing soft-
tissue sarcomas and ovarian stromal cell tumors when mutated in mice [22]. The current 
model of wts / LATS1 function suggests interaction with CyclinA / Cdc2, linking it directly to 
the cell cycle ([23], reviewed in [24]). 
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Mutations in the Drosophila gene salvador (sav) have been associated with increased cell 
growth and an increase in cell number. Also, Sav has been suggested to interact directly with 
Wts and thereby contributing to its function [25].  
 
In this report, we have determined at the full genome level the transcriptional signature of an 
adult brain tumor in Drosophila caused by homozygous mutation in the tumor suppressor 
gene brain tumor (brat). This gene encodes a member of the conserved NHL family of 
proteins, which appear to regulate differentiation and growth. These factors have been directly 
implicated in human tumor formation [26, 27]. Based on the analysis of loss- and gain-of-
function experiments, Brat acts in translation repression, ribosomal RNA synthesis, and 
negative regulation of cell growth [28-30]. Structural analysis indicates that the NHL beta-
propeller is the essential domain for both the translational repression and cell growth 
inhibitory activities of Brat [31]. Inactivation of brat results in neoplastic overgrowth and 
tumor formation in the larval brain and generally causes lethality in the larval third instar and 
pupal stages [32]. It has been hypothesized that in brat loss-of-function larvae the optic 
neuroblasts and ganglion mother cells are incapable of generating neurons and repesent the 
source of the brain tumor [33]. Tumor cells derived from homozygous brat larval brain tissue 
can grow not only in situ, but also after transplantation into adult host flies. The transplanted 
cells grow rapidly, forming metastases and secondary malignant tumors, and finally kill their 
host [34].  
 
Here we focus on the strong neoplastic adult brain phenotype caused by homozygous 
mutation of the bratk06028 allele. To analyze the transcriptional activity associated with this 
brain tumor, we carried out two independent genome-wide microarray expression studies 
using two different oligonucleotide array platforms to compare adult wildtype flies with flies 
displaying the adult bratk06028 mutant brain tumor. Our experiments identified 321 annotated 
genes that showed highly significant (p<0.0001) changes in expression levels due to loss of 
the tumor suppressor activity of brat. One fifth of these genes show homology to known 
mammalian genes involved in cancer formation. We observed significant upregulation of 
genes involved in the control of asymmetric neuroblast division. We also found significant 
upregulation of genes involved in ribosome biogenesis, translation, and RNA processing, 
suggesting a link between the tumor suppressor activity of brat and its role as a translational 
repressor during Drosophila development. 
 
 
Results  
 
Adult homozygous bratk06028 mutants show a strong neoplastic brain phenotype 
The brat mutant allele bratk06028 was generated by a Plac W transposon insertion in the non-
coding Exon 4 of the brat locus lying immediately upstream of the transcriptional start site 
[28, 32]. Larvae homozygous for this insertion manifest a strong neoplastic brain phenotype. 
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We found that 15% (n=979) of homozygous bratk06028 mutants eclose. These homozygous 
adult bratk06028 mutants show limited motility compared to Oregon R wildtype flies and their 
lifespan is strongly reduced; most of the homozygous bratk06028 mutants die after the first 10 
days. Histological analysis showed that homozygous adult bratk06028 mutants display a 
pronounced overproliferation in their brains as compared to Oregon R wildtype brains (Figure 
1). The penetrance of this phenotype is 100% (n = 300). Most of the newly hatched bratk06028 
mutants showed a head capsule completely filled with neoplastic tissue. In addition, we 
observed ectopic neuropil-like structures; these structures appeared bilaterally in ventro-
medial positions dorsal to the central brain complex and more ventro-laterally to the optic 
lobes (Figure 1B, arrowheads). In paraffin sections the size of the central brain structures and 
the optic lobes of bratk06028 mutants appeared reduced as compared to the wildtype, however, 
the overall morphology of neuropil subdivisions in these brains was retained.   
 
Transcriptional signature of the adult bratk06028 mutant brain tumor 
In order to gain insights into the genetic alterations associated with a fully developed brain 
tumor in vivo, we determined at the full genome level the transcriptome of the neoplastic 
brain tumors caused by homozygous bratk06028 mutation as compared to wildtype brain. To 
ensure cross-validation and increased significance of our results, we conducted two 
independent genome-wide gene expression studies to compare wildtype flies with 
homozygous bratk06028 flies using two different oligonucleotide array platforms (Table1). In 
the first experiment, RNA was extracted from homozygous adult bratk06028 fly heads and from 
isolated adult fly heads of Oregon R as control. The labeled cRNA of this experiment was 
hybridized to custom made full-genome GeneChips (roDROMEGa, experiment A). In the 
second experiment, RNA was extracted from dissected adult brains, and hybridization of 
labeled cRNA to commercially available full-genome Gene Chips involved a signal 
amplification step (DrosGenome1, experiment B; see materials and methods). Moreover, in 
this second experiment, the transcriptome of dissected adult brains of homozygous bratk06028 
mutants was compared to dissected adult brains of flies generated by transposon excision of 
the bratk06028 P-element (termed bratk06028 jumpout, see materials and methods). Precise 
transposon excision resulted in reversion of the bratk06028 neoplastic brain phenotype to 
wildtype-like brain (data not shown).  
 
Stringent quality control and filtering for the two resulting data sets was done independently 
(see materials and methods). After analysis, 1778 transcripts in the wildtype condition and 
2955 transcripts in the bratk06028 condition of experiment A were statistically judged as 
present.  This represents 12.7% and 21% of all transcripts on the roDROMEGa array, 
respectively. In experiment B, 5063 transcripts were judged as present in the wildtype-like 
bratk06028 jumpout condition and 4981 in the bratk06028 condition. This represents 36.3% and 
35.7% of all transcripts on the DrosGenome1 array, respectively. Transcripts in both datasets 
were considered as differentially expressed when the change between conditions was larger 
than 2-fold, their signal strength was above 10 in the condition with the higher expression 
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level, and the change had a significance value of p≤0.0001 (t-test). In experiment A 725 
transcripts were judged as differentially expressed, whereas in experiment B 1888 transcripts 
were judged as differentially expressed in the bratk06028 tumor condition (Table1).  
 
The core set of genes differentially expressed in bratk06028 neoplasms 
To strengthen the significance of our data, we considered those genes for further analysis that 
passed the filter criteria in both experiments. This was the case for 321 transcripts, 
representing a core transcriptional signature that characterizes the neoplastic tissue of adult 
homozygous bratk06028 mutants in a highly reproducible manner (Table 1). In both 
experiments, the majority of the 321 differentially regulated genes (279) showed an increased 
expression level in neoplastic adult bratk06028 mutants. 42 transcripts out of 321 differentially 
regulated genes showed a decreased expression level in the bratk06028 condition.  (5 transcripts 
out of the 321 genes showed an opposite differential expression change in experiment A and 
B). As shown in Figure 2, the majority of the 321 genes differentially regulated in bratk06028 
neoplasms displayed comparable expression level changes in both experiments. Only 88 
genes showed significantly higher expression level changes in experiment B as compared to 
experiment A.  This may be due to the fact that in experiment B cRNA hybridization to the 
array involved a signal amplification step (see materials and methods).  
 
The 321 genes differentially expressed in both experiments were grouped into functional 
classes according to their annotation in Flybase. The function of most of the differentially 
expressed transcripts were unknown (n=67).  A list of these genes is shown in Figure 8.  The 
remaining genes of known function were grouped into the functional classes metabolism 
(n=56), cytoskeleton/structural proteins (n=31), RNA binding/processing (n=27), 
transcription/replication/repair (n=20), translation (n=19), cell cycle (n=18), transcriptional 
regulation (n=17) chromatin structure (n=13), signal transduction (n=12), chaperones 
(n=11), transport (n=10), proteolytic systems (n=8), stress response (n=7), cell surface 
receptors/CAMs/ion channels (n=4), and apoptosis (n=1). You can find a list of these 321 
genes along with the fold change between experiments in Supplementary Table 3 [see 
Additional file 3]. 
 
Genes involved in metabolism, cell cycle and apoptosis 
Neoplastic overgrowth involves essential alterations in cell physiology, loss of cell 
proliferation control and resistance to cell death. Accordingly, we expected to observe the 
differential expression of genes linked to metabolism, cell cycle regulation and apoptosis in 
our gene expression profile studies. Indeed, transcript profiling of bratk06028 mutants identified 
transcripts of this type of which misregulation appears to be associated with malignant 
growth. 
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Among the genes involved in metabolism, we identified 41 transcripts with elevated 
expression levels (Figure 3). These genes included eyes absent (eya), whose activity is 
required for the survival of progenitor cells at a critical stage in eye morphogenesis [35] as 
well as uninitiated (und), the Drosophila methionine aminopeptidase 2, which was shown to 
be a putative regulator of translation initiation required for cell growth and patterning [36]. 
We also detected selenide, water dikinase (SelD) as differentially upregulated in bratk06028 
neoplasms. SelD encodes a product involved in selenocysteine biosynthesis, and mutational 
inactivation in SelD results in a reduction in cell proliferation in the imaginal discs and the 
larval brain [37]. Within the functional class metabolism, we also found 15 transcripts as 
significantly down-regulated in the bratk06028 tumor condition (Figure 3). Among these were 
bubblegum (bgm), encoding a product with long-chain-fatty-acid-CoA-ligase activity. Mutant 
analysis of bgm revealed that in young homozygous mutant flies the optic lobes appear 
normal however as the flies grow older the optic lobes show signs of regional degeneration 
[38].  
 
As expected, all of the transcripts positively regulating cell cycle showed increased expression 
levels in the tumor condition as compared to the wildtype situation. Among these we 
identified cyclin A, cyclin B, cyclin E, string (stg), cdc2, Cdk7, Cks, Set, abnormal spindle 
(asp), fizzy (fzy), polo, and Myb oncogene-like (Myb). These genes are involved in the 
regulation of highly conserved aspects of cell proliferation such as progression through G1, S 
and G2/M phases, spindle orientation and the maintenance of genomic integrity throughout 
mitosis. 
 
Of particular interest is the highly significant upregulation of the genes asp, fzy, rough deal 
(rod), and Myb. asp encodes a microtubule-associated protein that associates with the polar 
regions of the mitotic spindle. Mutants of asp are larval lethal, with a high frequency of 
aberrant (e.g. polyploid) cells arrested in metaphase in the larval brain, suggesting that asp 
may play a role in spindle pole organization during mitosis [39]. fzy encodes a product 
involved in cyclin catabolism and fzy mutants also show metaphase arrest with compact 
condensed chromosomes like asp mutants [40]. rod encodes a product involved in mitotic 
chromosome segregation which is localised to the kinetochore, and mutations in rod result in 
mitotic segregational failure due to delayed or incomplete release of sister chromatids [41]. 
Finally Myb encodes a proto-oncogene with transcriptional activator activity involved in 
centrosome cycle which is required to sustain the appropriate rate of proliferation, to suppress 
formation of supernumerary centrosomes, and to maintain genomic integrity [42].  
 
It is noteworthy that the activity of all of these genes involved in cell cycle regulation has 
been linked to several aspects of neurogenesis [43, 44]. Thus, all of these genes are known to 
be expressed during embryonic and larval development in mitotically active cells of the 
nervous system, the neuroblasts and ganglion mother cells (GMCs), suggesting that their 
elevated levels of transcriptional activity correlate with an elevated and aberrant activity of 
the cell cycle machinery in neoplasms of homozygous bratk06028 mutants.  
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We did not detect any significant alteration of gene expression concerning transcripts 
belonging to the functional class apoptosis, except elevated expression levels for thioredoxin 
peroxidase 2 (Jafrac2), which is involved in the induction of apoptosis [45]. The fact that we 
only identified one transcript involved in programmed cell death suggests that the apoptotic 
program is either impaired below detectability or is unaltered in neoplastic tissue of adult 
bratk06028 mutant brain tumors. 
 
Genes involved in translation and RNA binding/processing 
Recent studies have shown that brat acts as a translational repressor [29]. Moreover, mutant 
analyses demonstrated that brat-mutant cells are larger than wildtype cells and have enlarged 
nucleoli, which are associated with an increase in total rRNA production. Also, the C. elegans 
homolog of brat, ncl-1, is known for being a repressor of RNA polymerase I and III 
transcription and for being an inhibitor of cell growth. Loss of function mutations in ncl-1, 
result in enlarged nucleoli. The rates of rRNA and 5S RNA transcription are increased and 
cells are enlarged. [46]. These data suggest that excess ribosomal synthesis and cell growth 
may be important aspects of the tumorous phenotype of bratk06028 mutants [30]. Indeed, in 
addition to an elevated and aberrant activity of the cell cycle machinery, our gene expression 
profile of bratk06028 adult brain tumors detected genes involved in all aspects of ribosome 
synthesis and translation control. Thus, transcript profiling of bratk06028 mutants identified 19 
transcripts as differentially expressed belonging to the functional class translation and 27 
transcripts as differentially expressed in the functional class RNA binding/processing. All of 
these transcripts showed increased expression level in the tumor condition as compared to the 
wildtype situation (Figure 4).  
 
Among the transcripts that belong to the functional class translation we identified Eukaryotic 
initiation factor 1A (eIF-1A), Eukaryotic initiation factor 3 p40 subunit (eIF-3p40), and Int6 
homologue (Int6) that encode proteins with translation initiation factor activity involved in 
protein biosynthesis [47]. Moreover, genes involved in translation elongation factor activity 
like Elongation factor 1α48D (Ef1α48), Ef1γ, and eEF1δ were detected as significantly 
upregulated in the tumor condition. In addition, genes involved in 35S primary transcript 
processing (Fibrillarin, Fib) and in rRNA processing (Nop5) were identified as upregulated. 
Interestingly, we also detected upregulation of Ribosomal protein L1 (RpL) and Ribosomal 
protein L3 (RpL3), both of which encode structural constituent of the ribosome involved in 
protein biosynthesis. RpL3 is of particular interest as it has been mapped to the chromosomal 
region harbouring the M(3) 86D Minute mutation [48]. 
 
Among the transcripts that belong to the functional class RNA binding/processing we 
identified Rrp4 and Csl4, both encoding gene products with 3'-5' exoribonuclease activity 
involved in mRNA processing [49]. Also Developmental embryonic B (DebB) and SC35 with 
pre-mRNA splicing factor activity involved in mRNA splicing were detected as significantly 
upregulated [50]. In addition, Rm62 encoding a product with ATP dependent RNA helicase 
activity involved in RNA interference was upregulated in the tumor condition, as were U2 
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small nuclear riboprotein auxiliary factor 50 (U2af50) and U2 small nuclear riboprotein 
auxiliary factor 38 (U2af38), both encoding products with pre-mRNA splicing factor activity 
involved in mRNA splicing (reviewed in [47]). Within this functional class we also identified 
upregulated transcripts which are involved in various aspects of cell growth and proliferation, 
such as polyA-binding protein (pAbp) which encodes a product with poly(A) binding involved 
in positive regulation of translation. pAbp mutants display cytokinesis defects, and mutant 
analyses demonstrated that pAbp is required to connect the centrosome to the minus-ends of 
free microtubules (reviewed in [47]). Intriguingly, we also detected Small ribonucleoprotein 
Sm D3 (SmD3), which encodes a protein involved in mRNA splicing, as upregulated in the 
brain tumor condition. This is of particular interest since homozygous 12-day old SmD3 
mutant larvae show overgrowth of the brain, hematopoietic organs and imaginal discs and die 
during third instar larval or pupal stages [51]. Finally, we also identified staufen (stau), which 
has been shown to be involved in the asymmetric localization of cell fate determinants during 
neuroblast divisions [52], as upregulated in neoplastic tissue. 
 
Genes involved in chromatin structure, transcription/replication/repair, and 
transcriptional regulation 
In addition to the expected upregulation of genes involved in cell cycle regulation as well as 
ribosome synthesis and RNA processing, we also observed that the basal transcriptional 
machinery was significantly upregulated in the bratk06028 tumor condition (Figure 5). Within 
the functional class chromatin structure we found 13 genes with elevated expression levels. 
Among those are genes involved in various aspects of chromatin modeling such as 
Nucleoplasmin (Nlp), involved in nucleosome spacing, and Nucleosome assembly protein 1 
(Nap1) as well as Chromatin assembly factor 1 subunit (Caf1), both encoding proteins with 
histone-specific chaperone activity [53]. We also detected two suppressors of variegation, 
namely Suppressor of variegation 3-9 (Su(var)3-9) with histone methyltransferase activity 
[54] and Suppressor of variegation 205 (Su(var)205) involved in the establishment of 
chromatin silencing. Interestingly, mutant analysis of Su(var)205 revealed that larval brain 
neuroblasts show cytokinesis defects during mitosis [54]; this is also the case for gluon (glu), 
which we detected as significantly upregulated in the tumor condition. In glu mutants, larval 
brain neuroblasts show distinct abnormalities during chromosome segregation and lethality 
occurs during the late larval stage [55]. 
 
In the functional class transcription/replication/repair we identified 20 genes as differentially 
regulated in the bratk06028 tumor condition, all of them having elevated expression levels as 
compared to wildtype. Among them are the minichromosome maintenance (MCM) genes, 
which encode an evolutionary conserved family of molecules that form an important part of 
the pre-replicative complex, required for DNA replication [56]. We found two members of 
this complex (mcm2 and mcm3) as upregulated in bratk06028 neoplasms. Interestingly, Mcm2 
mutants persist as third instar larvae for several days, and dissection of wandering larvae 
demonstrates that their CNS is smaller than that of wildtype and that they lack identifiable 
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imaginal discs [57]. We also detected mutagen-sensitive 209 (mus209), involved in mitotic 
spindle assembly as upregulated. Mutants of mus209 show abnormal chromosome 
condensation [58], whereas mutations of rad50, a gene involved in DNA repair, result in 
elevated levels of anaphase bridges in dividing cells of third instar larval brain and imaginal 
discs. Moreover, RNA polymerase II 15kD subunit (RpII15), involved in transcription from 
Pol II promoter [59] and absent, small or homeotic disc 2 (ash2), a member of the trithorax 
group were detected as upregulated. Interestingly, mutant alleles for ash2 are larval pupal 
lethals and display imaginal disc and brain abnormalities [60]. 
 
Among the transcripts belonging to the functional class transcriptional regulation, we 
identified two members of the snail family of zinc-finger transcription factors, namely worniu 
(wor) and snail (sna) as significantly upregulated in bratk06028 neoplasms. During wildtype 
embryogenesis, both genes are expressed during neuroblast delamination, and mutant 
analyses suggest that Snail and Worniu function in neuroblasts, around the time of division to 
give rise to ganglion mother cells (GMCs) [61]. Moreover, we also detected upregulation of 
several other transcription factors involved in the control of proliferative activity of 
embryonic and postembryonic neuroblasts. Thus, we identified tailless (tll), deadpan (dpn), 
and castor (cas) as upregulated. tll is expressed in procephalic neuroblasts and required for 
their specification as tll mutants lack the anterior brain [62]. dpn encodes a pan-neural gene 
shown to be expressed in all neuronal lineages during embryogenesis as well as in neuroblasts 
of the larval CNS and in precursors of sensory neurons in imaginal discs. Loss- and gain-of-
function experiments suggest that dpn activity is critical for the proper regulation of cell 
proliferation in the larval brain [63]. cas is involved in a cascade of sequentially expressed 
transcription factors, which translates information on timing of GMC formation [64]. In 
addition, cas is known to be involved in post-embryonic brain development as small 
homozygous somatic mutant cas clones in the adult brain lead to ellipsoid body and 
mushroom body defects [65]. Finally, we also detected diminutive (dm), the Drosophila 
homolog of the proto-oncogene c-myc, as significantly upregulated in the bratk06028 tumor 
condition. Myc genes link patterning signals to cell division by regulating primary targets 
involved in cellular growth and metabolism [66].  
 
Genes involved in cytoskeleton/structural and signal transduction 
In previous studies, histological analysis of bratk06028 mutants indicated that the brain tumor 
phenotype is primarily due to uncontrolled divisions of optic lobe neuroblasts and GMCs 
[33]. Our microarray expression analysis supports the assumption that neuroblasts and/or 
GMCs are at the cellular origin of these brain tumors. This is not only evident by the 
significant upregulation of genes involved in neuroblast delamination and proliferation such 
as wor, sna, tll, dpn, and cas, but also by the elevated transcription levels of specific genes 
belonging to the functional classes cytoskeleton/structural and signal transduction (Figure 6). 
 
In the functional class cytoskeleton/structural, we found high levels of transcription in 
bratk06028 tumorous tissue for the genes miranda (mira) and inscuteable (insc). This is of 
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particular interest, since both proteins play essential roles in the asymmetric localization of 
cell fate determinants during neuroblast divisions. Miranda creates intrinsic differences 
between sibling cells by mediating the asymmetric segregation of transcription factor 
Prospero into only one daughter cell during neural stem-cell division. In insc mutants, mitotic 
spindles in neuroblasts fail to rotate into proper position and neuroblasts divide in random 
orientation resulting in general disorganization of the neuroblast array and defective 
neuroblast morphology (reviewed in [67]). Moreover, we also identified as significantly 
upregulated in the tumor condition ciboulot (cib), an actin binding protein, and the Drosophila 
profilin protein chickadee (chic), both of which cooperate in central brain metamorphosis 
[68]. Intriguingly, expression of big brain (bib) appears to be downregulated in the bratk06028 
tumor condition. bib encodes a product with connexon channel activity, which is required 
autonomously in epidermal precursors to prevent neural development (reviewed in [69]). 
 
Among those transcripts belonging to the functional class signal transduction, we identified 
several members of GTPase signal transduction pathways as significantly upregulated in 
bratk06028 neoplasms. Thus, we identified RacGAP50C, which has GTPase activator activity 
and is involved in Rho protein signal transduction, and also three members of the Ran GTPase 
signal transduction pathway, namely Segregation distorter (Sd), ran, and moleskin (msk). 
Moleskin, for example, appears to be involved in EGF receptor signalling pathway initiation 
of gene expression in response to Drosophila receptor tyrosine kinase signalling [70]. We also 
detected MAP kinase activated protein-kinase-2 (MAPk-Ak2), which has protein 
serine/threonine kinase activity, as significantly upregulated. In addition, we identified Notch 
(N) as significantly upregulated in the bratk06028 tumor condition. Notch encodes a 
transmembrane receptor mediating cell-cell communication, and Notch signalling has been 
implicated in a wide variety of cellular processes, including the maintenance of stem cells, 
specification of cell fate, differentiation, and proliferation [71]. Surprisingly, however, the 
Insulin-related peptide (Ilp2), a component of the insulin signalling pathway, was 
downregulated in the tumor condition. Overexpression of Ilp2 alters growth control in a 
Insulin receptor-dependent manner, suggesting a role for Ilp2 in controlling organismal size 
by augmenting both cell number and cell size of different organs (reviewed in [66]). 
 
Genes involved in cell surface receptors/CAMs, chaperones, proteolytic systems, stress 
response and transport 
Previous studies have shown that tumor cells derived from homozygous brat larval brain 
tissue can grow not only in situ, but also after transplantation into adult host flies. The 
transplanted cells grow rapidly, forming metastases and secondary malignant tumors that 
finally kill their host [34]. This suggests that loss of brat leads to the acquisition of invasive 
and metastatic properties of the resulting tumor cells. This acquisition of invasive and 
metastatic abilities is associated with altered binding specificities of cell adhesion molecules 
(CAMs), the activation of proteases, as well as chaperones and heat shock proteins mediating 
stress response [1, 72]. In accordance with this, our transcriptional analysis of bratk06028 tumor 
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cells identified genes as differentially regulated in the tumor condition belonging to the 
functional classes cell surface receptors/CAMs, chaperones, proteolytic systems, and stress 
response (Figure 7). Within the class cell surface receptors/CAMs we identified Neurotactin 
(Nrt), a transmembrane protein that localizes to cell-cell junctions where it mediates cell 
adhesion and cell signalling, as upregulated [73].  Three other genes belonging to the class 
cell surface receptors/CAMs were differentially downregulated in the bratk06028 tumor 
condition.  Among the classes proteolytic systems, chaperones and stress response, we 
identified genes upregulated like Ubiquitin carboxy-terminal hydrolase (Uch), involved in 
protein deubiquitination, and granny smith with leucyl aminopeptidase activity. Also the 
chaperones T-complex Chaperonin 5 (Cct5) and Cctgamma with chaperonin ATPase activity 
involved in protein folding and the heat shock proteins Hsp27, Hsp26, and Hsc70-4 were 
identified as significantly upregulated in the bratk06028 tumor condition. Finally, we detected 
10 transcripts belonging to the functional class transport as differentially regulated in 
neoplastic bratk06028 tissue. Among these is Pendulin (Pen), an adaptor molecule which is 
expressed in embryonic neuroblasts and the proliferating regions of the larval brain lobes and 
may be required for the normal transmission and function of proliferative signals in the cells 
[74].  
 
Vertebrate homologs of genes differentially regulated in bratk06028 neoplasms are 
involved in mammalian cancer formation 
Our analysis of the 321 genes differentially regulated in bratk06028 neoplasms revealed genes 
involved in general aspects of tumorigenesis such as elevated and aberrant metabolic activity, 
elevated and aberrant activity of the cell cycle and basal transcriptional machinery, as well as 
elevated and aberrant activity of ribosome synthesis and translation control. Considering the 
level of gene and pathway conservation, the similarity of cellular processes, and the emerging 
evidence of functional conservation of Drosophila genes that are homologous to mammalian 
oncogenes or tumor suppressor genes [16, 17], we wondered whether our data might reveal 
any parallels to the genetic alterations associated with mammalian cancer formation. This is 
of particular interest since one of the two human homologs of brat, TRIM3, has been mapped 
to chromosome 11p15 [75, 76], a region that has been termed the “multiple tumor-associated 
chromosomal region 1” due to the presence of numerous cancer-related genes in this region 
[77, 78]. 
 
We therefore searched available databases in order to identify vertebrate homologs of the 321 
genes differentially regulated in bratk06028 neoplasms and to determine their possible 
involvement in mammalian cancer formation. We identified 62 out of 321 Drosophila genes 
as having mammalian homologs, of which misregulation has been associated with various 
types of tumors (see Table 2). Mammalian homologs of genes involved in the regulation of 
conserved aspects of cell proliferation were found to be implicated in mammalian cancer 
formation. Among these are mammalian homologs of cyclins, Cdks, and genes involved in 
various other aspects of cytokinesis and the maintenance of genomic integrity. Thus, the 
 - 152 -
string homolog Cdc25B, encoding a dual-specific phosphatase that mediates cell cycle 
progression by activating cyclin-dependent kinases, has been shown to possess oncogenic 
potential and is frequently overexpressed in human prostate cancer tissues [79]. Drosophila 
CG9993 encodes for a long-chain fatty acid transporter and its rat homolog (FATP) shows 
elevated transcript levels in hepatoma cell lines [80]. Homologs of Drosophila MCM family 
of proteins are known as proliferation markers in vertebrates, and evidence exists that 
HsMCM2 is upregulated in primary human tumor tissue [81]. Furthermore, it has been shown 
that the rate and level of Mcm3 and MCM4 expression appears to be higher in cancer cells 
than in normal proliferating cells of the uterine cervix and dysplastic cells.  
 
Prominent examples of genes involved in mammalian cancer formation are the proto-
oncogenes Myb and Myc. The Myc gene is a central regulator of proliferation, differentiation, 
cell survival, and neoplastic transformation. It is found mutated or overexpressed in up to 
30% of human cancers and the Myc network appears to regulate a large number of genes, 
approaching 10% of human genes [82]. Similarly, the human homolog of Drosophila 
CG9772, called SCFSkp2, is an ubiquitin ligase encoding onco-protein that is one of the 
components of the machinery used to control Myc levels through the ubiquitin pathway. 
Interestingly, this ubiquitin ligase is also required for induction of Myc-responsive genes, 
suggesting that ubiquitination not only promotes Myc turnover but also “licenses” its 
transcriptional activity [83]. Examples of homologous genes involved in human brain tumor 
formation are the tailless ortholog Nr2f1 involved in retinoblastoma, and the homologs of 
Myb (MYB), dm (MYC), and Notch (NOTCH2), whose misregulation has been associated with 
human gliomas [71, 84].  
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Discussion 
 
A core transcriptional signature of neoplastic brain tissue in Drosophila 
In order to gain insights into the transcriptional alterations associated with brain tumors in 
vivo, we have determined the transcriptional signature of an adult brain tumor in Drosophila 
caused by homozygous mutation in the tumor suppressor gene brat. To this end, we have 
conducted two independent genome-wide gene expression studies using two different 
oligonucleotide microarray platforms to compare adult wildtype flies with flies displaying the 
adult bratk06028 mutant brain tumor. Cross-validation of our comparative analysis of adult 
wildtype heads compared to bratk06028 heads versus dissected bratk06028 brains compared to 
dissected adult brains of flies generated by transposon excision of the bratk06028 P-element 
identified a core transcriptional signature of bratk06028 neoplastic tissue. The obtained 
transcriptional signature revealed genetic alterations associated with malignant growth in a 
highly reproducible manner, despite the fact that both the biological material and the array 
platforms used differed considerably between the two experiments. This involved the use of 
stringent filter criteria such as a significance value of p≤0.0001 (t-test). Due to these very 
stringent filter criteria, the 321 transcripts detected as differentially regulated in the bratk06028 
tumor condition probably represent only a subset of genes that could be involved in brain 
tumorigenesis. For example, it has been shown that PTEN plays a crucial role in the highly 
conserved insulin/PI3-kinase (PI3K) signaling pathway involved in cell growth and 
proliferation (for review see [66] and the human homolog of PTEN is frequently lost in 
gliomas (reviewed in [84]). Although we did detect PTEN as differentially down-regulated in 
the brat tumor condition in both experiments, it was not incorporated into the core set of genes 
differentially regulated in bratk06028 neoplasms due to p-values below our cutoff value (see 
supplementary material).  
 
Nevertheless, our genome-wide microarray analysis in Drosophila identified characteristic 
features of malignant growth such as those found in human cancer. Thus, we detected gene 
expression changes indicative of elevated and aberrant metabolic activity, elevated and 
aberrant activity of the cell cycle and basal transcriptional machinery, and elevated and 
aberrant activity of ribosome synthesis and translation control associated with the adult 
bratk06028 mutant brain tumor. Our data are in accordance with assumptions that the vast 
catalog of cancer cell genotypes is a manifestation of essential alterations in cell physiology 
that collectively dictate malignant growth: self-sufficiency in growth signals, insensitivity to 
growth-inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), 
limitless replicative potential, and tissue invasion and metastasis [1]. This is further 
exemplified by the fact that for 20% of the genes differentially regulated in the Drosophila 
bratk06028 tumor condition it was possible to identify mammalian homologs associated with 
various types of tumors. These include homologs of Myb, Myc, cyclins as well as other genes 
involved in cell growth and proliferation control whose misregulation is frequently associated 
with mammalian cancer formation and malignant growth [1].  
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Brat acts as a tumor suppressor during Drosophila brain development 
Brat was originally identified as a growth suppressor of the larval brain of Drosophila, with 
mutant brains growing up to eightfold larger than normal [28, 32]. Loss of brat also conferred 
metastatic potential upon tissues transplanted into wildtype host flies [34]. Moreover, our 
analysis of the bratk06028 allele shows that a substantial amount (15%) of homozygous mutant 
flies eclose and show a strong neoplastic adult brain phenotype with 100% penetrance. These 
data demonstrate that Brat functions as a tumor suppressor during brain development of 
Drosophila. 
 
In general, tumor suppressors act as molecular antagonists to the formation of malignancy, a 
physiological state that is characterized by indefinite cellular growth and division [1]. This in 
turn requires elevated levels of transcriptional activity of genes involved in all aspects of 
aberrant cell cycle activity. Indeed, our genome-wide microarray expression analysis of 
bratk06028 neoplastic tissue revealed genetic alterations that can be attributed to malignant 
growth. We identified essential components of the cell cycle machinery like cyclin A, B, E, 
string and Myb as significantly upregulated in the tumor condition. This elevated cell cycle 
activity is accompanied by significant upregulation of genes involved in DNA replication, 
chromatin structure and cytokinesis, such as gluon, Mcm2 and Mcm3, and the Drosophila 
Myc homolog diminutive. Gain of function of these genes is frequently associated with 
malignant overgrowth and cancer in Drosophila [16]. Moreover, de-regulation of the proto-
oncogenes Myb and Myc characterizes one of the hallmarks of cancer, as the oncogenic 
activity of these genes in turn impairs differentiation and promotes growth [66]. In addition, 
we also observed significant upregulation of the Ran GTPase pathway since three members of 
it, namely Sd, ran, and msk, show elevated expression levels in the bratk06028 tumor condition. 
Recent data suggest that Ran GTPase signalling serves as a positional marker for the 
eukaryotic genome throughout the cell cycle by regulating microtubule nucleation and nuclear 
envelope formation around chromatin (reviewed in [85]). This together with the elevated and 
aberrant activity of several other structural components required for proliferation and 
cytokinesis emphasises the self-sufficiency of the cellular machinery during unrestrained 
growth. 
 
Proliferation control via ribosome synthesis regulation by brat? 
Recent results demonstrate that brat functions to repress ribosomal RNA synthesis and cell 
growth. brat mutant cells are larger than control cells, have enlarged nucleoli and contain 
excess rRNA. Furthermore, brat overexpression inhibits clone and organ growth, and leads to 
a decreased level of rRNA per cell [30]. Based on these observations it has been suggested, 
that in contrast to the cell growth regulation pathway of the insulin receptor and its effectors, 
brat affects cell growth not through the activity of ribosomes, but rather through the 
regulation of their synthesis [30]. Indeed, disruption of one or more of the steps that control 
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protein synthesis has been associated with alterations in the cell cycle and regulation of cell 
growth. For example mutations that inactivate the tumor-suppressor activity of RB or p53, or 
both, result in aberrant upregulation of essential components in the protein synthesis 
machinery and increase ribosome biogenesis, leading to enhanced mRNA translation rates 
(reviewed in [86]). Among the 321 genes differentially regulated due to loss of the tumor 
suppressor activity of brat, we identified several genes involved in ribosome biogenesis and 
RNA processing as significantly upregulated in neoplastic tissue. One of the most prominent 
examples is ribosomal protein RpL3 which maps to the chromosomal region harbouring the 
M(3) 86D Minute mutation [48]. However, although we observe several genes involved in 
protein synthesis and ribosome biogenesis as differentially upregulated in the bratk06028 tumor 
condition, it remains to be determined whether these phenomena represent the cause or 
consequence of tumor formation. 
 
Neuroblast polarity and asymmetric division 
Interestingly, we find that inscuteable (insc), staufen (stau), snail (sna), miranda (mira), and 
worniu (wor) have elevated transcript levels in bratk06028 brain tissue. Both insc and stau are 
involved in asymmetric segregation of cell fate determinants in dividing neuroblasts and insc 
expression is thought to be regulated by sna [52, 61]. Miranda is an adaptor protein involved 
in the distrinution of the Prospero gene product. Prospero is required to  distinguish the 
proliferative capabilities of NBs and GMCs [67]. As it is known that the Discs large (Dlg), 
Scribble (Scrib) and Lethal giant larvae (Lgl) tumor suppressor proteins regulate multiple 
aspects of neuroblast asymmetric cell division these findings strengthen the link between 
tumorigenesis and asymmetry in cell division [87]. 
 
 
 
Conclusions 
Taken together, our genome-wide microarray expression analysis of an adult brain tumor in 
Drosophila caused by mutation in the tumor suppressor gene brat identifies a core set of 
genes whose deregulation can be attributed to the genetic alterations associated with tumor 
formation and malignant growth. We detect aberrant and elevated activity in the transcription 
of genes involved in metabolic activity, cell cycle regulation, cytokinesis, as well as in basal 
transcriptional regulation. 20% of the genes we identified as differentially regulated in the 
bratk06028 tumor condition have mammalian homologs whose misregulation has been 
associated with various types of tumors. Moreover, we observed significant alterations in 
transcriptional activity of genes involved in ribosome biogenesis, translation and RNA 
processing due to loss of the translational repressor encoded by brat. This may indicate that 
loss of brat leads to overexpression of ribosomal proteins and increased ribosome function, 
which in turn may cause malignant growth. Considering the evolutionary conservation of 
gene structure and function, we propose that our results obtained by the first genome-wide 
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expression analysis of an adult brain tumor in Drosophila will also be valid for tumor 
formation in mammals. It will now be important to elucidate at the cellular and molecular 
level the mechanisms involved in the genetic alterations caused by mutation of the tumor 
suppressor brat, which ultimately lead to tumor formation, metastasis and invasiveness. 
 
 
Methods 
 
Fly strains and genetics 
The wildtype was Oregon R. The brat allele used in this study is bratk06028, balanced over 
CyO,P{w+mc =ActGFP}JMR1. Flies used for histology and for transcript profiling were 1 to 2 
days old homozygous P{w+mc=lacW},bratk06028 males and females, identified by the absence 
of GFP. For the control condition of the oligonucleotide array experiment, either wildtype 
Oregon R were used or flies generated by transposon excision of the k bratk06028 P-element. 
Excision of the bratk06028 transposon resulted in several viable strains, which were further 
characterized by genomic PCR. Using the primer pair 
5’AACAACCAAAACAACGGCAACC 3’ and 5’ AAACGGAGATAAGCCGACTTAC 3’, 
flanking the insertion site of the bratk06028 transposon in the brat genomic DNA, a fragment of 
211 bp was PCR amplified and sequenced from both strands. For all characterized strains, this 
sequence was indistinguishable from the genomic brat sequence of Oregon R control flies; 
strain “bratk06028 jumpout” was chosen for further work. For assessing the percentage of adult 
escapers in bratk06028, homozygous third instar larvae were identified by the absence of GFP, 
counted (n = 979) and collected into bottles containing standard food. Bottles were then 
subsequently checked on a daily basis for hatched flies during the following 4 weeks. All flies 
were kept on standard cornmeal/ yeast/ agar medium at 25°C. 
 
Histology 
For sectioning, adult flies were fixed, dehydrated, embedded in paraffin, and cut into 7µm 
sections as described by Heisenberg and Böhl [88]. Sections were mounted on coated glass 
slides with DePeX (Fluka), and neural structures were visualized with a Zeiss Axioskop 
microscope by autofluorescence (wavelength 488nm) and recorded using a Prog/Res/3008 
digital camera (Kontron, Zürich). 
 
Experimental paradigms and oligonucleotide arrays 
Two oligonucleotide array experiments were carried out. In the first experiment, a custom-
designed Drosophila oligonucleotide array (roDROMEGAa, Affymetrix) was used [89]. This 
array contains 14,090 sequences representing 13,369 single transcripts encoding Drosophila 
proteins deposited in SWISS-PROT/TrEMBL databases (Celera Genome/BDGP Release 
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no.1; [10] as well as prokaryotic and custom chosen control sequences. This array was used to 
compare the transcriptome from Oregon R control heads with heads of homozygous bratk06028 
flies; 5 replicates were done for the wildtype condition and 6 were done for homozygous 
bratk06028  (experiment A). In the second experiment, a commercially available Affymetrix 
Drosophila full genome array was used (Drosophila Genome Array, Affymetrix) which 
contains probe sets interrogating more than 13,500 genes from Drosophila melanogaster 
(experiment B). Sequences used to design this array can be found in Flybase (version 1). Over 
8,000 of the genes represented have at least one EST/cDNA match. Additionally, 
approximately 5,500 genes were identified using prediction algorithms. This array was used 
to compare the transcriptome of dissected Drosophila brains derived from bratk06028 jumpout 
with that of homozygous bratk06028 brains. 6 replicates were done for each of the two 
conditions. 
 
Preparation of biotinylated cRNA. 
Total RNA was isolated from 100 fly heads or 150 fly brains, respectively, using guanidinium 
isothiocyanate in combination with acidic phenol (pH 4.3) (fast RNA tube green kit from 
BIO101) in a fast prep homogenizer FP120 (Bio 101). After precipitation, RNA was dissolved 
in DEPC-treated water (Ambion) and spectrophotometrically quantified using a GeneQuant 
RNA/DNA calculator (Pharmacia Biotech). The quality of the RNA was checked on a 0.5x 
TBE agarose gel and the samples were stored at -80˚C. cDNA was synthesized upon total 
RNA as a template, using the SuperScript Choice System for cDNA synthesis (Gibco/BRL) 
with a T7-(T)24 DNA primer. This primer (5'-
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(T)24VN-3') was PAGE-
gel purified. For first strand cDNA synthesis, a typical 40µl reaction contained 10 –15µg 
RNA, 200 pmoles T7-(T)24 primer, 500µM of each dNTPs and 800 units reverse 
transcriptase (AMV Superscript II). The reaction was incubated for one hour at 42˚C. Second 
strand cDNA synthesis was carried out at 18˚C for two hours in a total volume of 340µl, using 
20 units E. coli DNA ligase, 80 units E. coli DNA polymerase I and 4 units RNase H in the 
presence of 250µM of each dNTP. After 2nd strand cDNA synthesis, 0.5µl RNase A 
(100mg/ml) (Qiagen) was added and the samples were incubated at 37˚C for half an hour. 
Thereafter 7.5µl proteinase K (10mg/ml) (Sigma) was added and the samples were further 
incubated at 37˚C for another half hour. After cDNA synthesis was completed, samples were 
phenol-chloroform extracted (3 times) using Phase Lock Gel (5 Prime-3 Prime, Inc.) and 
precipitated overnight at -20˚C with 2.5 volumes 100 % ethanol. After precipitation, the 
samples were stored at -20˚C. Biotinylated antisense cRNA was synthesized from the dsDNA 
template, using T7 RNA polymerase (MEGAscript T7 Kit, Ambion, Inc.). A 20µl reaction 
volume contained between 0.3-1.5µg cDNA, 7.5 mM of both ATP and GTP, 5.6 mM of both 
UTP and CTP and 1.8 mM of both biotinylated Bio-16-UTP and Bio-11-CTP (ENZO 
diagnostics) and 2µl 10x T7 enzyme mix. The reaction was incubated at 37˚C for 8 hours. 
Thereafter the unincorporated NTPs were removed by putting the sample over an RNeasy 
spin column (Qiagen). Aliquots of the reaction before and after cRNA synthesis were 
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analyzed by agarose gel electrophoresis. Samples were precipitated overnight at -20˚C, taken 
up in 20µl DEPC treated water and spectrophotometrically quantified. Susequently, the 
biotinylated antisense cRNA was fragmented by heating the sample to 95˚C for 35 min in a 
volume of 25µl, containing 40 mM tris-acetate (pH 8.1), 100 mM KOAc, 30 mM MgOAc. 
After the fragmentation, the samples were placed on ice. 
 
Hybridization and Scanning 
Gene chips were equilibrated at RT and prehybridized with 280µl hybridization buffer (1 x 
MES (pH 6.7)/ 1M NaCl/ 20 mM EDTA/ 0.01 % Tween 20) for 15 min at 45 0C with rotation 
at 60 rpm. Hybridization was done for 16 h at 45 0C (60 rpm) in  a final volume of  220µl 
hybridization buffer, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml acetylated BSA containing 50 
pM control oligo B2, spiked bacterial control RNAs (BioB, BioC, BioD, cre) and 15µg 
fragmented biotinylated cRNA. After hybridization, the arrays were briefly rinsed with 6 x 
SSPE-T buffer (0.9 M NaCl/ 0.06 M NaH2PO4/ 6mM EDTA/ 0.01 %Tween 20). Washing and 
staining were carried out on a Fluidics station 400 (Affymetrix, MAS 5.0) using 100 mM 
MES, 0.1M NaCl, 0,01 % Tween 20 as stringent wash buffer. Two different staining 
protocols were used. When comparing the transcriptome of Oregon R fly heads and 
homozygous bratk06028 fly heads, staining was carried out in 220µl 1 x MES buffer, 2.0 mg/ml 
acetylated BSA, 10 ng/ ml StreptavidinR-phycoerythrin conjugate (Molecular Probes) at 40 
0C for 15 min. In the second experiment comparing dissected brains of bratk06028 jumpout flies 
with homozygous bratk06028 brains, an additional antibody amplification step was included. 
Prior to staining, 220µl 1 x MES buffer containing 2 mg/ml acetylated BSA and 2µg/ ml 
biotinylated anti-streptavidin antibody (Vector) was applied onto the array for 30 min at 40 
0C. Following a washing step, staining was then performed using streptavidinR-phycoerythrin 
as described above. Following a final washing step, arrays were scanned with a commercial 
confocal laser scanner (Agilent).  
 
Data analysis 
The single arrays were analysed using Microarray Suite 5.0 (Affymetrix). Detailed analysis 
was carried out using Race-A (Roche), Excel2000 and Access2000 software (Microsoft), and 
GeneSpring (Silicon Genetics). In this process, the mean of all signal values of each array 
were set to 1, and all other signal values were expressed relative to it (normalization). A 
Nalimov outlier test was performed [90]. The data was grouped into control- and 
experimental conditions. For every gene in all 4 conditions a single mean signal value over 
the replicates was calculated. Also an unpaired t-test was performed for every gene per 
experiment to assess significance of change between conditions. The annotation of the two 
different arrays was linked (see below) using information from NetAffx [91] and Flybase 
[92]. Genes were judged as present when their presence attribute in the RACE-A software 
was above 0.75. Both datasets were filtered using a cutoff on the mean signal (≥ 10 in the 
condition the gene had to be present in), the changefold (≥ 2) and the t-test (≤ 0.0001). The 
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various control sequences present on the arrays were excluded from analysis. Subsequently 
the overlap of the two datasets was calculated using the database mentioned above. When 
more than one probe set was representing a gene the probe set with the highest statistical 
significance as judged by the t-test was chosen. In those cases were the p-value was identical, 
the probe set with the higher expression levels was chosen. 
The raw data of the two experiments can be found in Supplementary Table 1 and 
Supplementary Table 2 [see Additional files 1 and 2]. 
 
Linking the two different oligonucleotide arrays 
Using the probe set annotation information provided for the roDROMEGa array, we 
determined which probe sets on the Affymetrix "DrosGenome1" GeneChip were analogous to 
those on the Roche custom chip. To this end, a database was built with the following 
information: 1) Affymetrix "DrosGenome1" probe set annotations, 2) roDROMEGa 
annotations, and 3) FlyBase gene annotations. 
 
The Affymetrix "DrosGenome1" annotations were extracted from the June 2003 
DrosGenome1_annot_csv.zip file obtained from the NetAffx [91] Affymetrix web site 
(http://www.affymetrix.com/analysis/download_center.affx). The database tables contained 
probe set ID, gene symbol, FlyBase FBgns, and synonyms as annotated by Affymetrix for 
each of the 14,010 probe sets on DrosGenome1. The roDROMEGa array annotations were 
extracted from text dump files obtained from Roche. The database table contained probe set 
ID and gene symbol information for each of the 14,090 probe sets on the Roche custom chip. 
FlyBase gene annotations were extracted from the 29-08-2003 FlyBase genes dump file 
located at ftp://flybase.org/flybase/genes/genes.txt. The resulting database tables contained 
gene symbol, FBgns, and synonyms for all 43,177 annotations in FlyBase. During extraction 
of Affymetrix DrosGenome1 and FlyBase annotations from their source files, special cleanup 
was required to correct from HTML escape characters commonly used in Drosophila 
melanogaster annotation dump files. This was necessary because the annotations for the 
roDROMEGa array contained only fully spelled out words for gene symbols (i.e. 'alphaCop' 
instead of '&agr;Cop'). 
 
The 14,090 probe sets on the Roche custom Drosophila microarray represented 13,343 
distinct genes which were mapped to Affymetrix's DrosGenome1. Utilizing the database 
described above, we first mapped gene symbols annotated by Roche on their custom chip to 
gene symbols and synonyms annotated by Affymetrix on their DrosGenome1 chip. This 
search yielded 13,377 probe sets (12,784 genes) on the Roche Drosophila custom chip. The 
remaining 713 probe sets on the Roche custom chip which had no direct gene symbol or 
synonym match to DrosGenome1 were used in a three-way search using FlyBase genes data. 
These 713 Roche gene symbols were searched against all FlyBase gene symbols and 
synonyms and in case of a match all the corresponding FlyBase FBgns for these genes were 
used to search the Affymetrix FBgn annotations on DrosGenome1. This search resulted in 
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additional 449 probe sets (401 genes) on the Roche Drosophila custom chip which mapped to 
analogous probe sets on DrosGenome1. Of the remaining 172 unmapped Roche probe sets, 92 
were found to be either Affymetrix AFFX controls, Roche internal controls, or rRNA 
controls. Thus, 13,826 Roche probe sets (13,185 genes) have at least one analogous 
Affymetrix DrosGenome1 probe set.  172 probe sets (157 genes) on the Roche Drosophila 
custom chip dolfed our parameters and remained orphaned with no Affymetrix DrosGenome1 
match. A list with the orphaned probe sets can be found in Supplementay Table 4 [see 
Additional file 4] 
Functional classification and links to mammalian homologs involved in cancer  
The 321 genes differentially regulated in both experiments were grouped into functional 
classes by reviewing their annotation in Flybase. When there were vertebrate homologs 
annotated in Flybase we searched the PubMed bibliographic database 
(http://www.ncbi.nlm.nih.gov/PubMed/medline.html) for literature that linked the gene in 
question to cancer in vertebrates.  
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Table 1  - Overview of the array experiments  
    
    
   Experiment A Experiment B 
brat tumor adult brat [k06028] heads adult brat [k06028] brains 
RNA source 
control Oregon RS heads brat [k06028] jumpout brains 
Arrays used roDromega full genome Affymetrix full genome 
Number of replicates 
5 Oregon RS against 6  
brat [k06028]
6 brat [k06028] jumpout  against 6 brat 
[k06028]
Signal amplification no yes 
Differentially expressed genes 725 1888 
Overlap between the experiments 321 
Table 1 
Overview of the two independent genome-wide gene expression studies using two 
different oligonucleotide array platforms to compare adult control flies with flies 
displaying the adult bratk06028 mutant brain tumor. Row 1 and Row2 indicate the 
source from which total RNA was extracted. Row 1 indicates source of tumor tissue, 
Row 2 indicates source of control tissue used in the experiments. For experiment A 
(left column), total RNA was isolated from homozygous bratk06028 mutant heads (row 
1) as compared to total RNA isolated from Oregon R wildtype heads (row 2). For 
experiment B (right column), total RNA was isolated from dissected homozygous 
bratk06028 mutant brains (row 1) as compared to total RNA isolated from dissected 
brains derived from flies generated by transposon excision of the bratk06028 P-element 
(termed A2, bratk06028 jumpout; row 2). Row 3 denotes the two different Affymetrix 
oligonucelotide arrays used. Row 4 indicates the number of replicates carried out per 
condition for experiment A and experiment B, respectively. Row 5 displays whether 
or not a signal amplification step has been performed following cRNA hybridization 
to the arrays. Row 6 presents the number of transcripts differentially expressed 
between conditions for experiment A and experiment B, respectively. Row 7 indicates 
the number of genes that passed the filter criteria in both experiments. 
Table 2 
Drosophila genes differentially regulated in bratk06028 neoplastic tissue and their mammalian 
homologs shown to be involved in cancer formation. 
 
Fly gene Mammalian homolog Cancertype 
CG17498 HsMAD2L1 breast cancer 
CycE HsCCNE1 breast cancer 
MAPk-Ak2 HsMAPKAPK2 breast cancer 
Ent2 HsSLC29A1 breast cancer 
CG6546 HsBAF53A breast cancer 
FK506-bp1 HsFK506-bp1 childhood astrocytoma 
cib HsTMSB4X colon cancer 
UTPase HsDUT colorectal 
Ef1gamma HsEEF1G colorectal adenoma 
Aats-ile HsIARS colorectal cancer 
msk HsIPO7 colorectal cancer 
CG8235 HsSCYE1 fibrosarcoma, melanoma 
Bub3 HsBUB3 gastric cancer 
Myb MmMYB glioma 
CG5525 HsCCT4 hepatocelluar and colonic carcinoma 
cdc2 HsCDC2 hepatocellular cancer 
Lam HsLMNB1 hepatocellular cancer 
CG9993  MmFATP hepatoma 7288CTC 
CG31232 HsCCNK Karposi sarcoma 
Aats-his HsHARS laryngeal epithelial carcinoma  
ash2 HsASH2L leukemia 
und HsMetAP2 leukemia 
GTP-bp HsSRPR leukemia 
N HsNotch2 lung cancer, leukemia 
Dpit47 HsTTC4 melanoma 
nop5 HsNOP5/NOP58 melanoma 
btd HsEGR1 melanoma, prostate cancer 
Jafrac2 HsPRDX4 mesothelioma 
Nup98 HsNUP98 myeloid leukemia 
Rm62 HsDDX5 ovarian cancer 
fzy HsCDC20 pancreatic cancer 
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mfas HsTGFBI pancreatic cancer 
CG15000 HsNAB1  prostate cancer 
Hsp27 HsHSPB2 prostate cancer 
CG8142 HsRFC4 prostate cancer 
ran HsRAN prostate cancer 
Ef1alpha48D HsEEF1A1 prostate cancer 
tll MmNr2f1 retinoblastoma 
Ercc1 HsERCC1 squamous cell carcinoma of the head and neck 
CkIIbeta HsCSNK2B squamous cell carcinoma of the head and neck 
GstE1 HsGSTT1 thyroid cancer 
Mipp1 HsMINPP1 thyroid cancer 
CG9344 HsSNRPF uterine cancer 
RnrS HsRRM2 uterine cancer 
SmD3 HsSNRPD3 uterine cancer 
Mcm3 HsMCM3 uterine cervical carcinoma  
polo HsPLK various 
Cyclin A HsCCNA1 various 
Mcm2 HsMCM2 various 
Klp61F HsKIF11 various 
mus209 HsPCNA various 
CG9772 HsSKP2 various 
Fib HsFBL various 
stg HsCDC25B various 
CycB HsCCNB1 various 
Cdk7 HsCDK7 various 
eEF1delta HsEEF1D various 
crc HsATF4 various 
CG8586 HsKLKB1 various 
betaTub60D HsTUBB2 various 
BM-40/SPARC HsSPARC various 
dm HsMYC various 
Table 2 
Drosophila genes differentially regulated in bratk06028 neoplastic tissue and their mammalian 
homologs shown to be involved in cancer formation. Indicated are the Drosophila genes, their 
human (Homo sapiens, Hs) or mouse (Mus musculus, Mm) homolog, and the cancer type for 
which misregulation of the mammalian homolog has been reported in available databases like 
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Flybase and PubMed. References are given in the supplementary material (References for 
table 2) [see Additional file 5]. 
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Additional files 
 
 
Supplementary table 1  
Filename: SupplementaryTable1.xls 
Fileformat: Microsoft Excel2000 
Raw data of experiment A after analysis with the RACE-A package. Column 1: probeset ID, 
column 2: gene symbol, column 3: mean signal for Oregon R heads, column 4: mean signal 
for bratk06028 heads, column 5: fold change between conditions, column 6: T-test describing 
significance of change between conditions. 
Supplementary table 2 
Filename: SupplementaryTable2.xls 
Fileformat: Microsoft Excel2000 
Raw data of experiment B after analysis with the RACE-A package. Column 1: gene symbol, 
column 2: Flybase gene identifier, column 3: mean signal for A2 brains, column 4: mean 
signal for bratk06028 brains, column 5: fold change between conditions, column 6: T-test 
describing significance of change between conditions. 
Supplementary table 3 
Filename: SupplementaryTable3.xls 
Fileformat: Microsoft Excel2000 
All 321 genes the 2 experiments agree on as being differentially expressed between wildtype 
control and bratk06028. Column 1: gene symbol, column 2: Flybase gene identifier, column 3: 
fold change between conditions of experiment A, column 4:  fold  change between conditions 
of experiment B. 
Supplementary table 4 
Filename: SupplementaryTable4.xls 
Fileformat: Microsoft Excel2000 
The 172 probe sets of the roDROMEGa array that could not be linked to any probe set on the 
Affymetrix Drosophila genome 1 array. Column 1: roDROMEGa probe set ID, column 2: 
gene symbol. 
References for table 2 
Filename: References for table 2.doc 
Fileformat: Microsoft Word2000 
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List of references to the literature used for table 2 - mammalian homologs of genes 
differentially regulated in bratk06028 neoplastic tissue. 
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Figure 2
Expression level changes observed for the 321 genes identified in both oligonucleotide array experiments as 
differentially regulated in the brat tumor condition. X-coordinate shows relative fold-changes for each individual 
gene (y-coordinate) depicted in red for experiment A and depicted in orange for experiment B, respectively. Note 
that the two experiments A and B disagree on the differential expression level changes only for five transcripts. 
Please note that the highest expression levels are cut at a value of 80 due to the scaling of the y-axis.
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Differential expression of genes belonging to the functional classes metabolism, cell cycle and apoptosis. Fold-
changes for each gene are shown in red for experiment A and in orange for experiment B, respectively.
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Experiment A
Experiment B
Figure 4
Differential expression of genes belonging to the functional classes translation and RNA binding / 
processing. Fold-changes for each individual gene are shown in red for experiment A and in orange for 
experiment B, respectively.
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Transcription / Replication / Repair
Mcm2
mus209
RnrL
UTPase
Mcm3
CG8142
CG15220
CG9273
ash2
Rrp1
rad50
CG9135
mus210
RfC40
RpA-70
CG6258
Bap60
Ercc1
Rpb8
RpII15
3.17
5.26
5.38
9.81
4.26
3.10
8.01
5.87
5.72
5.12
5.03
4.63
4.13
4.39
4.42
2.95
3.56
2.58
2.80
2.64
17.86
11.50
10.34
10.30
8.87
8.80
7.64
7.08
6.90
6.78
4.34
4.14
2.90
2.82
2.77
2.19
20.99
21.24
26.57
38.79
Chromatin structure
HmgD
DF31
SMC2
Nlp
glu
Nap1
dre4
Caf1
rept
Su(var)205
His2Av
Su(var)3-9
dalao
6.23
4.83
6.25
5.72
3.59
5.00
13.48
3.66
4.41
5.60
3.04
7.69
19.50
14.68
10.62
8.69
7.76
7.26
6.09
5.51
5.44
4.08
3.23
3.20
2.68
20.69
Transcriptional regulation
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2.93
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25.32
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Experiment A
Experiment B
Figure 5
Differential expression of genes belonging to the functional classes chromatin structure, transcription / replication / 
repair, and transcriptional regulation. Fold-changes for each gene are shown in red for experiment A and in orange 
for experiment B, respectively.
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Cytoskeleton / structural
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Signal Transduction
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-3.74
19.25
6.98
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-8.20
Experiment A
Experiment B
Figure 6
Differential expression of genes belonging to the functional classes cytoskeletal / structural and signal transduction. 
Fold-changes for each gene are shown in red for experiment A and in orange for experiment B, respectively.
-178-
Cell surface receptors / CAMs
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Stress response
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Figure 7
Differential expression of genes belonging to the functional classes cell surface receptors /CAMs, chaperones, proteolytic 
systems, stress response, and transport. Fold-changes for each gene are shown in red for experiment A and in orange for 
experiment B, respectively.
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Figure 8
Differential expression of genes belonging to the functional class unknown function. Fold-changes for each gene are 
shown in red for experiment A and in orange for experiment B, respectively.
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9. Discussion 
 
Functional equivalence of hometic proteins and Labial target genes 
Homeotic proteins are evolutionary conserved transcription factors regulating a wide array of 
developmental processes. Albeit the large body of data accumulated about the DNA-binding 
domain of homeotic proteins, only little is known about their target genes.  
We used high density oligonucleotide arrays representing approx. 1500 genes to look at the 
transcriptional profile of transgenic Drosophila embryos carrying the lab gene under control 
of a heat-shock promotor. Heat-shock treatment led to ubiquitous overexpression of labial. 
The transcriptional response in this gain-of-function situation was subject to our 
measurements of relative transcript levels. 
Contrasting results from other labs stating that homeoproteins control the majority of 
zygotically active genes (Carr and Biggin, 1999; Liang and Biggin, 1998), we found a only a 
limited set of genes as being regulated by Labial. These nevertheless included transcripts 
encoding for a wide array of functions. 
A drawback of our approach using ubiquitous overexpression in embryos is the averaging of 
gene expression through several developmental stages and throughout the complete embryo. 
Although array technology can give an accurate image of relative transcript abundance, this 
integration can lead to masking of transcript levels. Especially as homeotic genes are likely to 
show high tissue specificity, activation and repression of a specific gene can occur in different 
tissues at different time points, thereby effectively blurring the transcriptional image 
measured by the array experiment. This could also be a reason for the failure in trying to 
validate the data using in situ hybridization experiments in contrast to the successful 
validation of our results using real-time PCR. 
 
As it is known that the specificity of homeotic proteins is modulated by other proteins, the 
lack of interaction of Labial with candidate co-factors like EXD or HTH (Nagao et al., 1998) 
in the source tissues may further distort our dataset.  
However, our data represents a good starting point for a more in-depth functional analysis of 
candidate labial downstream genes. 
 
Another study focusing on homeotic gene function that was conducted in the course of this 
thesis addressed the role of Labial in specification of the posterior tritocerebrum. Using 
genetic rescue experiments we replaced the labial gene in the developing tritocerebrum with 
all other homeotic genes. With the exception of Abd-B, all were able to replace labial in its 
function of giving segmental identity to this brain region.  
In vitro experiments have demonstrated that homeoproteins by themselves have indeed a low 
DNA-binding specificity and recognize similar nucleotide sequences (Ekker et al., 1994). 
This specificity has to be ensured by other means, for example through interaction with other 
transcription factors or by additional proteins binding to the same target sequence (reviewed 
in (Mann and Affolter, 1998; Mann and Carroll, 2002)). The abovementioned co-factors add 
to the complexity of the issue, as it is known that EXD and HTH are essential for the 
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segmental identity of Drosophila brain neuromeres (Nagao et al., 1998) and that they interact 
with homeoproteins (Chan et al., 1996). 
 
Hints towards why Abd-B is not able to replace labial function in the posterior tritocerebrum 
may be found when looking at the evolution of homeoproteins. Labial and Abd-B are most 
distant from each other in terms of sequence similarity because they represent the most 
ancestral Hox genes (Schubert et al., 1993).  
Interaction of homeoproteins with EXD and the DNA is mediated by the so-called 
hexapeptide, a motif that can be found in all Hox proteins, except in Abd-B (Chan et al., 
1996). This difference in peptide sequence could also be one of the major reasons for the 
functional difference of Abd-B when compared to the other Hox genes and represents a good 
entry point into further functional studies on homeoprotein target genes. 
 
Glial cells missing and regulation of neurogliogenesis 
The glial cells missing (gcm) gene was the focus of a further array study we directed during 
the time of this thesis. gcm encodes for a transcription factor and is thought to be a key 
regulator on the switch between glial and neuronal cell fate. To identify the target genes that 
run the glial differentiation program we used full-genome oligonucleotide arrays to analyze 
differential expression in wild-type embryos compared to embryos in which gcm is 
misexpressed throughout the neuroectoderm. Furthermore, samples were taken at two 
different developmental stages, namely at the time of initial gcm action in neuro-glial 
progenitors (stage 10) and at a later stage with the glial cells already differentiated (stage 
15/16). In both cases hundreds of differentially expressed candidate target genes could be 
found. 
 
The list of differentially regulated genes found in our study in the gcm gain-of-function 
situation demonstrates the complexity of neuroglial fate choice. The dataset represents a 
complicated genetic network. Furthermore, GCM seems to be able to act on all embryonic 
aspects of gliogenesis in Drosophila. This puts the gene into a class together with the Pax and 
Hox genes, for which a similar high-level position in genetic pathway control has been 
supposed. However, no detailed knowledge has emanated yet, that could explain how a single 
transcription factor can achieve such a comprehensive control over various genetic networks. 
Our data shows, that GCM is a direct regulator of a set of factors including REPO, PNTP1 , 
TTK69, and signal transducers such as the FGF-receptor HTL. These are prime candidates for 
the next lower level in regulating neurogliogenesis in the embryo of Drosophila. 
 
Evolutionary conservation of Otd/Otx transcription factors 
Also, we have analyzed the action of the orthodenticle (otd) gene and its vertebrate homolog 
Otx2 using transgenic overexpression and quantitative transcript imaging on the level of the 
complete genome. This resulted in hundreds of candidate target genes of otd and/or Otx2. 
Comparison of the two datasets showed that the otd and Otx2 transgenes control an 
overlapping set of genes in Drosophila. 
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Despite their strong evolutionary conservation, the two proteins display some profound 
differences in their molecular sequence. This can also be seen in the transcriptional profile 
following  overexpression of the transgenes. Otx2 does not seem to be able to replace otd  in 
full, as more than half of the candidate downstream genes of otd do not appear in the Otx2 
dataset. This is in accordance with in vivo experiments focusing on the cross-phylum rescue 
(Leuzinger et al., 1998; Nagao et al., 1998). 
The genes that do show up in both overexpession experiments are likely to embody the 
molecular basis for functional equivalence of the otd/Otx genes. 
 
In our experiments we discovered approximately 300 genes that respond to the overexpession 
of otd in the embryo. This supports the notion that homeoproteins regulate a subset and not all 
of the zygotically active genes in the genome (Leemans et al., 2001). The fact that among 
these genes many transcription factors can be found is consistent with the idea that 
homeodomain proteins are on a high position in the hierarchy of transcriptional regulators 
(Kablar et al., 1996). However, with our array study we are unable to differentiate between 
direct and indirect target genes. 
 
A very interesting finding of our experiments was the greater number of candidate target 
genes yielded by overexpression of the human Otx2 gene when compared to the Drosophila 
transgene. After quality control 700 genes remained to be significantly influenced by 
overexpression of the human Otx2 transgene. The transcript abundances of otd and Otx2 are 
not likely to be the reason for this discrepancy, as the otd transgene produced higher levels of 
transcript. Reasons for the disparity in target gene number may be a lower binding specificity 
of Otx2 compared to that of the otd transgene, higher promiscuity in co-factor interaction or 
the regulation of additional genetic cascades. 
 
Transcriptional profile of an adult Drosophila tumor 
In our brat array study we compared Drosophila wildtype adult brains with brat mutant adult 
brains. The fact that mutations in the brat gene cause brain tumors late larval stages has 
already been shown (Arama et al., 2000). Looking at the adult escapers of the bratk06028 line 
gave us the possibility to compare the transcriptome of a tumor in full effect with that of  
normal brain tissue.  
We have conducted two independent genome-wide gene expression studies using two 
different oligonucleotide microarray platforms. Subject of the comparison were adult wildtype 
flies and flies displaying the adult bratk06028 mutant brain tumor. The two experiments were 
cross-validated to identify a core transcriptional signature of bratk06028 neoplastic tissue.  
 
Albeit the considerable differences between the two experiments in terms of  the biological 
material and the array platforms, a highly reproducible transcriptional signature of malignant 
growth could be generated.  
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Due to very stringent quality control (t-Test p≤0.0001) the 321 transcripts detected as being 
differentially regulated in the bratk06028 tumor condition probably represent only a subset of 
genes that could be involved in brain tumorigenesis. An example for a gene that did not make 
it into our core dataset is PTEN. It is a protein with important function in the highly conserved 
insulin/PI3-kinase (PI3K) signaling pathway involved in cell growth and proliferation (for 
review see (Saucedo and Edgar, 2002)) and is frequently lost in human gliomas (Zhu and 
Parada, 2002). PTEN was detected as being differentially down-regulated in the brat tumor 
condition. Due to a p-value above our threshold it did not make it into the core dataset. 
However, distinctive transcriptional features of  cancer cells, including those prevalent in 
humans, could be identified. Our dataset includes gene expression changes suggesting 
elevated and aberrant metabolic activity, elevated and aberrant activity of the cell cycle and 
basal transcriptional machinery, and elevated and aberrant activity of ribosome synthesis and 
translation control. 
 
Cancer involves a multi-step process in which a cell has to acquire a variety of traits in order 
to become able to divide continually regardless of cellular environment (Hanahan and 
Weinberg, 2000). This requires a very different transcriptional program when compared to a 
normal neuronal cell. As expected we found a very high amount of genes being differentially 
expressed when compared to wildtype.  
We did not detect any significant alteration of gene expression for transcripts belonging to the 
functional class apoptosis, except elevated expression levels for thioredoxin peroxidase 2 
(Jafrac2), which is involved in the induction of programmed cell death (Tenev et al., 2002). 
The fact that we only identified one transcript in this functional class suggests that the 
apoptotic program is either impaired below detectability or is unaltered in neoplastic tissue of 
adult bratk06028 mutant brain tumors. 
 
It has been speculated that the cellular source of the bratk06028 tumor are GMCs in the optic 
lobes of Drosophila (Kurzik-Dumke et al., 1992). When looking closely at the data we indeed 
find genes of the cascade temporally controlling GMC differentiation. In neuroblast lineage 
development there are five genes expressed in the neuroblasts in a temporally transitional 
manner. These genes are hunchback (hb), Kruppel (Kr), pdm, castor (cas) and grainy head 
(gh). GMCs born at specific time points retain the expression of the currently active gene 
from this cascade and also bequeath it to their neuronal progeny (Isshiki et al., 2001; Skeath 
and Thor, 2003). This is data stemming from embryonic development. 
Interestingly, we find castor, a gene from this cascade, coming up very strongly in the 
bratk06028 tumor brains. Another gene, grainy head is also significantly expressed. As these 
transcripts can also be found in neuroblasts, the possibility remains that neuroblasts are the 
source of the tumor. castor expression could be evidence for relatively late neuroblasts 
continuing to divide and feeding the tumor with new cells, or for late born GMCs transformed 
into cancer cells. So far, no genetic marker is known to differentiate neuroblasts from GMCs 
in the larval stages of Drosophila (Ceron et al., 2001).  
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Interestingly, we find elevated transcript levels of insc, stau, mira, pon and baz in bratk06028 
brains. This result makes it very likely that the cells responsible for this neoplasm are indeed 
either neuroblasts or GMCs. It also makes the pathway controlling asymmetric division of 
neuroblasts a prime candidate for investigating the nature of brat malfunction. The consistent 
differential expression of multiple genes contained in this pathway may even suggest that 
defects in asymmetry are causal for the malignant growth. 
However, a decision as to which of the two cell types are responsible for the fatal proliferation 
can not be helped by these findings. It is still subject to research whether insc does segregate 
into the GMC after division. This question is complicated by the fact that asymmetric division 
of neuroblasts can happen in different modes in the larvae (Ashraf and Ip, 2001; Ceron et al., 
2001). 
Along these lines, the highly significant upregulation of the genes asp, fzy, rough deal (rod), 
and Myb is also of special interest. asp encodes a microtubule-associated protein that 
associates with the polar regions of the mitotic spindle. Mutants of asp are larval lethal, with a 
high frequency of aberrant (e.g. polyploid) cells arrested in metaphase in the larval brain, 
suggesting that asp may play a role in spindle pole organization during mitosis (Saunders et 
al., 1997). fzy encodes a product involved in cyclin catabolism. In fzy mutants display 
metaphase arrest with compact condensed chromosomes similar to asp mutants (Dawson et 
al., 1993). rod encodes a product involved in mitotic chromosome segregation which is 
localized to the kinetochore, and mutations in rod result in mitotic segregational failure due to 
delayed or incomplete release of sister chromatids (Scaerou et al., 1999). Finally Myb encodes 
a proto-oncogene with transcriptional activator activity involved in centrosome cycle which is 
required to sustain the appropriate rate of proliferation, to suppress formation of 
supernumerary centrosomes, and to maintain genomic integrity (Manak et al., 2002). 
The activity of these genes involved in cell cycle regulation has been linked to several aspects 
of neurogenesis (Ohnuma and Harris, 2003; Ohnuma et al., 2001). Thus, all of these genes are 
known to be expressed during embryonic and larval development in mitotically active cells of 
the nervous system, the neuroblasts and ganglion mother cells (GMCs), suggesting that their 
elevated levels of transcriptional activity correlate with an elevated and aberrant activity of 
the cell cycle machinery in neoplasms of homozygous bratk06028  mutants.  
 
Fig. 9. Genes involved in asymmetric division and cellular polarity of neuroblasts. In red rounded fold 
changes in gene expression are depicted when comparing wt adult brains with brat mutant brains. This 
data is from experiment B, comparing dissected brain as RNA source. 
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A very interesting gene showing lower transcript abundance in tumor brains compared to 
wildtype brains was anachronism (ana). It encodes for a secreted glycoprotein that is 
expressed in glia cells and acts as a suppressor of neuroblast proliferation. In ana mutants, 
quiescent postembryonic central brain and optic lobe neuroblasts enter S phase prematurely 
(Ebens et al., 1993). This may be a hint for direct brat action in glia cells or for the neoplastic 
cells affecting gene expression in glia. 
 
It has been shown that hb is expressed in embryonic neuroblasts and that it has a role in cell 
fate specification in the Drosophila central nervous system (Novotny et al., 2002; Urbach and 
Technau, 2003). The translational repression of hb by a complex of Nanos, Pumilio, and Brat 
in the very early embryo might also apply for hb function in later development. However, in 
our transcriptional screen hb shows no differential expression. 
 
As the underlying neuropil structures in adult homozygous bratk06028 flies look very similar to 
those in the wildtype, the cellular phenotype of the tumor most likely does not affect the 
complete population of a cell type. If all neuroblasts, or all glial cells would be affected it 
would be highly unlikely that an even remotely normal neuropil could develop. 
These findings also argue the hypothesis that the tumor starts in the larval optic lobes (Kurzik-
Dumke et al., 1992). Tumor growth emanating from the optic lobes would possibly disrupt 
neuropil structures in this region. On the other hand one could argue, that a tumor developing 
from the cortex of the developing optic lobes could leave the neuropil structure untouched. 
This will be subject to further studies. 
 
Recent studies have shown that brat mutant cells are enlarged compared to control cells, have 
lager nucleoli and possess excess rRNA. This suggests a function of Brat in repression of cell 
growth  and ribosomal RNA synthesis. brat gain-of-function experiments demonstrated 
inhibition of growth in clones and organs, and a decrease of rRNA per cell (Frank et al., 
2002).  These findings may suggest that Brat affects cell growth by regulating ribosome 
synthesis, and not by controlling their activity (Frank et al., 2002), representing an alternative 
way of cell growth regulation independent of the insulin receptor pathway. 
We identified a number of genes involved in ribosome biogenesis and RNA processing as 
being significantly upregulated in the neoplastic tissue. Among these is the ribosomal protein 
RpL3 which maps to the chromosomal region harboring the M(3) 86D Minute mutation 
(Lambertsson, 1998). However, the question whether protein synthesis and ribosome 
biogenesis are cause or consequence of tumor growth in bratk06028  neoplasms cannot be 
answered by interpreting our dataset. 
 
Furthermore, we found that for 20% of the genes differentially regulated in the tumor 
condition it was possible to identify vertebrate homologs associated with various types of 
tumors. Among these were homologs of Myb, Myc, cyclins as well as other genes involved in 
cell growth and proliferation control that are thought to be involved in mammalian cancer 
formation and malignant growth (Hanahan and Weinberg, 2000). This underlines the potential 
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of  Drosophila as a high-speed model system in terms of studying developmentally related 
diseases.  
 
One of the two experiments of our study showed much higher sensitivity than the other (Loop 
et al., 2004). The magnitude of differences can be best appreciated when only looking at the 
second experiment that showed a very good reproducibility and a higher sensitivity than the 
other experiment. With reasonable criteria in terms of quality control (p-value <= 0.01, 
Change more than 2-fold, signal >=10 in the higher condition) we filtered over 3500 genes as 
being differentially expressed in the bratk06028 adult brains. This demonstrates the fundamental 
difference of a cancer transcriptome compared to normal relatively homeostatic brain tissue. 
 
Genome-wide transcript profiling in Drosophila brain development 
Gene expression lies at the basis of most biological processes. This holds especially true for 
developmental mechanisms where it is crucial to gain knowledge about spatio-temporal 
expression patterns of genes. For a long time in biological research transcriptional research 
could only be performed on a gene-per gene basis. With the advent of expression array 
technologies it became possible to monitor gene expression of thousands of genes with a 
single experiment (Duggan et al., 1999; Lipshutz et al., 1999). Drosophila, together with yeast 
and C. elegans, has been leading the way in application of these high-throughput 
technologies, as in these model organisms the complete genomic sequence was available 
early.  
 
In the course of this thesis five complete GeneChip studies were conducted covering different 
functional aspects of Drosophila nervous system development and developmentally related 
disease of the brain. Three of these studies were performed using arrays representing the 
complete fly genome while the other two were based on a custom array, representing only 
about 1500 fly genes. As the technologies mentioned above are relatively young and were 
even more so at the time some of these studies were done, a lot of issues arose in terms of 
what can be done with these tools and how to interpret the results. 
 
Controlling reproducibility of the transcript measurements is a prime step to a successful 
experiment. This can be done by doing statistics on the data. In the simplest case this means 
doing a Student`s t-Test to check if two measurements representing two different conditions 
are really different. To perform these statistical tests there have to be replicates of the 
measurements. During our studies we used at least 4 measurements per condition equaling 4 
arrays. This is rather on the low side. In later studies we used 6 replicates raising the statistical 
power of the tests (Loop et al., 2004). Replicating experiments has proven to be a good way to 
control for between-sample variation and reduce the number of false positives in the resulting 
dataset. 
 
The most crucial part of any experiment is the initial paradigm chosen to conduct it. In the 
case of array experiments the RNA source lies at the core of this problem. In our first study 
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using GeneChips, standard wildtype embryos from the developmental stages 10-17 were 
compared with heatshocked wildtype embryos within the same range of ages (Leemans et al., 
2000). This led to the problem that the resulting transcriptional profile was averaged over time 
and space. It comprised expressional aspects of all embryonic tissues developing during 17 
hours leading to a reduced reproducibility between samples. 
The precision of the transcriptional snapshot can only be as high as the spatio-temporal 
precision that can be achieved in preparing the RNA source tissue. As there is still a 
considerable amount of RNA needed to hybridize a single GeneChip (above 5µg) this poses 
severe problems when very small tissue samples or even single cells are to be investigated. 
When there is too much RNA extracted coming from tissues that are not of interest or from 
time points irrelevant to the experiment, the signal-to-noise ratio in terms of transcriptional 
information will drop. These problems may be overcome by methods like laser 
microdissection (Simone et al., 1998) or cell sorting methods like FACS and MACS 
(Montalta-He, personal communication). Another way to increase the RNA amount is linear 
amplification of the target sequences by multiple rounds of cDNA synthesis and in-vitro 
transcription. This method is thought to introduce only minor artifacts into the measured 
expression profiles (Baugh et al., 2001; Dumur et al., 2004). 
 
Another issue arising with array experiments on the genomic scale is the problem of 
independent validation of the results. As per today, no feasible method has been devised to 
confirm the vast amount of data springing from a GeneChip experiment. In our hands 
verification using real time PCR was a reliable way to confirm expressional changes. 
Furthermore, we used in situ hybridization of RNA to whole-mount embryos, an approach 
that proved to be less sensitive, enabling us only to verify gross changes in gene expression. 
Both approaches are no high-throughput methods and therefore cannot be used to validate 
array experiments in an exhaustive manner. This also means that stringent filtering of the data 
sets and raising the number of replicate experiments is important to push the number of false 
positives down to a reasonable level. 
 
When using array platforms like spotted microarrays and GeneChips one has to be aware that 
the genomic annotation of the different model system is a work in progress. The sequences on 
the array represent a snapshot of the genomic annotation at the time of array-design. This 
sometimes poses problems when updating a dataset resulting from an array experiment to a 
new release of the genome, and when comparing experiments done with different platforms. 
In our array study comparing wt adult brains with tumor brains dissected from brat mutant 
flies, custom software had to be developed to be able to merge data from a custom Drosophila 
GeneChip with that produced with the commercially available Drosophila GeneChip (Loop et 
al., 2004).  
Comparison of data from different platforms not always gives satisfactory results (Michaut et 
al., 2003). The reasons for this may vary, including the above-stated annotational differences, 
or incompatibilities in experimental design. 
The use of arrays to produce transcriptional snapshots is headmost a screen for expressional 
change under different conditions, may they be of genotypic or environmental origin. 
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Depending on how far apart the experimental RNA sources are in terms of qualitative and 
quantitative gene expression, an array experiment will yield a smaller or bigger number of 
differentially expressed genes. In the case of our analysis of the brat mutant brains, the 
resulting dataset of differentially expressed genes would have been in the range of several 
thousands, would we have taken into account the experiment using the commercially 
available array only, and used generally accepted cut-off values for our stringency criteria ( a 
p-value lower than 0.01 is generally considered being “highly significant”) (Loop et al., 
2004). The idea behind our data management was to combine the two experiments using 
different array platforms and a slightly different experimental paradigm to strengthen the 
results and take into account only those genes both experiments agreed on.  
The main differences between the experiments were: using fly heads as RNA source as 
opposed to dissected brains, the different GeneChip platforms and hybridizing to the arrays 
without or including signal amplification. Arguably, amplifying the signal using an antibody 
should be the major reason for differences, as it raises the sensitivity of the method. 
Transcripts of lower abundance can be detected, raising the number of detected differentially 
expressed genes. The noise was not increased by signal amplification, as the reproducibility as 
judged by the number of detected highly significant transcript changes, was still very good 
(Loop et al., 2004).  
 
When compared to the other GeneChip studies done during the period of this thesis, the brat 
study shows the advantages of a defined tissue source. The extremely good statistical outcome 
for many genes has its reason in a lower transcriptional noise level. The wildtype adult brain 
is a complex tissue, nevertheless. Comparing it to a brain containing a high-magnitude tumor 
will clearly show the completely different transcriptional program of cancer cells. 
 
Still, one of the major difficulties a researcher embarking on a full-genome transcription 
profiling experiment has to face, is the sheer amount of data to follow-up. After having done a 
thorough quality control hundreds or thousands of candidate genes may remain. The first 
steps have to include grouping these genes into functional bins. This has become a bit easier, 
recently, as a gene ontology (GO) is being developed (Ashburner et al., 2000). The GO 
consists of three structured, controlled vocabularies that describe gene products in terms of 
their associated biological processes, cellular components and molecular functions in a 
species-independent manner. Integrated into data-mining software like GeneSpring (Grewal et 
al., 2003) the GO becomes a powerful tool in getting insights into the result of high-
throughput expression screens. Even more information can be gathered from an array 
experiment by grouping the genes into specific genetic cascades for which already functional 
data exists (see Fig. 9).  
Having boiled down the dataset to a set of good candidates the biological follow-up has to 
begin. Complete biological follow-up of array experiments yielding thousands of 
differentially expressed genes is a task beyond the capabilities of any lab. Ways around this 
dilemma can be to narrow down the experimental paradigm so that the resulting dataset is 
small. Comparison of the transcriptional profiles of two very similar tissues would be such a 
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case. However, this is not always possible. Nevertheless, such expression studies add to the 
wealth of data the scientific community can use to accelerate research decisions. 
 
The experiments conducted to follow-up array experiments span the complete range of 
methods available in biological research. In case of a classical array study that, for example, 
screens for target genes of a transcription factor, these would include loss- and gain-of-
function experiments using the candidate downstream genes found in the dataset, if possible 
in mutant background of the gene of interest that was used in the array study. This tedious 
gene by gene approach still is the prime way to elucidate functional information on the 
genetic pathways controlling biological processes. 
 
A good way to narrow down a dataset emanating from an array study focusing on 
transcription factors is to apply additional bioinformatics methods like in silico screening for 
enhancers containing binding sites for the protein of interest. This combinatorial approach has 
been exploited to great success in a screen for target genes of the morphogen dorsal (Alon et 
al., 1999). 
 
Of exceedingly high importance will be the setup of standardized ways to annotate and 
publish array data. As more and more ways to analyse it will be devised, standardization is the 
only way to prevent old array data to become to obscure to be instructive. Leading the way 
was the Gene Expression Omnibus (Edgar et al., 2002). The GEO is a high-throughput gene 
expression / molecular abundance data repository, as well as a curated, online resource for 
gene expression data browsing, query and retrieval. Another initiative relevant in this respect 
is MIAME (minimum information about a microarray experiment), describing a minimal set 
of information that has to be included with array experiments to enable the interpretation of 
the results of the experiment unambiguously and potentially to reproduce the experiment 
(Brazma et al., 2001). 
 
The GeneChip studies conducted during this thesis have certainly proven that the method has 
matured to give reproducible results. Array studies have been utilized in a wide range of 
research fields. They do not give instant gratification but produce a huge amount of data that 
has to be tackled with patience. 
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